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Abstract 
Background: Preterm birth (before 37 weeks of gestation) is a major cause of infant 
mortality and morbidity worldwide, and preventing its burden is a health care priority. 
Even in adulthood, individuals who were born preterm perform, on average, worse on 
tests of cognitive functioning than term-born peers do, and may have more mental health 
problems.  
Early growth failure is common among preterm individuals, and some studies have 
suggested that those preterm individuals who grow poorly in infancy have more 
neurodevelopmental problems later on in childhood. It is unclear whether these 
associations persist into adulthood and whether they extend beyond the smallest and 
most immature of preterm infants, to the majority of preterm infants who are born late 
preterm (at 34-36 completed weeks of gestation). It also remains unknown whether early 
postnatal growth patterns predict mental health outcomes - some partly conflicting 
evidence suggests that intrauterine growth restriction at least associates with mental 
health problems.  
The mechanisms explaining the associations between growth and neurodevelopment are 
also unclear. Early growth reflects a number of intertwined early-life environmental 
factors and individual characteristics, and while altering neonatal nutrition can affect 
growth, it is not known whether changes in nutrition can improve long-term 
neurodevelopmental outcomes. It has even been suggested that faster growth and higher 
nutritional intakes during the early postnatal period can present a trade-off between 
improved neurodevelopment and increased cardiovascular risk. 
Methods: The 157 participants of the Helsinki Study of Very Low Birth Weight Adults 
(HeSVA, birth weight <1500g) and the 108 participants of the Arvo Ylppö Longitudinal 
Study (AYLS, gestational age 34-36 completed weeks) examined in this thesis were born 
in Finland between 1978 and 1986. They were invited to adult follow-up visits between 
2004 and 2012. Among these young adults, I examined whether growth in weight, length, 
and head circumference between different early growth periods (between preterm birth, 
term age, and 12 months of corrected age in HeSVA, and between late preterm birth, 5 
and 20 months of corrected age, and 56 months of age in AYLS) was associated with 
performance in neuropsychological tests, with self-rated symptoms of depression, 
attention deficit hyperactivity disorder, and other mental health problems, or with 
diagnosis of mental disorder based on a psychiatric interview in adulthood. In the AYLS 
cohort, the participants also reported final grade point average and special education in 
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comprehensive school. I further examined whether daily intakes of energy in total, of 
energy from human milk, and of carbohydrates, protein, and fats during the initial 
hospitalization, which were relatively low compared to modern recommendations, 
predicted adult cognitive functioning (HeSVA). As growth variables, I used standardised 
residual change scores from linear regression models where weight, length, and head 
circumference z scores were regressed on corresponding measures at previous time 
points, creating uncorrelated residuals that reflect growth conditional on previous 
history. These growth variables were then used as independent variables in linear and 
logistic regression models to predict the outcomes, while taking into account several 
potential confounders including child and parental background characteristics and 
neonatal morbidity.  
Results: Faster growth during the first months of life was associated with better adult 
cognitive functioning in both cohorts. The size and direction of the effects were similar: 
for each SD faster growth in weight, head circumference, and length between birth and 
term age, the HeSVA participants had 0.23-0.41 SD higher general intelligence quotient, 
executive functioning component, and visual memory scores. For each SD faster weight 
gain and head growth from birth to 5 months, and head growth from 5 to 20 months, the 
AYLS participants had 0.19-0.41 SD higher general intelligence quotient and executive 
functioning component scores and grade point average. Those who grew faster also had 
lower odds of having received special education at school. Growth after these time periods 
did not predict cognitive functioning or school outcomes. In contrast, there were no 
consistent associations between early growth and adult mental health in either cohort.  
Even when taking into account several important neonatal complications and illnesses, 
the associations between early growth and adult cognitive functioning could not be 
wholly explained. Neonatal morbidity however seemed to largely account for the 
associations between higher energy intake between the first six weeks of life and better 
cognitive functioning among the HeSVA participants.  
Conclusions: Faster growth during the first weeks and months of life after preterm birth 
is associated with better cognitive functioning, and these associations persist into 
adulthood. The mechanisms explaining these associations are largely unclear, but seem 
outcome-specific. Early intakes of nutrition may reflect or possibly even mediate the 
effects of neonatal morbidity on neurodevelopment, however the neonatal morbidities 
commonly associated with preterm birth do not wholly account for the associations 
between early growth and long-term neurodevelopment. 
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Tiivistelmä 
Tausta: Ennenaikainen syntymä (ennen 37 täyttä raskausviikkoa) on tärkeimpiä pienten 
lasten kuolleisuuden ja sairastavuuden syitä ympäri maailman, ja sen haittojen ehkäisy 
on terveydenhuollossa ensiarvoisen tärkeää. Vielä aikuisuudessakin ennenaikaisesti 
syntyneet suoriutuvat keskimäärin ikätovereitaan heikommin kognitiivisten toimintojen 
testeissä ja heillä on mahdollisesti enemmän mielenterveysongelmia. 
Varhainen syntymänjälkeinen kasvuhäiriö on tavallista ennenaikaisesti syntyneillä 
imeväisillä, ja joidenkin tutkimusten mukaan niillä ennenaikaisesti syntyneillä lapsilla, 
joiden kasvu on heikkoa imeväisiässä, on myös enemmän kehityksellisiä ongelmia 
myöhemmin lapsuudessa. On epäselvää, säilyykö tämä yhteys aikuisuuteen, ja koskeeko 
se pelkästään kaikkein pienimpinä ja ennenaikaisimpina syntyneitä lapsia, vai myös 
hieman ennenaikaisena syntyneitä (34–36 täyttä raskausviikkoa). Ei myöskään tiedetä, 
onko varhainen kasvu syntymän jälkeen yhteydessä mielenterveyteen - osittain 
ristiriitaiset tutkimustulokset viittaavat siihen, että ainakin syntymää edeltävä 
kasvuhäiriö liittyy mielenterveyden häiriöihin. 
Mekanismit, jotka selittävät kasvun ja aivojen kehityksen välistä yhteyttä tunnetaan 
huonosti. Varhainen kasvu heijastelee useita varhaisia, toisiinsa kytkeytyneitä 
ympäristötekijöitä ja yksilöllisiä ominaisuuksia. Vaikka varhainen ravitsemus voi 
vaikuttaa kasvuun, ei tiedetä, voidaanko ravitsemusta muuttamalla vaikuttaa 
myönteisesti ja kestävästi aivojen kehitykseen ja kognitiivisiin taitoihin. On jopa 
ehdotettu, että nopeampi kasvu ja suurempi energiansaanti imeväisiässä voi vaikuttaa 
myönteisesti aivojen kehitykseen, mutta toisaalta lisätä sydän- ja 
verisuonisairastavuuden riskiä.  
Menetelmät: Tämän väitöskirjan kohteena olevaan kahteen aineistoon kuului Pikku-K-
tutkimuksen (engl. Helsinki Study of Very Low Birth Weight Adults) 157 pikkukeskosena 
syntynyttä osallistujaa (<1500g) ja Arvo Ylppö -tutkimuksen (engl. Arvo Ylppö 
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Longitudinal Study) 108 hieman ennenaikaisena syntynyttä osallistujaa (34–36 täyttä 
raskausviikkoa). Nämä osallistujat syntyivät Suomessa vuosien 1978 ja 1986 välillä, ja 
heidät kutsuttiin aikuisiän seurantavaiheeseen vuosien 2004 ja 2012 välillä. Tutkin, 
miten varhainen painon, pituuden ja päänympäryksen kasvu eri ajanjaksoina ennusti 
suoriutumista kognitiivisten toimintojen testeissä, itse raportoituja masennuksen ja 
tarkkaavuus- ja ylivilkkaushäiriön oireita ja muita mielenterveyden ongelmia sekä 
psykiatrisen haastattelun perusteella diagnosoituja mielenterveyden häiriöitä 
aikuisuudessa. Lisäksi Arvo Ylppö -tutkimuksessa osallistujat raportoivat peruskoulun 
päättötodistuksensa keskiarvon ja kertoivat, olivatko saaneet erityisopetusta. Pikku-K-
aineistossa tutkitut kasvukaudet sijoittuivat ennenaikaisen syntymän, lasketun ajan ja 12 
kk korjattua ikää vastaavan ajankohdan välille. Arvo Ylppö -aineistossa kasvukaudet 
sijoittuivat hieman ennenaikaisen syntymän, 5 ja 20 kk korjattua ikää vastaavien 
ajankohtien, sekä 56 kk iän välille. Lisäksi selvitin Pikku-K-aineistossa, ennustaako 
päivittäinen keskimääräinen energiansaanti ja hiilihydraattien, proteiinin, rasvojen, ja 
ihmismaidosta saatavan energian määrä syntymää seuranneena sairaalassaoloaikana 
aikuisiän kognitiivisia taitoja. Nämä ravitsemustasot olivat aineistossani nykypäivän 
suosituksiin verrattuna matalia.  
Kasvumuuttujina käytin standardoituja residuaalimuuttujia. Ne olivat peräisin 
lineaariregressiomalleista, joissa standardoitua paino-, pituus- ja päänympärysmittaa 
kasvukauden lopussa ennustettiin vastaavilla standardoiduilla mitoilla aiempina 
ajankohtina. Näin syntyi residuaalimuuttujia, jotka olivat riippumattomia aiemmasta 
kasvuhistoriasta. Näitä residuaalimuuttujia käytettiin riippumattomina muuttujina 
lineaari- ja logistisissa regressiomalleissa ennustamaan aikuisiän vastemuuttujia samalla 
huomioiden useita mahdollisia sekoittavia tekijöitä, kuten lapsen ja hänen vanhempansa 
taustaan ja varhaiseen sairastavuuteen liittyviä tekijöitä.  
Tulokset: Nopeampi kasvu ensimmäisten elinkuukausien aikana oli yhteydessä 
parempaan aikuisiän kognitiiviseen testisuoriutumiseen molemmissa aineistoissa. 
Näiden yhteyksien kokoluokka ja suunta olivat samankaltaiset: yhden keskihajonnan 
verran nopeampi painon, päänympäryksen ja pituuden kasvu syntymän ja lasketun ajan 
välillä oli Pikku-K-aineistossa yhteydessä 0.23–0.41 keskihajontaa suurempaan 
älykkyysosamäärään sekä toiminnanohjausta ja visuaalista muistia kuvaaviin 
komponenttipisteisiin. Arvo Ylppö -aineistossa yhden keskihajonnan verran nopeampi 
painon ja päänympäryksen kasvu syntymän ja 5 kk välillä, ja pään kasvu 5 ja 20 kk välillä 
oli yhteydessä 0.19–0.41 keskihajontaa korkeampaan älykkyysosamäärään, 
toiminnanohjauskomponenttipisteisiin ja päättötodistuksen keskiarvoon, ja niillä jotka 
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kasvoivat nopeammin, oli myös pienempi todennäköisyys saada erityisopetusta. Kasvu 
näiden ajanjaksojen jälkeen ei ennustanut neurokognitiivisia tai koulusuoriutumiseen 
liittyviä tuloksia. Kasvun ja aikuisiän mielenterveyden välillä ei havaittu johdonmukaisia 
yhteyksiä kummassakaan aineistossa. 
Tutkimuksessa otettiin huomioon useita varhaiseen sairastavuuteen liittyviä tekijöitä, 
jotka eivät kuitenkaan täysin selittäneet kasvun ja aikuisiän kognitiivisten taitojen välistä 
yhteyttä. Vastasyntyneen sairaudet kuitenkin vaikuttivat selittävän suurelta osin ne 
yhteydet, jotka havaittiin ensimmäisen kuuden elinviikon aikaisen korkeamman 
energiansaannin ja paremman aikuisiän neurokognitiivisen suoriutumisen välillä Pikku-
K-aineistossa. 
Johtopäätökset: Nopeampi kasvu ensimmäisten elinviikkojen ja -kuukausien aikana on 
yhteydessä parempiin kognitiivisiin taitoihin aikuisilla, jotka ovat syntyneet 
ennenaikaisesti. Kasvun ja kognitiivisten taitojen ja mielenterveyden kehityksen yhteyttä 
selittävät mekanismit ovat suurelta osin epäselviä, mutta vaikuttavat eroavan riippuen 
siitä, millaiset aikuisiän ominaisuudet ovat tarkastelun kohteena. Varhainen 
energiansaanti voi heijastella tai jopa välittää vastasyntyneisyyskauden sairastavuuden 
vaikutuksia kognitiiviseen kehitykseen, mutta ennenaikaiseen syntymään tavallisesti 
liittyvät komplikaatiot eivät vaikuta kokonaan selittävän varhaisen kasvun ja aikuisiän 
kognitiivisten taitojen välisiä yhteyksiä. 
 
Avainsanat: ennenaikainen syntymä; pikkukeskonen; raskausviikot; syntymäpaino; 
kognitio; älykkyys; toiminnanohjaus; muisti; mielenterveys; masennus; tarkkaavuus- ja 
ylivilkkaushäiriö; päihdehäiriöt; ahdistuneisuushäiriöt; koulutus; kasvu; painonnousu; 
pituus; päänympäryksen mittaus; energiansaanti; ihmismaito; imeväisikäinen; aikuinen; 
riskitekijät; seurantatutkimukset; pitkittäistutkimukset; varhainen 
ohjelmoitumishypoteesi 
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1. INTRODUCTION 
Preterm birth is associated with an increased risk of early morbidity and 
neurodevelopmental impairment, but the majority of preterm infants come to cope well 
as adults. Previous studies have suggested that growth failure after preterm birth is very 
common and may reflect a multitude of factors such as prenatal adversity, early illness, 
and inadequate nutrition, and it is also associated with poorer cognitive functioning in 
childhood. However it remains unknown whether the associations between early growth 
and neurodevelopment persist into adulthood, and whether they extend beyond smallest 
and most immature of preterm infants. It is also unclear whether increased nutritional 
intakes, which can improve short-term growth, translate into long-term 
neurodevelopmental benefits. 
Individuals who are born preterm may also have more mental health problems, but the 
aetiology of these problems seems somewhat different from that underlying cognitive 
vulnerability. It may be that intrauterine growth restriction and its prenatal causes - 
rather than preterm birth per se - is associated with mental health adversity, however the 
evidence is somewhat conflicting. Few studies have evaluated whether growth restriction 
after preterm birth, during the early period which coincides with late gestation among 
term-born individuals, predicts mental health outcomes.  
In the four studies that are included in this thesis, I have examined whether growth after 
preterm birth predicts cognitive and mental health outcomes among two cohorts of 
preterm adults.  The participants of the Helsinki Study of Very Low Birth Weight Adults 
(HeSVA, birth weight <1500g, maximum n=157) and of the Arvo Ylppö Longitudinal 
Study (AYLS, gestational age 34-36 completed weeks, maximum n=108) were born in 
Uusimaa, Finland between 1978 and 1986, and they were invited to adult follow-up visits 
between 2004 and 2012. I review the previous body of literature in Section 2, list the aims 
of the current study in Section 3, describe the cohorts and the methods in Section 4, 
summarise the main results in Section 5, and shortly discuss the findings in Section 6. 
The original publications are presented in the Appendix. 
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2. REVIEW OF THE LITERATURE 
2.1. Definitions and prevalence of preterm birth 
Preterm birth is defined as birth before 37 completed weeks of gestation.1 The rate of 
preterm birth varies greatly by region, from just above 5% in northern Europe to up to 
18% in some areas of Sub-Saharan Africa: worldwide, one in every ten infants is born 
preterm.2  
Preterm birth can be further sub-divided into extremely preterm (gestational age [GA] 
<28 weeks), very preterm (28 to <32 weeks, or, alternatively, <32 weeks), moderately 
preterm (32 to <34 weeks, or, alternatively, 32 to <37 weeks), and late preterm (34 to <37 
weeks) birth (Figure 1).1 The majority of preterm children are born close to the 37-week 
limit of term birth: an estimated 84.3% of preterm births are moderate to late preterm, 
while only 15.6% of preterm births occur at <32 weeks, and 5.2% at <28 weeks.2 The cut-
offs separating different subgroups of preterm individuals based on gestational age, or 
even that dividing infants into preterm and term-born are, of course, somewhat arbitrary: 
different organs experience developmental spurts at different times, and together these 
interlinked changes form the rapid, continuous process of fetal maturation.  
In the case of non-live birth, the lower limit of preterm birth, in contrast to miscarriage, 
has varied by region and over time, making it more difficult to reliably estimate the rates 
of preterm birth worldwide. One 
widely accepted definition, in line with 
the International Classification of 
Diseases, 10th revision, proposes that 
all deliveries at ≥22 weeks of gestation 
or at ≥500 grams of birth weight, and 
any delivery of a newborn who shows 
signs of life, be considered a birth.2 
Over the last 30 years - since around the time the preterm participants of this study were 
born - understanding of gestational age as a crucial determinant of infant survival and 
morbidity has increased, and the assessment of gestational age has become more 
reliable.1 Before, GA simply referred to the time elapsed between the mother's last 
menstrual period (LMP) and birth, and preterm birth was defined as birth at fewer than 
259 days since the first day of the mother's last menstrual period.1 Currently, the single 
Figure 1. Gestational age categories. 
 
 
 
 
Preterm
Late preterm
< 37
34 to < 37
Category Gestational weeks
Moderately preterm 32 to < 34 or 32 to < 37
Very preterm < 32 or  28 to < 32
Extremely preterm <28
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most reliable way of assessing GA is routine ultrasound measurement of fetal size during 
the first trimester.1 Although less reliable due to variation in menstrual cycles among 
women and in the timing of conception in relation to ovulation, as well as recall errors, 
LMP continues to be the most widely used way of estimating GA, and the best available 
approach in many low-income settings.1 External and neurological assessment of the 
neonate, such as the Dubowitz examination, can also help the clinician establish 
gestational age.1 The best estimate of gestational age is often the result of a combination 
of all the available information. 
In addition to gestational age, birth weight has also been used to pick out the most 
vulnerable neonates. The limit of extremely low birth weight (ELBW) is one kilogram, 
and the limit of very low birth weight (VLBW) is 1.5 kg, at which birth weight nearly all 
infants are born preterm; the limit of low birth weight is 2.5 kg (Figure 2).1,3 Easy to 
measure, low birth weight was previously used as a primary indicator of early adversity. 
However, while useful as markers of neonatal vulnerability and immaturity, birth weight 
cut-offs cannot be used interchangeably with gestational age classifications. Firstly, birth 
weight at a given gestational age can vary by several hundred grams between individuals 
and still be considered within normal range. For example, for those born at 37 weeks of 
gestation, the lower limit of term birth, the 10th and 90th centile range of birth weight 
spans from 2.33 to 3.32 kg for girls and from 2.38 to 3.45 kg for boys.4 Secondly, even 
children who are born too small are not necessarily born too early: instead of or in 
addition to low gestational age, lower-than-normal birth weight can reflect a non-optimal 
intrauterine environment which has led to prenatal growth restriction.  
The rate of preterm birth has been increasing during the last decades in most countries 
with reliable data, but the reason for this is not fully understood.2 This trend may be 
partly due to increased registration of extremely preterm births, perhaps because even 
more immature infants now have a chance of survival.2 Changes in obstetric practices, 
increased maternal age and obesity, and increased rates of multiple gestation may also 
explain why the rates of moderate 
and late preterm birth, in particular, 
have increased in some, but not all 
high- and middle-income 
countries.2,5 Fortunately, the most 
recent data suggest that rates of 
preterm birth may finally be in 
Figure 2. Birth weight categories. 
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decline even in some countries that have previously shown an increasing trend, including 
the US.6 
Currently in Finland, where this study was conducted, 5.9% of all children are born 
preterm, and 0.8% are born with VLBW.7 These rates have remained quite stable for 
decades: in 1987, when the Finnish national register of births was first established, the 
rate of preterm birth was 5.6%, and 0.9% of children were born with VLBW.7 
2.2.  Aetiology of preterm birth 
 
Preterm birth can be spontaneous or provider-initiated. Several mechanisms including 
infection, breakdown of immunological tolerance of foreign genetic material, vascular 
abnormality and placental senescence, uterine overextension, cervical changes, and 
stress-related hormonal changes are likely to contribute to the risk of preterm birth. 
Underlying the activation of one or several of these interlinked pathways are a 
multitude of shared risk factors, many of which remain poorly understood. 
Preterm birth is commonly divided into two major subtypes based on its immediate 
cause: the spontaneous and the provider-initiated preterm birth. Spontaneous preterm 
birth occurs after spontaneous onset of labour (regular contractions and cervical change 
before 37 weeks of gestation, accounting for 40-45% of preterm births), or after preterm 
premature rupture of membranes (p-PROM, spontaneous rupture of membranes at least 
1h before the onset of contractions and before 37 weeks of gestation, accounting for 25-
30% of preterm births).8 One third (30-35%) of preterm births are provider-initiated: 
these include induced labour and caesarean section for maternal indications such as pre-
eclampsia, for fetal indications such as intrauterine growth restriction and distress, and 
for non-medical reasons.8–11 However, underlying these different types of preterm 
delivery can be several interlinked pathophysiological pathways and a multitude of risk 
factors.12,13 Although producing an exhaustive list of these aetiological factors - some of 
which almost certainly still remain undiscovered - is not possible, a variety of key 
mechanisms and risk factors for preterm birth are listed in Figure 3.  
The timely onset of labour is orchestrated by a complex pathway of parturition. As the 
result of changes in endocrine and paracrine signalling, such as a decline in progesterone 
action and a complex inflammatory response, the uterine myometrium awakes from its 
quiescence to a contractile state, the cervix ripens to allow for dilation, and the decidua 
becomes  activated  in  preparation  for  membrane  rupture and for the separation of the 
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Figure 3. Main types, proposed mechanisms and key risk factors of preterm birth. 
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Figure 3. Main types, proposed mechanisms and key risk factors of preterm birth.
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chorioamniotic membranes and of the placenta from the uterus.13,14 However, what 
prompts these changes at 40 weeks of gestation, and what causes them to sometimes 
occur prematurely, remains largely unknown: endocrine clocks, inflammatory and 
mechanical factors, and cell senescence have been implicated as interlinked components 
of the pathway leading to parturition, and premature activation of one or several of the 
components can lead to spontaneous preterm birth. 
Infection plays a key role in preterm birth. In more than one in every three cases of very 
preterm birth, placental lesions consistent with acute chorioamnionitis are present, 
suggesting possible infection.15 Transabdominal amniocentesis studies have revealed 
microbial invasion of the amniotic cavity in 10-34% of cases with preterm labour with 
intact membranes, and in 17-58% of cases with p-PROM, however reliably estimating the 
rate of microbial invasion is challenging.8,15 Infections can both activate an inflammatory 
pathway to spontaneous preterm birth, and lead to fetal or maternal distress and 
provider-initiated preterm delivery. The pathogens causing these infections seem to 
mainly originate from the mother's normal microbiota, and can ascend from the lower 
genital tract, or, more rarely, spread through the placenta, through the fallopian tubes, 
or during an invasive procedure.8 Non-intra-amniotic infections and changes in the 
normal microbiota of the mother can also increase the risk of preterm birth, partly by 
predisposing to intra-amniotic infections. These conditions include, for example, 
bacterial vaginosis (OR for preterm delivery 2.19, 95% CI 1.54-3.12),16 periodontal 
disease,17 malaria,1 and viral infections including but not limited to maternal human 
immunodeficiency virus infection.18,19  
The inflammatory pathway to parturition can be activated also in the absence of any 
demonstrable microbial or parasitic infection. One potential reason for this seems to be 
the breakdown of the maternal tolerance of paternal antigens expressed by the placenta 
or by the fetus. This can lead to an immunological response similar to an allograft 
rejection, during which maternal T-cells attack against the foreign material and cause 
inflammatory placental lesions and an increased risk of preterm birth.20  
Placental vascular defects have also been implicated in the aetiology of preterm birth. In 
some cases, during early pregnancy, the utero-placental arteries which supply blood to 
the placenta and thus deliver oxygen and nutrients from the mother to the fetus are not 
formed and remodelled properly. It has been suggested that placental arterial defects 
accelerate placental senescence, which in turn partly triggers the onset of labour through 
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sterile inflammatory signals.21 In addition to increased risk of spontaneous preterm birth, 
defective vascular architecture also contributes to pre-eclampsia and fetal growth 
restriction, which are important indications of provider-initiated preterm birth.22–24 
These problems are also discussed in section 2.4.3.2.  
Abnormal cervical tissue architecture and remodelling are also likely to contribute to the 
risk of preterm birth. For unknown reasons, the cervix may "ripen", or be functionally 
remodelled prematurely.25 Cervical surgery can also increase the risk of p-PROM, 
especially if performed during pregnancy.26 
Multiple pregnancy is a major risk factor for preterm birth, carrying a nine-fold increased 
risk of preterm birth compared with singleton pregnancy.27 A proposed mechanism 
behind the high rates of spontaneous preterm delivery in twin and higher-order multiple 
pregnancies is uterine over-distension, resulting in an inflammatory activation of 
parturition.13 Risk factors for multiple pregnancy include certain ethnic backgrounds, 
advanced maternal age, and the use of assisted reproductive technology and the transfer 
of two or more embryos in particular.28,29 
The release of maternal, placental, and fetal stress-related hormones such as the 
corticotropin-releasing hormone, cortisol, urocortins, and oxytocin is mandatory for 
maintaining homeostasis in the face of diverse external or internal threats to the mother 
and to the fetus. Glucocorticoid signalling in particular has been shown to shape fetal 
development and long-term outcomes.30,31 It would seem that the physiological stress 
response pathways can contribute to the activation of the spontaneous pathway to 
parturition and to complications that call for provider-initiated preterm birth.32 
However, the physiological stress response can be triggered by a variety of physical and 
psychological stimuli in interaction with the genetic and epigenetic build-up of an 
individual,33 and the specific effects of these stimuli on the risk of preterm birth remain 
largely unclear. Physical strain may increase the risk of preterm delivery during 
complicated pregnancies, but for the great majority of expectant mothers, regular 
moderate-intensity physical exercise carries minimal risk and has significant benefits 
such as a reduced risk of gestational diabetes.34 Psychosocial stress - and, some argue, 
subjective perception of stress in early pregnancy in particular - may predict preterm 
delivery to a moderate degree, and behavioural, infectious or inflammatory, and 
neuroendocrine mechanisms have been hypothesised to underlie this association: 
however, the relationship remains controversial.35–38  
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Furthermore, several aspects of the mother's background and medical history may help 
estimate the risk of preterm delivery even though the mechanisms underlying these 
associations are unclear. One of the strongest and most obvious risk factors for preterm 
delivery is having had a preterm delivery in the past: women who have given birth to a 
preterm singleton have a recurrence risk of 20% in the current singleton pregnancy.39 
Another, weaker maternal background risk factor is low education.40 For example, in 
Finland in the late 1980's, soon after the birth of our cohort members, the risk of preterm 
delivery was somewhat higher for women with basic, compared with tertiary education 
(OR 1.44 [95% CI 1.17-1.77] for very preterm birth, and OR 1.58 [95% CI 1.41-1.76] for 
moderately preterm birth).41 Other markers of low socioeconomic status, such as 
residence in poor neighbourhoods have also been shown to associate with preterm 
delivery (OR 1.23, 95% CI 1.18-1.28 for most vs least deprived quintile).42 Black women 
may be twice as likely as white women to give birth preterm (OR 2.0, 95% CI 1.8-2.2), 
based on studies conducted mainly in the US: both genetic and environmental factors 
may contribute.43 Overweight and obesity increase the risk of preterm delivery, and the 
higher the body mass index (BMI), the higher the risk: for example, for extremely preterm 
delivery, mothers with an early-pregnancy BMI of 25-30 had an adjusted OR of 1.23 (95% 
CI 1.13-1.35), and mothers with a BMI >40 had an OR of 2.91 (95% CI 2.21-3.83), 
compared with normal-weight mothers in a large Swedish register cohort.44  Maternal 
smoking is also a risk factor for preterm birth, especially when continued throughout the 
pregnancy.45 Maternal exposure to ambient fine particulate matter may also increase the 
risk of preterm birth.46  
Finally, genetic factors influence the duration of pregnancy.47 A very recent genome-wide 
association study identified six loci that are associated with gestational duration and 
preterm birth: the implicated genes have previously been shown to play a role in uterine 
development, inflammatory and immunological pathways, and vascular function.48 
Nonetheless, the genetic determinants of preterm birth remain largely elusive. 
2.3. Early mortality and morbidity among preterm infants 
 
Preterm birth is a key risk factor for neonatal mortality and morbidity including, for 
example, respiratory morbidity, infection, gastrointestinal problems, metabolic 
disturbances, and retinopathy. The brain of the preterm neonate is also susceptible to 
lesions and to disturbances in maturation. Underlying this vulnerability are a number 
of immaturity-related factors, many of which remain unclear. With decreasing 
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gestational age at birth, the frequency and severity of these problems tend to increase, 
and some illnesses are quite specifically confined to the most immature of preterm 
infants. 
2.3.1. Mortality 
Preterm birth is the leading cause of neonatal death in the world, and the most common 
cause of child death in almost all high- and middle-income countries.1 Worldwide, more 
than a million children die each year from complications of preterm birth, making 
preterm birth second only to pneumonia as the most common cause of child death.1 For 
those who survive, the long-term risk of morbidity including neurodevelopmental 
problems is increased. In principle, the lower the gestational age at birth, the greater the 
risk of immaturity-related health problems and long-term morbidity, and the higher the 
costs of early care.  
Degree of prematurity is also the most obvious and important determinant of mortality 
among preterm infants. In large (>1000 individuals) European and US cohorts born in 
the 21st century, rates of survival to discharge improve from 5% or less for infants born at 
22 weeks of gestation, to 90-92% for those born at 28 weeks of gestation, as shown in 
Figure 4.49–51 In Finland, detailed national perinatal data that are currently available for 
the first week of life reveal 1st week mortality rates of 15% for extremely preterm (<28 
weeks), 2.1% for very preterm (28 to <32 weeks), 0.49% for moderately (32 to <34 
weeks), 0.30% for late preterm (34 to <37 weeks), and 0.032% for term (37 to <42 weeks) 
infants born alive in 2015.7 
Close to the lower limit of viability, survival rates across hospitals and countries vary 
considerably. In low-income countries, more than two in every three very preterm infants, 
and almost all extremely preterm infants die during the neonatal period.1 Even in high-
income settings, differences can be quite striking: for example, in a recent large Japanese 
cohort, much higher discharge survival rates than those depicted in Figure 4 were reported 
(37% and 64% for infants born at 22 and 23 weeks of gestation, respectively).52 The 
differences between countries and hospitals are likely to arise heavily from differences in 
treatment practises. To illustrate, one US study found that the interquartile ranges for 
hospital rates of active treatment within the US alone were 8-100% among infants born at 
22 weeks, 52-97% among infants born at 23  weeks, and 95-100% among infants born at 
24 weeks of gestation.53 
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Survival rates have increased over time, reflecting improved maternal and infant care.49,54 
Since the late 1970s and early 1980s, when our cohort members were born, the chances of 
survival have increased for extremely preterm infants in particular. In 1978-1985, 71% of 
VLBW infants survived into early childhood in the Finnish region of Uusimaa, where our 
participants were recruited: 20% of all the VLBW infants died within the first week of life.55 
In 2011-2013 in the same region, 92% of VLBW and/or very preterm infants survived to 
the age of one year: 5% died within the first week of life.56 
Figure 4. Rates of survival to discharge in proportion to the number of live births according to 
gestational age at birth in the EPICure (born in the UK in 2006),49 EPIPAGE-2 (born in France in 
2011)50 and NICHD NRN (born in the USA in 2000-2011)51 cohorts. 
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2.3.2. Respiratory morbidity 
When a newborn takes his or her first breaths, the alveoli fill up with air, putting in motion 
a cascade of physiological changes that enable infants to rely on their own lungs for gas 
exchange, instead of depending on the placenta. However, lungs are slow to reach this 
ability to adapt to the extrauterine environment, compared with many other vital organs, 
and respiratory problems often form the most immediate threat to the preterm neonate. 
It is no surprise that improvements in the treatment of these problems have become some 
of the most important hallmarks of neonatology. In the late 1980s and 1990s, exogenous 
surfactant, which prevents the collapse of alveoli, became commercially available, and the 
antenatal administration of corticosteroids, which promote fetal lung maturation, became 
standard treatment for women at high risk of preterm delivery.1,49,54 Respiratory support 
strategies have also changed: non-invasive ventilation, such as nasal continuous positive 
airway pressure have reduced the need of mechanical ventilation and, in some cases, its 
complications.57   
Even so, respiratory distress syndrome (RDS) affects almost all extremely preterm 
infants,58 and even infants born late preterm at 34 weeks of gestation have a 40-fold risk 
of RDS, compared with term-born infants.59 Among preterm neonates, the cause of RDS 
(previously called hyaline membrane disease), is the deficiency of alveolar surfactant 
combined with the structural immaturity of the lungs, commonly leading to cyanosis, 
grunting, retractions, and tachypnoea very soon after birth.57 In severe cases and if 
untreated, RDS may result in progressive hypoxia, respiratory failure, and death, but for 
most neonates, problems usually begin to resolve within a few days.57 
Among very preterm infants, early respiratory distress may also be followed by a chronic 
pulmonary disease, bronchopulmonary dysplasia (BPD). First described by Northway et 
al. in 1967 as lung injury in preterm infants resulting from oxygen and mechanical 
ventilation,60 BPD in the 1970s and 1980s used to present with typical radiographic 
findings of pulmonary cysts and hyperinflation from approximately one week of age 
onwards, along with cyanosis and a prolonged need for oxygen treatment.60–62 However, 
after the prevention and management of respiratory distress improved in the 1990s, the 
radiographic findings became more rare, and BPD was re-defined as the use of 
supplemental oxygen at 36 weeks of postmenstrual age.63 Nowadays, somewhat more 
detailed, severity-based criteria are often used, recognizing mild BPD after prolonged 
oxygen treatment even when the infant at 36 weeks is breathing room air.61 Using this 
definition, two-thirds of extremely preterm infants suffer from BPD, and severe BPD 
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affects about 18% of extremely preterm infants, according to a large US study of infants 
born in 2003-2007.58 Close to the upper limit of very preterm birth, severe BPD becomes 
increasingly rare, affecting only a few percent of infants born at 29 to 31 weeks.50  
In late preterm infants, BPD is absent, but the risk of respiratory distress and failure, 
transient tachypnoea of the newborn, persistent apnoea and bradycardia, pulmonary 
hypertension, pneumothorax, pneumonia, and the need for interventions is still higher 
than in term-born peers, and sparse evidence suggests that the risk of long-term 
respiratory consequences may be increased.59,64,65  
2.3.3. Central nervous system morbidity 
Intraventricular haemorrhage (IVH), or periventricular-intraventricular haemorrhage, 
results from bleeding in the germinal matrix, a layer from which first neurons and later 
glial cells arise during fetal development.66,67 This highly vascularised fetal structure 
generally disappears by term age, but in the very preterm infant, its capillaries' fragility 
and inability to auto-regulate cerebral blood flow make is susceptible to bleeding, 
especially during the first few days after birth.66,67 In addition to low gestational age, 
disturbances in cerebral blood flow and haemostasis contribute to the pathogenesis of 
IVH, and its risk factors include hypoxia, severe RDS, patent ductus arteriosus (PDA), high 
ventilator pressure, prolonged labour, vaginal delivery, septicaemia, and 
thrombocytopenia, whereas antenatal corticosteroid use protects against IVH.67–70 
Further, genetic and epigenetic differences in the areas of the genome that contribute to 
coagulative and inflammatory pathways have been implicated in the pathogenesis of 
IVH,71 and it may be that preterm birth not only causes IVH, but the two also share 
common underlying genetic and prenatal environmental risk factors.  
The modified Papile grading system describes the severity of IVH. In grade I, the 
haemorrhage is confined to the germinal matrix, and in grade II, blood is seen in the lumen 
of a lateral ventricle, but it has not distended the ventricle.67,72,73 In grade III, IVH extends 
over more than half of the ventricle on a parasagittal view, leading to ventricular dilation, 
and in grade IV, a parenchymal haemorrhagic infarction is seen in the periventricular 
tissue, apparently caused by venous obstruction by the haematoma: together, types III and 
IV can be referred to as severe IVH.67,72,73  
Neonatal cranial ultrasound to detect IVH was introduced in 1979,74 and earliest studies 
in the 1980s reported that 30-50% or even more very preterm or VLBW infants had IVH, 
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and approximately one in ten had severe IVH.75,76 In recent years, a large US study 
reported that 16% of extremely preterm infants who survived the first 12 hours had grade 
I-II IVH and 16% had severe IVH.58 In France and Sweden, quite similar rates of severe 
IVH or other intra-parenchymal haemorrhage were reported among extremely preterm 
infants (10-13%),50,77 with rates dropping below 1% at the 32-week limit of very preterm 
birth.50 Among late preterm infants, the risk of IVH is very small (absolute risk 0.41%, 
according to a recent meta-analysis), but still higher than among term-born infants 
(0.09%).65 Progressive severity of IVH is associated with progressively higher odds of 
neonatal death and of neurodevelopmental impairment, and severe IVH, in particular, is 
a risk factor for cognitive delay and cerebral palsy.66 The association between IVH and 
cognitive functioning is also discussed in section 2.5.3.1. 
A subset of preterm infants with IVH, including approximately one in four preterm infants 
with severe IVH, develop hydrocephalus, in which the flow of cerebrospinal fluid is 
disrupted and intracranial pressure rises.78,79 Increased orbitofrontal head circumference, 
fontanelle fullness, and suture splaying may follow as the immature skull gives room for 
the accumulating fluid, and treatments ranging from serial lumbar punctures and 
temporary shunts to permanent ventriculo-peritoneal shunts are used to relieve the 
pressure.78  
Other potential early complications of IVH (both resulting from IVH and adding to the 
damage caused by IVH) are neonatal seizures or convulsions, however hypoxic-ischemic 
encephalopathy and infarction, infections and malformations of the central nervous 
system (CNS), and metabolic disturbances can result in neonatal seizures also in the 
absence of haemorrhage.67,80 Difficult to reliably detect in the preterm infant, reported 
rates of neonatal seizures vary: a recent study using continuous electroencephalography 
together with video monitoring reported seizures in 5% of 120 very preterm infants,81 and 
an older study reported clinically diagnosed seizures in 6% of VLBW neonates born in the 
1980s,82 but amplitude-integrated electroencephalography studies have reported rates as 
high as 48% among very preterm infants.83 Among late preterm infants, the risk of 
recorded seizures or convulsions is low (0.20%), much like among term-born infants 
(0.12%).65 
White matter injury (WMI) is common among preterm infants. The aetiology of WMI is 
multifactorial and likely to partly overlap with that of IVH. Hypoxia and ischaemia, 
inflammation, nutritional deficiencies, and hormonal disturbances have been suggested 
to disrupt the myelinisation and maturation of white matter, leading to both cognitive and 
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motor problems, such as cerebral palsy.84–86 In the 1980s, cerebral ultrasound made the 
diagnosis of cystic periventricular leukomalacia (PVL) possible, but later, as neonatal 
treatment and imaging have improved, this severe form of injury has become uncommon 
(affecting about 2% of very preterm infants50), and instead, more subtle and diffuse lesions 
without macrocystic areas have become the predominant form of WMI, detected on 
magnetic resonance imaging in about one-third of very preterm neonates.84,86  
Preterm birth also increases the risk of grey matter abnormalities, including the reduced 
growth, abnormal structure, and altered functional connectivity of the cerebral cortex and 
of the subcortical structures including the cerebellum, the hippocampus, the basal ganglia, 
and the thalamus.86,87 White matter injury can predispose to grey matter abnormalities, 
but the two also share common risk factors, such as severe immaturity and hypoxia.86,87 
Unlike IVH and cystic PVL, grey matter injury cannot be readily detected or ruled out 
using neonatal cerebral ultrasound, and early prevalence rates are poorly available, but it 
seems plausible that insults to the structure and maturation of grey matter during the early 
critical period of development plays a role in the aetiology of neurodevelopmental 
problems among preterm infants. The term encephalopathy of prematurity has been used 
to describe the complex constellation of developmental and destructive brain injury typical 
to premature infants, a combination of both PVL and neuronal and axonal disease of the 
cerebral cortex and of the subcortical structures.85 
2.3.4. Patent ductus arteriosus 
In the fetus, the ductus arteriosus connects the main pulmonary artery to the descending 
aorta, diverting the majority of blood pumped by the right ventricle of the heart away 
from the lungs. Ordinarily, within the first hours or days after birth at term, the 
pulmonary blood flow and the partial pressure of oxygen in arterial blood increase and 
the vasodilating prostaglandin levels decrease, and the smooth muscle of the ductus 
arteriosus constricts, causing the closure of the shunt.88 Then, within the next 2-3 weeks, 
the ductus closes also anatomically, becoming the fibrous ligamentum arteriosum.88 
In the preterm infant, compared with the term-born, ductus arteriosus is less sensitive to 
the increased oxygen concentration and more sensitive to circulating vasodilators, and 
often fails to close (functionally, as well as anatomically) during the first three days of life: 
this is called PDA, or persistent PDA.89 PDA is a common finding in very preterm infants. 
For example, US and US/Canadian cohort studies have reported PDA in 46% of 
extremely preterm infants born in 2003-2007,58 in 31% of VLBW infants in born in 
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199090 and in 2004-2005,91 and in 1.3% of late preterm infants in a meta-analysis92 of 
two studies conducted in the 1980s.93,94  
PDA can be a symptomless finding on an echocardiograph and close spontaneously 
without causing any harm,91 but in some infants - especially those already struggling with 
RDS and other complications of immaturity - high-volume left-to-right shunting through 
the PDA increases pulmonary blood fluid volume and the risk of pulmonary oedema and 
(possibly) BPD, and adds to the workload of the heart.88,89 PDA is also associated with 
IVH, WMI, necrotising enterocolitis (NEC), and renal failure, but understanding of when 
and which treatment for PDA actually reduces morbidity is limited: indomethacin and 
ibuprofen remain the first option in many places, with surgical ligation often used as a 
last resort.89,95  
2.3.5. Systemic infections  
The risk of infection is increased among preterm infants because of several reasons. The 
immune system of the preterm infant is immature and innate pro-inflammatory and 
antiviral responses are attenuated, and the maternal transfer of antibodies which mainly 
takes place during late gestation and continues through breast-feeding is disrupted.96 
Preterm infants also often need medical interventions such as mechanical ventilation and 
intravenous lines, which breach the physical barriers against pathogens.96  
Sepsis, or septicaemia, refers to symptoms of a systemic inflammatory response 
accompanied by an infection (which has spread to the blood stream): the "gold standard" 
definition of neonatal sepsis is the combination of both clinical signs (such as tachypnoea 
or apnoea, hypo- or hyperthermia, tachy- or bradycardia) and the detection of pathogens 
in the blood (i.e. positive blood culture), but non-specific clinical findings and sometimes 
misleading blood culture results make for a diagnostic challenge.97 In preterm neonates, 
a late onset, usually associated with gram-positive organisms such as coagulase-negative 
staphylococci is common.98–100 In the US in 1993-2012, 32% of extremely preterm infants 
who survived the first three days had blood culture positive late-onset sepsis, but rates 
have declined over the last decade.54 Early onset within the first three days is less common 
and more lethal, with quite stable rates of 2% among extremely preterm US infants in 
1993-2012 at least:54 important pathogens, contracted from the birth canal or from 
infected amniotic fluid, include Escherichia coli and group B streptococci.98,100,101 
Corresponding rates of sepsis were reported among extremely preterm infants in Sweden 
in 2005-2007.102 Among late preterm infants admitted to neonatal intensive care, sepsis 
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is often suspected, at least enough to merit blood culture workup, but the risk of culture 
positive sepsis is quite low (0.36%, compared with 0.13% in full-term infants).65,100 
Neonatal meningitis is an inflammatory response of the CNS, often in response to the 
spread of the same pathogens which cause sepsis.103 Mortality from neonatal meningitis 
is high, and 20-50% of survivors have long-term complications, such as visual and 
hearing deficits, cerebral palsy, cognitive impairment, and epilepsy.103 The US Neonatal 
Research Network and the international Vermont-Oxford Trial Network reported rates 
of 1-3% among VLBW or extremely preterm infants born in 1987-1988,104 1990,90 and 
2003-2007.58  
2.3.6. Necrotising enterocolitis 
NEC is a life-threatening gastrointestinal disease that primarily affects premature 
infants. The typical patient is a very premature infant, aged approximately one week to 
one month, who has previously tolerated enteral feeds, but then deteriorates in a matter 
of hours or days and develops feeding intolerance, abdominal distension, and bloody 
stools.105,106 Abdominal radiography may shows gas within the wall of the bowel, in the 
portal vein, and even in the free peritoneal space: surgery reveals a necrotic, sometimes 
perforated portion of the intestine.105 Mortality among patients is high (15-63%, 
depending mainly on the degree of prematurity), and survivors have an increased risk of 
intestinal problems such as strictures, stoma complications, and short bowel syndrome, 
growth delay, and neurodevelopmental impairment.105 
NEC is thought to occur as a result of an exaggerated inflammatory response of the 
immature intestinal epithelium to altered microbiota, and very preterm birth, bacterial 
colonization, and formula feeding apparently act as major risk factors.105 Although the 
first descriptions of "gangrenous enterocolitis" among preterm infants date back to the 
1800s, NEC, much like the survival of very preterm infants in general, apparently 
remained rare until the 1960s and 1970s.107,108 Mizrahi and colleagues first used the term 
NEC to describe the disease in 1965,109 and Bell and colleagues combined clinical and 
radiographic data to describe the stages and surgical treatment of the disease in 1978.110 
In some of the earliest estimates, 6-8% of VLBW infants born in the US in 1975-1978111 
and in 1987-1988104 were diagnosed with NEC. Since the late 1980s, a large body of 
research has shown regional differences both in incidence rates of NEC, and in the 
temporal trends of NEC incidence. For example, a register study of all children born in 
Sweden in 1987-2009 reported an initial decrease in the incidence of NEC, followed by a 
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steady increase from about 1995 onwards among preterm infants:112 for extremely 
preterm infants, the increase continued throughout the study period,112 reaching an 
overall incidence of 5.8% among extremely preterm infants born in Sweden in 2003-
2008.102 In comparison, the Neonatal Research Network in the US reported an increase 
from 7% in 1993 to 13% in 2008, and a decrease to 9% in 2012, among extremely preterm 
VLBW infants.54 Among late preterm infants, the risk of NEC is very small (approximately 
0.11%) but apparently still higher than among term-born infants (less than 0.01%).65 
2.3.7. Retinopathy of prematurity 
In very preterm infants, the immature retinas are susceptible to abnormal vascularization 
and retinal detachment, and consequent visual impairment, which together form the 
retinopathy of prematurity (ROP).113 Low gestational age at birth, high oxygenation 
targets, and poor growth and nutrition during the neonatal period increase the risk of 
ROP.113 The majority of extremely preterm infants may develop some degree of ROP,58,113 
and severe ROP, characterised by extraretinal fibrovascular proliferation and a risk of 
retinal detachment, has been reported among 6-34% of extremely preterm 
infants.49,50,58,102 There is no clear evidence that the overall incidence would have changed 
substantially over the last few decades.113  
2.3.8. Metabolic disturbances 
Finally, preterm birth increases the risk of several types of early metabolic disturbances 
in the neonatal period, such as hypoglycaemia,114 hypothermia,115 and hyperbilirubinemia 
or jaundice requiring phototherapy or, in extreme cases, blood exchange transfusion.116 
Metabolic problems are very common among very preterm neonates, but the risks are 
increased also among late preterm infants.65 While often transient in nature, these 
disturbances reflect the problems the preterm infant has in adapting to the extrauterine 
environment. Some of the disturbances, such as severe hyperbilirubinemia,117 may quite 
directly harm the health and neurodevelopment of the infant, while others, such as 
neonatal hypoglycaemia,118,119 seem to have little independent effect on 
neurodevelopmental outcomes. 
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2.4.  Growth and nutrition of preterm infants 
Unprepared to adjust to the postnatal environment, preterm infants struggle to keep up 
with the growth trajectories that would be expected of term-born individuals during 
late gestation and early infancy. This early period represents a time of rapid growth 
and organ maturation, regulated not only by genetic build-up but also by 
environmental factors both before and after birth. Among preterm infants, growth 
problems can reflect a number of factors that include early postnatal morbidity and 
inadequate nutrition.  
2.4.1. Different growth measures reflect different qualities 
The interaction of a multitude of genetic and environmental factors, including sex, 
ethnicity, nutrition, physical activity, and chronic and transient illnesses affect the rate 
and timing of human physical growth. Different measurements of growth, such as weight, 
height (or length, when referring to infants), and head circumference (which usually 
refers more specifically to the occipito-frontal circumference), reflect partly different 
underlying factors and develop differently during the prenatal period, infancy, childhood, 
adolescence, and adulthood.  
For example, weight gain is quick to reflect the balance between energy expenditure and 
intake throughout the lifespan. In contrast, head growth is quite closely correlated with 
the growth of the brain, except in cases with hydrocephalus: for example, one study of 
very preterm infants reported a linear correlation coefficient of 0.68 for head 
circumference and brain tissue volume based on MRI at term.120 Head growth mirrors 
the early growth spurt of the brain, which takes place during the last trimester of gestation 
and the first postnatal months, and unlike height and length growth, most head growth 
occurs during this early period.120–122  
Length or height gain has been modelled using three additive main components:123 the 
fetal-infant component, which reflects the "nutrition-dependent" phase of growth during 
which length growth is described to mark the growth of lean body mass, protein accretion 
and organ growth and development,124,125 the childhood component, which reflects the 
"growth-hormone-dependent" phase of growth during which disturbances along the 
growth hormone (GH) and insulin-like growth factor (IGF) axis become most 
apparent,125 and the puberty, during which the conjoint and independent effects of sex 
steroids and the GH-IGF axis induce a rapid growth spurt and the end of height growth.126 
However, it is apparent that this model is quite the simplification: growth is regulated by 
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both environmental factors and a complex endocrine system - including not only GH and 
IGF but also other hormones such as the thyroid hormone, insulin, and cortisol - during 
the entire growth period. 
2.4.2. Comparing growth against the population norm 
To assess the growth of an individual against that of a population, two major types of 
growth charts are used: standard growth curves (or charts) aim to describe optimal 
growth among healthy individuals and under ideal conditions, whereas reference growth 
curves (or charts) describe average growth among a given population, including both 
healthy and non-healthy individuals.127 Further, growth charts for neonates may either 
describe average or optimal size at birth (which reflects growth in utero), or average or 
optimal extrauterine growth (which is influenced both by pre- and postnatal factors).  
Recently, the INTERGROWTH-21st Consortium released its international neonatal 
standard charts which describe optimal weight, length, and head circumference at birth 
according to gestational age, spanning from 24 to 32 weeks (published in 2016)128 and 
from 33 to 42 weeks of gestation (published in 2014).4 Quite smoothly in line with these 
charts are the standard growth curves released by the World Health Organization (WHO) 
in 2006 that describe optimal growth in weight, length, head circumference, and several 
other growth indicators from birth to 5 years of age.129,130 Based on these data, Figure 5 
shows normal human growth in length or height, head circumference, and weight from 
24 weeks of gestation to 5 years of age.  
Any measurements can, of course, be subject to measurement error and this can interfere 
with reliable growth monitoring. For example, the INTERGROWTH-21st Consortium 
reported that among their trained observers, inter- and intra-observer technical error of 
measurement values ranged from 0.3 to 0.4 cm for neonatal head circumference, and 
from 0.3 to 0.5 cm for length.131 The WHO Multicentre Growth Reference study group 
reported quite similar levels of technical error of measurement.132 To interpret these 
values, one can expect that two-thirds of the time, differences between replicate measures 
will be within ± the value of the technical error of measurement.132  
Growth charts are (usually) created separately for boys and for girls. Country-specific 
charts aim to take into account regional and ethnic differences in physiological rates of 
growth. Some have also suggested that other background factors should be taken into 
account when creating growth charts: for example, parity and multiple birth are 
associated  with  fetal  growth  rates.133,134  However, others will argue that some of these  
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Figure 5. Mean length-for-age or height-for-age (cm), head circumference-for-age (cm), and 
weight-for age (kg) in boys (solid lines) and in girls (dotted lines). The range from -2 to +2 
standard deviations is shown in light grey for each indicator, and for boys and for girls 
separately. Data were derived from international standard curves that describe normal size at 
birth among infants born at 24, 28, and 32 weeks of gestation128 and at 36 and 40 weeks of 
gestation,4 and normal growth among children from 1 to 60 months of age.129,130  
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differences in growth reflect pathological rather than physiological processes and 
separate growth charts will not help identify high-risk individuals. The multitude of 
factors associated with growth are discussed in more detail throughout this part 2.4. 
To assess the growth and development of a preterm infant against a term-born 
population, the degree of prematurity needs to be taken into account. Postmenstrual age 
(PMA) is used to describe the combined duration of gestation (GA) and of time elapsed 
since birth.135 Corrected age (CA), also called age corrected or adjusted for prematurity, 
describes the duration of the postnatal period from the expected date of delivery (PMA 
40 weeks) onwards.135 Finally, calendar or chronological age refers simply to the time 
elapsed since birth.135 For example, a preterm infant who is born 10 weeks before the 
expected day of delivery ("due date"), will have a GA of 30 weeks at birth. On the due 
date, the same infant will have a calendar age of 10 weeks, a PMA of 40 weeks, and a CA 
of 0 days: this time point is also called term age or term equivalent age.  
PMA is used to describe the age of preterm infants soon after birth, especially during the 
extrauterine period between birth and term, while CA is used later, after term age.135 No 
consensus exists over when to stop using CA and use calendar age instead: the American 
Academy of Pediatrics recommends that CA only be used for children up to 3 years of 
age,135 however one should consider the context and the focus of the assessment when 
deciding when to stop correcting for prematurity.136,137 
In this thesis, I have used birth size reference charts published by Pihkala et al, based on 
data on infants born in 1979-1983, and infant growth reference charts published by Sorva 
et al, based on data on children born in 1959-1971.138–140 These charts were chosen 
because they were based on data from Finland from approximately the time when our 
study participants were born. Since then, new Finnish growth charts have been 
published, based on data from children born between 1996 and 2009.141,142 These new 
growth references show that Finnish children nowadays are slightly larger at birth (about 
130 g heavier and 0.3 cm longer, at term),141 slightly taller in infancy, childhood, and 
adulthood (reaching, eventually, an about 1.8-1.9 cm higher average adult height),142 and 
slightly heavier in proportion to height from about 10-12 years of age onwards, but not 
before this age,142 compared with the earlier Finnish reference populations born around 
the 1960s and 1970s. These temporal trends are hypothesised to reflect changes in 
maternal and child nutrition and health. In the late-preterm cohort, growth was 
monitored until the age of 56 months, and the WHO child growth standard charts 
published in 2006 were used to standardise size at follow-ups.  
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2.4.3. Prenatal growth 
2.4.3.1.  The normal course of prenatal growth and development 
Growth during the prenatal period is determined both by the fetal genome and by the 
prenatal environment, which in turn is the result of an interplay between maternal, 
placental, and fetal factors. The first eight weeks of development (called the 
preimplantation and embryonic period, or just the embryonic period) are characterised 
by the formation of the all major organ systems. The rest of the gestation, the fetal period, 
is characterised by rapid fetal growth and functional maturation. During the fetal period, 
the second trimester represents the period of most rapid length growth for the fetus, 
whereas the most pronounced weight gain occurs during the third trimester of 
gestation.143 On average, healthy males grow slightly faster than healthy females, and at 
term, the gender difference in birth weight, length, and head circumference is about 120 
g, 7 mm, and 6 mm, respectively.4 
The growth and development of the brain continues throughout and after the prenatal 
period. During the 3rd week of embryonic development, the neural plate is formed, and 
during the 4th, it folds to form the neural tube.143 The neuroepithelium of the neural tube 
begins to proliferate, producing the precursors of most of the different cells of the CNS: 
first, the young neurons which migrate and develop into the grey matter of the CNS, then, 
the glia cells, and last, the ependymal cells lining the ventricles.143 The surface of the 
cerebral hemispheres is smooth until the 4th month, when the first indentation on the 
lateral wall begins to form to separate the temporal lobe: by the 6th month, additional 
clefts to separate the frontal, parietal, and occipital lobes have emerged, and during the 
last few months, intense further folding in addition to increase in total volume occurs, to 
allow for a rapid increase in the cortical area.143  
Both the mother, the fetus, and the placenta produce hormones to respond to continuous 
changes in the demands of the fetus, the needs of the mother, and the resources of the 
surrounding environment, as also discussed earlier in section 2.2. IGF, produced by the 
mother, the fetus, and the placenta, is important in regulating fetal growth, both directly 
and indirectly through changes in placental capacity.144,145 Insulin is important in 
promoting tissue growth by increasing glucose and amino acid uptake and utilization, 
and while the mother provides glucose (the primary source of energy for the fetus), the 
fetus itself produces its insulin.144,145 The thyroid hormone is also growth stimulatory, and 
the placenta seems to modulate, to some degree, the responsiveness of the maternal 
hypothalamic-pituitary-thyroid axis and also act as barrier between the maternal and 
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fetal hypothalamic-pituitary-thyroid axes.32,144 In contrast, glucocorticoids are 
predominantly catabolic, limiting growth and inducing structural and functional 
maturation of the lungs, the brain, and other organs in preparation for life outside the 
womb.31,144 Glucocorticoids are produced both by the fetus and by the mother, and their 
action is regulated by the placenta: in addition to modulating transport from mother to 
child, the placenta can respond to cortisol by increasing the production and release of 
placental corticotropin-releasing hormone, which in turn can activate the fetal (and 
maternal) hypothalamic-pituitary-adrenal axes. 
In the mother, the effect of placental growth hormone together with other endocrine 
changes promote IGF production, insulin-resistance, and the mobilization of maternal 
nutrients in spite of accumulating maternal fat stores to ensure a sufficient supply of 
energy for the fetus, while placental lactogen and prolactin in turn promote insulin 
production and increase energy intake.146 It would seem that in the malnourished 
mother, the placenta will up-regulate energy uptake to maintain a sufficient supply for 
the fetus, while in the hyperglycaemic mother, the fetus will increase insulin production, 
speeding up anabolism and weight gain.145,147 Meanwhile in the hypoxic or anaemic 
mother, the placenta will change its metabolism to spare oxygen for fetal use and reduce 
glucose transport.145,147 However, direct human evidence of how the placenta, mother, 
and fetus orchestrate the regulation of fetal growth  is scarce, and the exact mechanisms, 
such as epigenetic alterations and nutrient-sensing pathways of placental adaptation 
remain largely unclear.145,147 
2.4.3.2. Intrauterine growth restriction 
Intrauterine growth restriction (IUGR) can be defined in several ways. An antenatal 
ultrasound examination may reveal a relatively small fetus and, if repeated, an aberrant 
growth rate. At birth, infants are usually called small-for-gestational-age (SGA) if their 
birth weight is below the 10th percentile, or two or more standard deviations (SD) below 
the mean birth weight, when taking into account gestational age and sex.148,149 SGA status 
is widely used as a proxy of IUGR, however small size at birth may also reflect normal 
physiological variation, rather than a pathological process.148,150  
Several other background factors can affect growth rates: for example, first-born infants 
and twins tend to be slightly smaller than the offspring of multiparous mothers and 
singletons are, and maternal size correlates positively with neonatal size. It has been 
argued that some of these associations reflect physiological rather than pathological 
differences and should be taken into account when identifying individuals at risk of 
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adverse outcomes.133 For example, one large study suggested that the lower cut-off for 
optimal birth weight (at which mortality and morbidity is lowest) is about 150 g lower for 
twins than it is for singletons.134 In contrast, adjusting for parity results in lower rates of 
SGA birth among primiparas, but it is unclear whether this adjustment will improve the 
identification of high-risk infants.151 The question of ethnicity is also complicated: for 
example, the INTERGROWTH-21 collaboration have argued that their standards 
describe how all fetuses everywhere should grow when there are minimal constraints,4 
but others have suggested that ethnic disparities in fetal growth rates are the result of 
both genetic and environmental differences, occur to a small degree even under optimal 
circumstances, and should be taken into account when judging whether SGA status might 
reflect non-pathological variation.148,152,153 
Figure 6 lists the key risk factors for IUGR.145,149,150 Suboptimal utero-placental 
transfusion is thought to represent a common pathway through which many of the risk 
factors for IUGR affect growth.149 A variety of chronic disorders associated with vascular 
disease can cause reduced utero-placental blood flow.149 Maternal use of tobacco, alcohol, 
and narcotics during pregnancy represent crucial and modifiable risk factors: maternal 
smoking, for example, is associated with a 3.5-fold increase in the risk of SGA birth.149 
Problems in early trophoblast invasion lead to abnormal placental vascular architecture 
and reduced perfusion: this defective remodelling of the placental spiral arteries has been 
implicated in the pathogenesis of pre-eclampsia and increases the risk of IUGR.145,154 Pre-
eclampsia and many of the other risk factors for IUGR also increase the risk of preterm 
birth - both spontaneous and provider-initiated, as previously discussed in section 2.2. 
IUGR may involve more than just weight gain, and the assessment of other growth 
indicators such as length and head circumference can help determine the cause, timing, 
and prognosis of IUGR. For example, insufficient placental perfusion will often lead to 
"asymmetrical" IUGR, in which the fetus redistributes its limited resources to prioritise 
brain development, at the cost of weight gain and other non-vital processes, and this so-
called "brain sparing effect" then leads to head size at birth that is closer to normal than 
weight is.150 In contrast, early insults such as embryonic infections and exposure to 
teratogens are more likely to underlie "symmetrical" IUGR, characterised by poor weight 
gain as well as poor head growth (and, often, poor length growth).150 Any condition that 
impacts the important processes of fetal brain growth, including the proliferation, 
differentiation, and death of cells can lead to microencephaly ("small brain"), which in 
turn leads to primary microcephaly ("small head"), defined as a head circumference that 
is  two  or  more  SD  below  the  mean for gestational age at birth.155  To distinguish severe,  
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Figure 6. Key risk factors for intrauterine growth restriction. 
 
  Chromosomal abnormalities such as trisomy 21
Other genetic and congenital disorders, such as congenital
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Multiple gestation
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malaria
Tobacco and alcohol use, and the use of narcotics and
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Figure 6. Key risk factors for intrauterine growth restriction.
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so-called "true microcephaly", a cut-off of 3 SD is also used, leading to incidence 
estimates varying generally from 0.001% to 0.2%.155 Recently, amidst the Zika virus 
epidemic and related local increases in microcephaly, some controversy regarding the 
definition and diagnosis of microcephaly has arisen.156,157   
2.4.3.3. Macrosomia 
Macrosomia refers to large size at or before birth. To identify those at risk of birth 
asphyxia, meconium aspiration, stillbirth, and caesarean section, for example, studies 
may use simple birth weight cut-offs of 4000, 4500g or 5000g.158 To take into account 
gestational age, neonates can also be classified as large-for-gestational-age if their birth 
weight is above the 90th percentile (or two or more SD above mean birth weight for 
gestational age), to distinguish them from appropriate-for-gestational-age (AGA) and 
SGA infants.158 The most important risk factors for macrosomia and for being born large-
for-gestational-age  include maternal diabetes mellitus (both pre-pregnancy and 
gestational), obesity, and high weight gain during pregnancy.158–162 Multiparity, advanced 
maternal age, non-smoking status, maternal height, and rare genetic syndromes have 
also been identified as risk factors for macrosomia.158–162 
2.4.4. Postnatal growth 
2.4.4.1.  Targeting fetal growth rates  
The early postnatal period for the preterm infant coincides with the period of rapid fetal 
growth for the term-born individual: between 24 and 40 weeks of gestation, a fetus will 
experience a more than 50% increase in length and head circumference and will more 
than quintuple its weight.4,128 Even at 34 weeks, the earliest limit of late preterm birth, 
cortical volume is only about half and total volume only 65% of the term brain, with major 
maturation still to occur.121  
Both the European Society of Paediatric Gastroenterology, Hepatology, and Nutrition 
(ESPGHAN),163 and the American Academy of Pediatrics164 recommend that the target 
growth for preterm infants parallel the rate of intrauterine growth. Weight gain is usually 
described in terms of weight gain velocity, which (usually) refers to the velocity of weight 
gain relative to size, measured in grams of weight gain, per kilogram of bodyweight, per 
day.165 A relatively stable early weight gain velocity of about 17-18 g/kg/day is generally 
recommended before term age.166 As size increases, relative velocity decreases, however, 
going down to only about 4-5 g/kg/day by 50 weeks PMA.166 The rates of head growth 
and length growth (also called linear growth), in contrast, are usually described in 
centimetres per week regardless of attained size: both should follow the fetal rate of 
approximately one cm per week.124,165 Change in z scores over time can also be used to see 
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whether size is getting closer to fetal expectiations.165 However, some controversy exists 
over whether these recommendations are actually optimal for later health and 
development, or whether growth targets for preterm infants, especially concerning 
weight and length, should differ from the fetal norm.124 
2.4.4.2.  Birth slows down growth 
Some disruptions from the fetal growth pattern seem unavoidable even among healthy 
preterm infants, who lack the continuous nutrient infusion of the fetus and the maturity 
and fat stores of the term-born infant. Firstly, immediately after birth, both preterm and 
term-born neonates experience a short initial period of weight loss, which probably 
reflects both fluid loss and a transient nutritional deficit.167,168 The lowest weight of a 
preterm infant is usually recorded towards the end of the first week, and after this nadir, 
healthy preterm infants regain their birth weight during the 2nd or 3rd week of life, 
extremely preterm infants more slowly than others.167 A recent study of healthy preterm 
neonates followed from birth to 21 days of life suggested that the initial weight loss offsets 
the growth trajectory by about 0.8 z scores, and after this drop from the original birth 
weight percentile curve (which a fetus of the same size at the same PMA would be 
expected to follow) to a slightly "lower curve" (which a slightly smaller fetus would have 
been expected to follow), the shape of the healthy, well-nourished preterm neonate's 
growth curve parallels the fetal growth curve.167  
In turn, a few weeks before full-term birth, a fetus (whose weight is also rapidly increasing 
but growth velocity decreasing) will experience a dip in weight gain velocity, followed by 
the normal initial weight loss immediately after birth, and then a period of faster weight 
gain to "get back on track"- meanwhile, a preterm infant around the same PMA will 
merely carry on exhibiting a steadily declining growth velocity relative to size.166,169 The 
normal slowing down of growth that occurs among term-born individuals as birth 
approaches has been attributed to limited placental supply, an increase in corticosteroid 
action to promote organ maturation near birth, and even some methodological problems 
of cross-sectional data, which may exaggerate the magnitude of this "dip".145,166  
Head circumference measurements can also show a small decrease during the first days 
of life, due to resolving of oedema and moulding of the head.170 In one small study, 
occipito-frontal head circumference reduced by 2.0% during the first week of life among 
9 preterm infants born by elective caesarean section, and by 0.7% among 25 preterm 
infants born by vertex vaginal delivery, after which head circumference began to 
increase.171 
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2.4.4.3.  Extrauterine growth restriction 
Poor postnatal growth is one of the most common problems among preterm infants, and 
can be defined and described in several ways. Extrauterine growth restriction or 
retardation (EUGR),166,172–176 or simply postnatal growth failure,58,177–179 is often defined 
as weight below the 10th percentile at discharge,172,173,175,177 but different time points such 
as 36 weeks PMA58,178,179 or 28 days after birth,176 or a combination of several time 
points166,174 have also been used. Based on SD scores, poor early growth (called, for 
example, preterm growth restraint,180 early neonatal growth failure,181 or severe postnatal 
growth failure182) has also been defined as weight below -2 SD at 3 months CA, for 
example,180 or as a >1 SD181 or >2 SD182 decrease in weight z scores between birth and 
discharge. In addition to weight, EUGR and related classifications have also been 
extended to similarly describe small head circumference and length.172,180,181 
Rates of EUGR have decreased over time, but are still high. In a large US study of infants 
born at 23 to 34 weeks of gestation in 1997-2000, 28%, 34%, and 16% had weight, length, 
and head circumference below the 10th percentile at discharge, respectively.172 The 
problem is especially pronounced among the most immature infants: 79% of the 
extremely preterm survivors of the National Institute of Child Health and Human 
Development Neonatal Research Network (NICHD NRN) cohort born in the US in 2003-
2007 (GA 22-28 weeks)58 and 75% of the extremely preterm survivors of the ELGAN 
study born in the UK in 2002-2004 (GA 23-27 weeks)176 had weight <10th percentile at 
PMA 36 weeks58 and at 28 days of life,176 respectively.  
Worse yet, among the VLBW infants of the NICHD NRN born in 1995-1996, 97% had 
weight <10th percentile at PMA 36 weeks.179  Among the VLBW participants of the North 
American Vermont-Oxford collaboration born in 2013, 50.3% had weight below the 10th 
percentile at discharge, and 27.5% had weight below the 3rd percentile: this was a 
significant improvement from 2000, when 64.5% and 39.8% of the VLBW infants of the 
same collaboration study had discharge weight below the 10th and the 3rd percentile, 
respectively.177 Differences in fetal growth references can affect the number of preterm 
infants who are classified as having EUGR. Moreover, infants who are SGA at birth are 
understandably more likely to be below the 10th percentile in weight also at discharge, i.e. 
have EUGR.172,183 As a result, the large proportion of SGA children can help explain why 
cohorts in which birth weight cut-offs are used as an inclusion criterion (e.g., VBLW 
cohorts) report poorer growth outcomes than cohorts with a gestational age cut-off (e.g. 
extremely preterm cohorts) do: the latter has become the more common inclusion 
criterion during the recent decades.  
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2.4.4.4.  Early growth and illness  
Several illnesses are associated with growth problems, and together with the patterns of 
prenatal growth, immaturity-related early morbidity seems important in explaining 
variance in growth during the initial hospital stay after preterm birth.168,184 
Some studies have observed no clear association between IVH and postnatal head 
sparing102 or EUGR for weight,102 during the initial hospitalization, however others have 
reported that infants with severe IVH183 and cystic PVL185 have poorer weight gain and 
head growth up to about 2 years of age.  BPD  and a long period of oxygen treatment have 
been associated with poor growth in weight, length, and head circumference at the 
Neonatal Intensive Care Unit (NICU), however the differences may at least partly even 
out by 18-22 months CA.172,183,185–187 NEC disrupts early weight gain quite dramatically 
and also affects length and head growth.172,186,187 Neonatal infections such as sepsis are 
also associated with growth problems, including restricted neonatal head growth.186–188 
These associations between illness and growth are explained by a number of intertwined 
mechanisms. Several underlying factors can result both in poor growth and in morbidity: 
they include low gestational age, intrauterine growth restriction, certain congenital 
malformations, and genetic disorders.172,189 These factors can act as confounders behind 
both growth and morbidity, but they can also increase the likelihood of illness which then 
acts as a mediator affecting growth.190  
One of the ways through which illness can lead to poor growth is by disrupting the 
nutritional balance. Firstly, this can be through inadequate intake. For example, the 
severely ill infant may lack the ability or the stamina to suckle breast milk or actively take 
in other forms of enteral nutrition, may not tolerate enteral feeds even when given them 
passively, and may receive parenteral nutrition that is not optimal for growth.191–193 
Secondly, illness may increase nutritional needs: for example, BPD and sepsis increase 
energy expenditure.194,195  
Illness can affect growth also through inflammatory pathways. Chronic inflammation, 
neurotoxic effects of the cytokine response, and disturbed regulation of the GH-IGF axis 
caused by early illness have been implicated in the aetiology of brain injury and reduced 
head growth, reduced length growth, and changes in body composition, but direct 
evidence from preterm infants is scarce.124,187,188 
Medications and other treatments used in the management and prevention of illness may 
also reduce growth. For example, the administration of catabolism-promoting 
corticosteroids to prevent BPD may disrupt growth, and the concern for NEC and other 
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complications may lead to interruption of enteral feeds and to suboptimal 
nutrition.172,196–198 Even aspects of the hospital environment itself may inhibit normal 
growth. For example, the pain, noise, and lack of normal interaction with parents that the 
hospitalised preterm infant experiences have been implicated as risk factors for postnatal 
growth failure.199–201  
The microbiota of the preterm infant seems like a promising crossing point for these 
different pathways between preterm birth, illness, and growth, and has raised an intense 
interest in the recent years. The early development of the gut microbiota in the preterm 
infant is affected by the structural and immunological immaturity of the gut itself, and by 
factors which alter microbial exposure and growth, such as pre- and postnatal antibiotics 
and other medications, caesarean section, infection control measures, and altered 
nutrition including reduced breast-feeding.202–204 Together, these factors contribute to 
the development illnesses such as NEC and late-onset sepsis, as discussed in section 2.3, 
and may contribute both to early growth failure and later acceleration of growth among 
preterm infants.202–204 
2.4.4.5.  Early growth and nutrition  
Adequate nutrition is, of course, the prerequisite of adequate growth. But what is 
adequate? Neonatal growth, especially in weight, can certainly be increased by providing 
more macronutrients than what the average human milk contains (and what the preterm 
neonate would be able to suckle), both through parenteral and enteral supplementation. 
ESPGHAN recommends increased daily intakes of energy (110-135 kcal/kg) and protein 
(4.0-4.5 g/kg of body weight below 1000g and 3.5-4.0 g/kg of body weight between 1000-
1800g) for preterm infants to make growth as similar to fetal growth rates as possible.163 
However, evidence of nutritional interventions that would have any long-term effects on 
growth, let alone improve other aspects of development, is scarce. 
Most evidence seems to exist for the effects of human milk: compared with (enriched) 
formula, on its own it seems to result in slightly slower early weight and length 
growth.163,205,206 However, human milk (vs formula) reduces the risk of NEC and is 
associated with other potential benefits (discussed in sections 2.5.3.4 and 2.5.3.5), and is 
thus the recommended choice of enteral nutrition.163,205,206 Quite fascinatingly, during the 
first weeks after delivery, mothers of preterm infants provide, on average, milk that has 
a higher energy and protein content than milk produced by mothers of term infants 
has.207 However, this little nudge from nature is insufficient for meeting the 
recommended levels of intake for preterm infants, and ESPGHAN thus recommends that 
maternal milk be fortified or, if neither maternal or donor human milk is available, 
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enriched "preterm formula" be provided to preterm infants, until they attain at least 
about 1800g of bodyweight.163,208 
Indeed, multinutrient-enriched human milk (vs non-fortified human milk) before, but 
not after hospital discharge, has been associated with slightly faster in-hospital growth 
rates in weight, length, and head growth among preterm infants, but the very limited data 
that span beyond infancy have shown no long-lasting benefits.209,210 Limited evidence 
indicates that multinutrient-enriched preterm formula (vs ordinary term formula) 
increases weight, length, and head circumference up to 18 months, but in the absence of 
evidence of substantial long-term benefits, the use of preterm formula is not 
recommended after discharge.211 Higher intake of protein212,213 and glutamine214 (from 
either parenteral or enteral feeds,214 formula,213 or fortified human milk212) seems to 
accelerate early weight, length, and head growth, but trial evidence of any substantial 
long-term benefits is yet again lacking.212–214 Early parenteral nutrition increases in-
hospital weight gain at least in observational studies, and energy- and protein enriched 
parenteral nutrition may increase head growth during hospitalization, but again there is 
no evidence of long-term benefits.215,216 Provision of additional calcium,217 phosphorus,217 
or taurine218 has not been shown to significantly influence growth even during the 
neonatal period.  
2.4.4.6.  Early growth and gender 
Some,172,219 but not all studies220 have suggested that preterm males are more likely than 
preterm females to be shorter172,219 and lighter172,219 and have a smaller head 
circumference172 than same-sex fetal or full-term reference populations at discharge172 
and even after infancy.219 Of course, the growth references against which preterm infants 
are compared are different for boys and girls. Males are expected to be slightly larger than 
females throughout gestation and infancy, with a postnatal peak in length growth velocity 
soon after birth. This peak difference in growth velocity between the sexes mirrors in 
magnitude and coincides in timing with a transient surge in testosterone levels at about 
1 month of age, suggesting that there is a transient "mini-puberty" and a resulting "mini 
growth spurt".126,221 In girls, a similar transient activation of the hypothalamic-pituitary-
gonadal axis, and subsequent follicle development is seen immediately after birth, but 
testosterone levels are lower.221,222  
Interestingly, the mini-puberty of infancy is different for preterm and term infants. It 
would appear that preterm boys and girls experience a much higher surge in follicle-
stimulating hormone levels than term-born infants do, resulting also in more pronounced 
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gonadal activation: in boys, this occurs around one month after birth, regardless of 
gestational age, and in girls, the surge is observed immediately after birth, decreasing 
after about one month in term-born girls, and after about three months in preterm 
girls.222,223 It has been hypothesised that this surge is needed to complete genital 
development. For example, the "mini-puberty" could promote the spontaneous descent 
of undescended testes (a condition much more prevalent among preterm vs term-born 
boys),224 but these are speculations, and the role of this mini-puberty remains unclear. 
2.4.4.7.  Catch-up growth and growth beyond infancy 
After an initial period of EUGR, IUGR, or both, many preterm infants will begin to "catch 
up", as if attempting to get back on some set pathway of growth that they were 
momentarily diverted from. The term "catch-up growth" describes the general 
phenomenon of accelerated growth after a transient period of growth restriction,225 be it 
during or after infancy, among preterm or term-born individuals, and after prenatal or 
postnatal growth failure. A common definition of catch-up growth describes it as an 
increase in weight, length, or head circumference z score over time that occurs after a 
previous period of growth restriction (such as IUGR or EUGR) and that results either in 
size above the -2 SD cut-off at some chosen time point, or in a growth rate that is greater 
than the median for age and gender.148 
Catch-up in weight usually begins in early infancy among preterm individuals and may 
continue, to a lesser degree, throughout childhood and even during adolescence.219,226 
After adolescence, the BMI of preterm individuals is not significantly different from that 
of term-born peers, suggesting overall catch-up weight gain that is proportionate to 
height, at least in young adulthood.227 
The individual patterns of length and height catch-up growth vary considerably, and 
many preterm individuals fall short of their expected final height. Some individuals are 
born short and remain short throughout and after infancy, reflecting perhaps genetic 
build-up, while others exhibit periods of both growth acceleration and deceleration, 
which could reflect an attempt to reach the maximal genetic potential while struggling 
with illnesses and other environmental factors.198,228  
Adult findings highlight the importance of the early period of height growth among 
preterm individuals for final attained height. Among term-born, healthy, well-nourished 
humans, adult height is thought to mainly reflect genetic potential, and can be predicted 
quite accurately based on sex and mid-parental height. However, among extremely 
preterm individuals, size at 2 years of age is a stronger predictor of adult height than mid-
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parental height is, and poor growth - both in utero and in infancy - seems to mainly 
account for the persisting difference in adult height between preterm and term-born 
adults.180,226,229,230 In addition to the differences in infant length growth, some evidence 
suggests that preterm adolescents undergo puberty slightly earlier than term-born 
adolescents do.231 This could further contribute to the difference in adult size, including 
the difference in final attained height. 
The magnitude of this adult height gap varies between studies:219,226,229,230,232 regional and 
temporal differences in height as well as differences in the distribution of gestational age, 
size for gestational age at birth, and sex among the participants in different studies are 
likely to contribute. In a large Swedish register study, very preterm AGA women were 1.7 
cm shorter, and moderately and late preterm AGA women were 0.5 cm shorter than term-
born women, but when maternal factors were taken into account or when preterm women 
were compared with their term-born sisters, moderately or late preterm birth no longer 
affected adult height, however very preterm birth continued to result in a 2.0-2.4 cm 
reduction in adult height.233 Large Swedish and Norwegian studies among men have 
reported similar results: very preterm men were about two centimetres shorter than 
term-born men, and being short for gestational age at birth further increased the odds of 
being short in adulthood.234,235   
Infancy is a crucial time period for head growth, coinciding with the brain growth spurt 
of late gestation and early infancy.120–122,124 Even at term, the brain is only about a quarter 
of its adult volume: most of the remaining growth results from the myelination of the 
nerve fibres, with some additional growth due to the increase in the size of neuronal cells 
and the proliferation of neuronal processes.143 Fortunately, even among infants who 
struggle to keep up and catch-up with weight and length growth, head growth is often 
spared.187,236,237 Gestational age is again meaningful. Among extremely preterm infants, 
head size z scores tend to be slightly below the reference throughout infancy, but still 
closer to expected values than weight scores, and preterm infants with higher gestational 
age do not seem to significantly differ from term-born peers.236,237 Grouped together,  
ELBW adults232 (or adolescents)238 have been reported to have about 1-2 cm smaller head 
circumference, compared with term-born peers.232,238 SGA birth has also been associated 
with smaller head circumference in adulthood.239 While some short-term evidence of the 
effects of enriched early nutrition exists, it remains unclear how early nutrition might 
best promote head growth in the long term, as discussed in section 2.4.4.5.  
More worrying than the difference in head circumference are the underlying differences 
in the development of the brain, of which head circumference is a crude proxy. As 
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described in section 2.3.3, the brain of the preterm infant is vulnerable to injury, and 
those who grow poorly, also show delayed cortical grey matter maturation.240 Adult 
imaging studies have reported, rather consistently, that the volume of the whole brain 
and of specific regions including the grey and white matter of the temporal, frontal, 
insular, and occipital areas, thalamus, caudate nucleus, putamen, globus pallidus, and 
corpus callosum is reduced among young adults who were born preterm, as summarised 
by Raju et al. in a 2017 review of the literature.241 
2.5.  Adult health and wellbeing among former preterm infants 
Individuals who were born preterm continue to differ from term-born peers in terms of 
health and well-being even as adults, but the differences are more subtle than during 
the neonatal period. Both preterm birth and intrauterine growth restriction may be 
associated with increased risk factors for cardiovascular disease and with a risk of 
mental disorders. Preterm birth is also associated with poorer cognitive functioning 
and academic attainment in adulthood. Immaturity-related morbidity and social 
environmental factors seem to partly explain these differences, but identifying early on 
those individuals who will have persisting difficulties is not straightforward. Research 
concerning postnatal growth or nutrition among preterm infants and adult physical or 
mental health is scarce and somewhat conflicting, however a few studies suggest that 
faster growth during early infancy may be associated with better cognitive functioning 
beyond early childhood. 
2.5.1. DOHAD 
The Developmental Origins of Health and Disease (DOHAD) hypothesis claims that early 
life events alter the risk of later health. Something of a paradigm, the DOHAD framework 
is now used to examine and understand how humans and other organisms attempt to 
adapt to their surroundings throughout the lifespan, using early environmental cues.242 
The DOHAD framework stems largely from the work of David Barker, Clive Osmond, and 
colleagues in 1980s and 1990s, when birth weight, a reflection of the prenatal life, was 
shown to predict the risk of diabetes and cardiovascular illness later in life in a manner 
that was robust, consistent, and surprising at the time.243–245 First called the Fetal Origins 
of Adult Disease hypothesis, or simply the Barker hypothesis, the framework later 
became known as DOHAD, as it became apparent that the role of events during the early 
postnatal period could also be understood from this perspective.242,246 
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To explain the association between early growth restriction or preterm birth (as birth 
weight per se does not differentiate between the two) and later cardiovascular risk, many 
DOHAD researchers suggest that when struggling with scant resources, the fetus or 
infant is "programmed" to survive on the limited resources that are expected also in the 
future. However, under the lavish conditions of modern society, this programming will 
prove somewhat maladaptive, leading to high blood pressure, accumulation of adipose 
tissue, and other risk factors for cardiovascular disease and diabetes. Early epigenetic 
alterations of key regulatory genes which evoke a "thrifty phenotype" have been suggested 
to be the central mechanism behind this programming.242,246,247 
Gluckman and colleagues have presented the "predictive adaptive response hypothesis", 
which many would argue fits quite well within the DOHAD framework.242,246,248 They 
suggest that the early programming response that results in this thrifty phenotype may 
actually serve two purposes: it can both represent an adaptive response for immediate 
survival (under harsh conditions) and a predictive response to ensure survival to 
reproductive age. As an example, they argue that the earlier age of menarche among low 
birth weight individuals who experience catch-up growth may lead to better reproductive 
success: in uncertain times, rapid postnatal growth could increase fitness, outweighing 
any harmful effects in late adulthood.248 
In contrast, supporters of the "maternal capital hypothesis" argue that any external cues 
that the fetus receives of its surrounding environment are passed on and modified by the 
mother, and the maternal phenotype (rather than the nutritional resources of the outside 
environment itself), dictates the surrounding that the fetus must adapt to.249 This early 
adaption does not occur to ensure "fit" to the environment that awaits the individual later 
on in life, but rather to ensure an early "fit" between the nutritional needs of the offspring 
and the capacity of the mother, making the offspring more "affordable" for the mother 
and thus more likely to survive the crucial early period of development.249 However, 
according to this maternal capital hypothesis, if environmental constraints are relaxed, 
the offspring will change its strategy of adaption and catch-up.249  
From the perspective of DOHAD and of the debate within and surrounding it, as well as 
from the point of view of the clinicians and parents who care for preterm babies,  the 
long-term outcomes of preterm infants, both SGA and AGA, the effects of the early 
postnatal environment, and the role of postnatal growth are interesting. Do preterm birth 
and IUGR affect adult health and wellbeing? Is there a trade-off between rapid early 
growth leading to perhaps cardiovascular disease or diabetes later on, and some benefit 
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of that rapid growth? Are the effects associated with early growth merely the effect of 
prenatal events, or can the trajectory of development be altered after birth? 
2.5.2. Physical health   
2.5.2.1.  Preterm birth poses a risk to adult physical health  
Preterm birth and IUGR have been shown, independently of each other, to be risk factors 
for type 2 diabetes in several studies of mostly middle-aged individuals born much before 
the era of modern neonatology.250 As discussed in the previous section, these studies stem 
from the work of David Barker and colleagues, who studied low birth weight as a risk 
factor for cardiovascular disease and related morbidity in the 1980s and 1990s.243–245 
Since then, studies concerning the risk of coronary heart disease (CHD) and stroke after 
preterm birth specifically have reported somewhat conflicting results. In a large Finnish 
study, stroke and CHD before 65 years of age were not associated with preterm birth, 
except that early preterm women had an elevated risk of CHD.251 In a large Swedish 
register study, ischaemic heart disease was associated with SGA birth, but not with 
gestational age per se.252  
Preterm adults also exhibit risk factors for adult cardio-metabolic disease, which are 
easier to study also among young adults.250 Clearest perhaps is the slightly elevated blood 
pressure.227 The large Adults Born Preterm International Collaboration (APIC), which 
also includes the cohort of VLBW individuals examined in this thesis, reported recently 
that VLBW adults had 3.4 mmHg higher systolic and 2.1 mmHg higher diastolic blood 
pressure.253 The finding was not limited to a specific subgroup such as SGA individuals.253 
A non-optimal lipoprotein profile is another cardio-metabolic risk factor seen among very 
preterm adults.227,254 Impaired glucose regulation has been reported in some studies,250 
including our own cohort,255 but a recent meta-analysis failed to show significant 
differences in fasting glucose or insulin levels.227 As lifestyle risk factors, VLBW adults 
are less physically active and may have less healthy diets, yet as protective factors, they 
report smoking less and using alcohol less frequently, and have sleep rhythms which 
indicate a morning preference.250  
Preterm birth also seems to have long-lasting effects on pulmonary health. Preterm 
adults have poorer lung function and more asthma compared with term-born peers.241 
Those who have suffered BPD in infancy are at an increased risk, and cohorts of the early 
1990s report poorer outcomes than those from the turn of the millennium.241  Finally, 
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preterm birth and IUGR are risk factors for reduced nephron numbers in the developing 
kidney and kidney disease in later life.256 
2.5.2.2.  Early growth and adult physical illness 
Research concerning early growth and adult physical illness among the preterm 
population is scarce and somewhat conflicting. Among the VLBW adults studied in this 
thesis, growth between birth and term was not associated with adult blood pressure (after 
taking into account gestational age).257 Lower flow-mediated dilation, an early marker of 
atherosclerosis, was associated with slower weight gain during the first 2 weeks in our 
VLBW cohort,258 but a British study reported the opposite effect among 216 preterm 
adolescents.259  
Glucose regulation was unrelated to early growth in our VLBW cohort, except among the 
31 SGA participants among whom faster growth was associated with higher fasting and 
2-hour insulin concentrations in the oral glucose tolerance test.255 In the Dutch POPS 
cohort of 346 very preterm young adults, rapid weight gain between birth and 3 months 
CA was weakly associated with higher insulin levels,260 and weight gain from birth to 3 
months and from 3 to 12 months CA was associated with higher adult weight, height, 
BMI, waist circumference, fat mass, fat-free mass, and percentage body fat.261 In another 
Dutch cohort of 169 preterm young adults, a weak association was also observed between 
weight gain between birth and term and insulin secretion, but the association was 
attenuated to non-significance after adjustment for a number of potential covariates 
including fat mass.262 Within the same cohort, faster weight gain relative to length growth 
was associated with a non-optimal adult lipid profile and body composition.263 In line, in 
a US study, more rapid increase in BMI but not in length, between preterm birth and 4, 
12, and 18 months, was associated with higher odds of obesity among 633 young adults.264 
2.5.2.3.  Early nutrition and adult physical illness 
Little evidence exists of the adult health effects of early nutrition in the preterm 
population, but the existing data do not support the hypothesis that discouraging weight 
gain during hospitalization would reduce the risk of cardio-metabolic morbidity.265 
Among the participants of our observational VLBW cohort, higher protein intake during 
the first three weeks after birth was associated with a healthier body composition and a 
higher metabolic rate in young adulthood.266  
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In an series of two separate randomised controlled trials, Lucas and colleagues compared 
preterm formula against standard formula267 and preterm formula against donor milk,268 
in a total of 926 British preterm infants born in the early 1980s (birth weight <1850g).269 
In an adolescent follow-up study of about 23% of these infants at 13-16 years, no 
difference in proinsulin, insulin, or glucose levels between these different feeding groups 
were observed, but 32-33 split proinsulin concentrations were higher among those who 
had been allocated to nutrient-enriched diets.269 Also, donor milk (compared with 
preterm formula) was associated with lower mean arterial blood pressure.270  
2.5.3. Cognitive functioning and academic outcomes 
2.5.3.1. Preterm birth poses a risk of long-term neurodevelopmental problems 
The nature and origins of individual differences in cognitive functioning are a 
controversial topic, and mixed terminology is used to describe these phenomena. 
Psychometric tests that identify individual differences in cognitive functioning can cover 
domains such as verbal and non-verbal reasoning, processing speed, executive function, 
memory, and spatial ability.271 Performance across these tests show a substantial and 
positive correlation, and the underlying 'general cognitive ability', also called simply 
'general intelligence', 'g', or described in terms of an 'intelligence quotient' (IQ),271 is 
thought to reflect a general broad capability to reason, plan, solve problems, think 
abstractly, comprehend complex ideas, and learn quickly and from experience.272  
Several studies have shown that the average IQ of very preterm,273–275 extremely 
preterm,276,277 ELBW,277 and VLBW275,278–280 young adults is lower than that of term-born 
peers. For example, as reported by Pyhälä and colleagues in the VLBW cohort studied in 
this thesis, VLBW adults had 0.57 SD lower full-scale IQ, 0.68 SD lower performance IQ, 
and 0.29 SD lower verbal IQ, compared with term-born controls (which would 
correspond to about 8.6, 10, and 4.4 IQ points, respectively), after adjustment for sex and 
age.280  
Large Norwegian and Swedish register studies among male conscripts have shown that 
with increasing gestational age up to full term, the average cognitive performance 
improves, and even late preterm adults perform poorer than term-born peers.281,282 These 
differences seem persistent: in a Finnish study of 919 elderly men and women, late 
preterm birth was associated with the risk of mild cognitive impairment.283 
Some have reported that visuospatial functioning among (early) preterm adults may be 
more impaired,279 while others have reported a somewhat bigger difference in verbal 
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functioning scores:274 most studies (including that in our VLBW cohort) report that both 
are affected.273,279,280 Performance in tests of executive functioning (including tests 
reflecting, for example, verbal fluency,273–275,280 response inhibition,274,275 and processing 
speed274–276,280) seems also poorer among preterm adults, compared with term-born 
adults, and although adjustment for IQ attenuates the differences, it does not make them 
disappear altogether.275,280 Studies on memory function are scarce: in our cohort, 
performance in tests that reflect visual memory encoding, but not so much storage and 
retrieval, was poorer among VLBW young adults, compared with term-born peers.280 
Further, late preterm birth was associated with poorer memory performance in late 
adulthood in the previously mentioned Finnish study.283  
Preterm birth also affects academic outcomes. With decreasing gestational age, the odds 
of completing high school or having a university degree decrease.284 Even when adjusting 
for some potential confounders or after excluding severely impaired individuals, 
extremely preterm,276,277,285 very preterm,274 ELBW,277 and VLBW279,280 adolescents and 
young adults perform worse in tests of reading, spelling, and mathematical or arithmetic 
skills,277,285 and are more likely to have received special education,279,280,285 and to choose 
practical upper secondary school programmes rather than pursue more academically 
challenging programmes.276 According to some276 but not all280 studies, preterm 
adolescents also receive lower final grades than term-born peers. Poor educational 
outcomes and cognitive impairments together can mediate the effects of preterm birth 
on adult socioeconomic attainment in a broader sense, possibly contributing to lower 
incomes of extremely preterm adults in adulthood.286 
Late preterm individuals' long-term educational attainment has received less attention 
than that of early-preterm individuals. One meta-analysis of the few available studies 
suggested that late preterm adults are (very slightly) less likely to have completed high 
school than term-born peers,287 in line with a Finnish study that found that late-preterm 
elderly adults had lower life-time socioeconomic attainment than term-born adults.288 
According to childhood studies, late preterm children have poorer school skills and an 
increased need of special education.287 Interestingly, educational attainment also seems 
to moderate the association between late preterm birth and cognitive impairment so that 
this association may only be seen among less educated (and not highly educated) elderly 
adults, perhaps reflecting differential cognitive reserve or neuroplasticity.283  
The existing literature does not suggest consistent sex differences in the association 
between preterm birth and adult cognitive ability.273,276,280 Some,278 but not all275,280 
studies have reported that SGA status is an additional risk factor for poorer cognitive 
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functioning: it may be that this is true for those SGA preterm infants who also had small 
head size at birth.278  
Of perinatal variables, severe (grade III-IV) IVH is an important and independent 
predictor of poorer adult IQ.277,289  In a study of very preterm or VLBW adults, severe IVH 
decreased adult IQ by an average of 9 points, after taking several other neonatal health, 
treatment, and family factors into account.289 Two studies that looked at any IVH, rather 
than severe IVH, reported no association however,274,276 and one can hypothesise that the 
seemingly conflicting results could be due to the small number of participants with severe 
IVH in those studies which did not detect a difference (n=7 in one274 and n=6 in the other 
study276). Further, one study specifically compared 93 preterm adults who had had mild 
IVH against 273 preterm adults without IVH and reported that mild IVH has very little 
independent predictive value over adult neurodevelopment, after adjusting for 
demographic factors.290 Studies on adolescents and children however support the 
importance of neonatal brain abnormalities (both severe IVH and more subtle changes 
including but not limited to grade II IVH) in predicting neurodevelopmental outcome 
including IQ, executive functioning, verbal memory, and poorer academic attainment 
and skills in childhood.285,291–293 This discrepancy between child and adult studies could 
be taken as a sign of compensation and plasticity (resulting in the diminished role of early 
brain insults in predicting adult cognitive functioning), or as a result of methodological 
reasons. A great number of things concerning the health, survival, imaging, and 
treatment of preterm infants has changed over the years, and not enough adult follow-up 
studies are present to draw well-based conclusions. 
Concerning other perinatal variables, some evidence suggests that although a long period 
of mechanical ventilation and BPD can predict poorer adult cognitive functioning 
independently of several potential confounders,276,289 the effects may be limited to those 
who receive postnatal corticosteroid treatment,277 and one adolescent study found no 
association between BPD and cognitive outcomes at all.291 Trial evidence would certainly 
be needed to weigh any potential long-term risks of corticosteroid treatment against 
benefits.277 Altogether, evidence concerning the independent effects of illness-related 
neonatal variables such as corticosteroid treatment, BPD, or neonatal infection on 
neurodevelopment is not uniform and is mostly limited to studies among young 
children.294 
Parental education277,278,282 and other proxies of parental socio-economic status (SES) 
such as parental occupation275,277,282 are predictive of IQ, as should be expected based on 
studies among the general population, but the association between preterm birth and 
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cognitive functioning remains even when differences in SES are taken into account. One 
recent study of very preterm and VLBW adults reported that being born to a family with 
high SES was associated with approximately 9 points higher IQ, and coming from a lower 
SES background with 2 points lower IQ, compared with the comparison group whose 
family was classified as middle-SES based on parental education and occupation (after 
taking into account several other potential confounders).289 Together, the morbidity, 
treatment, and social environmental factors identified within the first few months of life 
alone explained more than a third of the variance in cognitive abilities among VLBW 
adults.289  
It is important to keep in mind that mostly these deficits between preterm and term-born 
infants are quite subtle, and the majority of preterm adults cope as well as any term-born 
peer. For example, even those VLBW adults who quite clearly perform more poorly than 
term-born peers in neuropsychological tests that assess executive functions, but who are 
free of major disabilities, do not themselves report experiencing any more problems 
related to executive functioning in their everyday lives.295 
However, preterm birth is also associated with a small but elevated risk of severe 
neurocognitive impairment. Intellectual disability is an umbrella term for a collection of 
developmental disabilities characterised by early onset, low IQ, and difficulties in 
independent daily life. In a large Norwegian register study of adults born in 1967-1983, 
4.4%, 1.8%, 1.0%, 0.7%, and 0.4% of those born at 23-27, 28-30, 31-33, 34-36, and ≥37 
completed weeks of gestation, respectively, had an intellectual disability.284 Although 
environmental insults can contribute to intellectual disability, its severe forms tend to 
have genetic causes which can have widespread effects not only on cognitive ability, but 
also on perinatal and postnatal complications and growth.296  
Finally, preterm birth is associated with neurodevelopmental problems beyond cognitive 
functioning. The prevalence of cerebral palsy (CP) is about 9%, 6%, 2%, 0.3% and 0.1% 
among adults born at 23-27, 28-30, 31-33, 34-36, and ≥37 completed weeks of gestation, 
respectively.284,297 Likely etiological risk factors for CP include genetic susceptibility and 
early hypoxia, growth restriction, and infection, and while CP can present without any 
effect on cognitive ability, it increases the risk of comorbid cognitive impairment.297–299 
Blindness and deafness are rare in modern high-income settings, affecting less than 1% 
of even extremely preterm individuals in a Swedish study,77 but milder hearing and visual 
impairments such as somewhat reduced visual acuity and contrast sensitivity are more 
common.300–302 Of course, CP and sensory impairments can also limit the options for 
reliable neuropsychological assessment.  
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2.5.3.2.  Effects of early growth after preterm birth on cognitive and academic 
outcomes in adulthood 
Very few studies have looked at the association between early growth after preterm birth 
and adult cognitive functioning. In the first publication that I am aware of, Brandt and 
colleagues compared head circumferences among the preterm SGA participants of the 
Bonn Longitudinal Study born in Germany in 1967-1978 (birth weight <10th percentile, 
nearly all VLBW).239 They first classified the SGA infants into "head catch-up" (n=27) and 
"no head catch-up" (n=19) groups based on whether or not the infant's head 
circumference significantly differed from that of VLBW AGA (n=65) and term-born 
(n=85) controls at 12 months CA, using a method which was not detailed in the 
publication. They then compared these two groups of SGA individuals and observed that 
those in the "head catch-up" group had 16 points higher IQ than those in the "no head 
catch-up" group at the mean age of 23 years, even though head circumference had not 
been different at birth (statistically significantly, at least). Infants with major 
malformations or chromosomal abnormalities were excluded, and birth weight, 
gestational age, optimality scores that reflect pre- and neonatal adversity, or parental 
head size were not different between these two groups, but the "head catch-up" group 
were more likely to be born after pre-eclampsia and to have a higher energy intake during 
the first 10 days of life than the "no head catch-up" group. The follow-up rate was an 
impressive 93% of adult preterm survivors. In another study among the same 
participants, the adult IQ of those SGA individuals who showed "height catch-up" (n=21, 
height z scores steadily increased to adulthood) did not differ from that of the "no height 
catch-up" group (n=25, height z scores decreased or remained unchanged).228 While 
these studies represent an era when under 40% of VLBW neonates survived, and the 
choice of methodology was not optimal for revealing the effects of postnatal growth 
independently of earlier growth, they hinted that early head growth after preterm birth 
could provide an early, perhaps even modifiable marker of adult outcome. 
The next adult study suggested that also AGA preterm infants who grow faster have 
higher adult IQ.278 In this study, Weisglas-Kuperus and colleagues assessed weight and 
length gain among the very preterm or VLBW, AGA (birth weight and length above -2SD) 
adults of the POPS study born in the Netherlands in 1983, when neonatal survival rate 
was already 77%.278 Those who had weight and length above -2SD also at 3 months CA 
(n=274) had 4.1 points higher IQ at 19 years, compared with those who were short, light, 
or both at 3 months CA (n=79), after adjusting for gestational age, sex, and parental 
factors including SES. 59% of adult survivors underwent neuropsychological assessment. 
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Belfort and colleagues showed that post-term growth in length, but not in BMI, predicted 
adult IQ among preterm adults with birth weight ≤2500g.264 The participants were 633 
young adults born in the US in 1984-1985, representing 60% of those preterm infants 
who had originally taken part in the Infant Health and Development Program.264 A larger 
increase in length z scores between term and 4 months CA was associated with lower odds 
of having low IQ (<85 points) at 18 years (OR 0.78). Length growth between 4 and 12 or 
12 and 18 months, adjusted for earlier growth, or BMI increase during any of these 
periods did not predict low IQ in adulthood. Child and maternal age, sex, gestational age, 
maternal smoking, and parental factors including SES and a maternal IQ estimate, as 
well as participation in the educational intervention were adjusted for.  
Finally, Stein et al. reported educational outcomes among adults from low- and middle-
income countries (Brazil, Guatemala, India, Philippines, and South Africa).229 They noted 
that among the 492 preterm adults with schooling data available, those who had faster 
length growth in infancy, independently of birth length, sex, or study location were more 
likely to have completed secondary school.229 
2.5.3.3.  Effects of early growth on cognitive and academic outcomes: evidence from 
childhood follow-up studies 
In line with these adult studies are the many studies on preterm,303 early preterm (<33 
weeks),304 very preterm,184,305–307 extremely preterm,181,308,309 VLBW,184,306,310 and 
ELBW187,311–313 children, which have shown that poor growth in infancy is associated with 
poor cognitive functioning at 16-36 months CA187,304,310,313,309 and at 5-10 
years181,184,303,305–308,311,312 (calendar age, in most studies). However, four studies on 
preterm,314 VLBW315,316 and ELBW236 children showed no statistically significant 
associations between growth after birth and cognitive functioning at approximately 2 
years236,316 or 4-8 years.314,315 Most of these growth studies and some studies on size as a 
predictor of cognitive functioning were reviewed (and presented in table format) by Ong 
and colleagues in 2015.317  
Almost all of these studies associated growth with general estimates of cognitive 
functioning and development181,184,187,303–308,310–313,309 (such as IQ303,305–308,311). Some 
additionally showed that early growth is associated with both general estimates of both 
verbal and non-verbal reasoning.303,305 Visuo-motor integration showed a weaker, if any 
association with growth in the few studies that additionally examined it.303,305 Further, a 
few studies reported that faster early growth predicts better school outcomes, including 
a lower rate of teacher-reported learning problems312 and better reading and spelling 
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skills.303,308 In addition to the cognitive outcomes, in some,181,187,236,304,308,310,313,309,316 but 
not all305,311 studies, poor early growth was associated with poor motor development. 
More specifically concerning the timing and measure of growth, several (but not 
all181,307,310,315,316) studies reported that better cognitive functioning184,187,304–306,308,312,313,309 
and school outcomes308,312 are associated with faster head growth during time periods 
that included the very first weeks and months of life: from birth to discharge,187 to 4 
months CA,312 to 2 years CA,306,308 and to 6-10 years,184,305 from NICU admission to 
discharge,309 from the 1st week of life to term,304 and from the day of regaining birth 
weight to discharge.313 What about time periods that did not include the first few weeks 
or months of life? Several studies reported that head growth from discharge to 3 
months,307 term to 2 years,306 and from discharge to 16-36 months CA,309 to 5 years CA,181 
or to 6-10 years184 was associated with better cognitive outcome, whereas one reported 
effects between before but not after term.304 Head growth after infancy (which occurs to 
a much lesser degree) was not associated with improved performance.307,308,312,315  
Faster weight gain after birth has also been associated with better cognitive functioning. 
These associations have been found in studies that have looked at growth periods 
extending from birth to discharge,181 to 2-3 years CA,303,306,310 and to 5-10 years,184,311 from 
the 1st week of life to term,304 and from the day of regaining birth weight to discharge.313 
However, other studies have reported that weight gain from birth to 1-2 years236,308,316 or 
to 4-7 years314 was not associated with cognitive outcome, and more rapid weight and 
BMI gain after term seems unrelated to general estimates of cognitive functioning.304,308 
It has been suggested that rapid early postnatal weight gain (along the intrauterine rates) 
is a good marker of sufficient nutrition and good health during a time when almost all 
preterm infants are below the expected mean weight, but the increase in fat-free-mass, 
rather than the accumulation of fat mass, is the component of weight gain that better 
predicts neurodevelopment among hospitalised preterm infants.318 
Rapid length growth after birth was not associated with childhood cognitive functioning 
in a number of studies which examined growth from birth to approximately 2 years 
CA306,310,316 or to 5 years311, and from the 1st week of life to 12 months CA.304 One study 
reported that length gain between birth and discharge, but not between discharge and 6-
10 years, was associated with better cognitive functioning in school-age very preterm 
children.184 Offering some support to this was a study of VLBW children that reported 
that length in infancy, but not at birth, was predictive of neurodevelopment at 2 years: 
however, this latter study did not, strictly speaking, examine growth per se (but rather, 
reported the effects of length at different time points, after showing that size at birth did 
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not significantly differ among the participants), and the authors only adjusted for birth 
head size and weight when analysing the effects of birth length, but not when analysing 
those of later length.319 Further, the adult study by Belfort et al. (described in the previous 
section) also reported childhood outcomes, showing that length growth from term to 4 
months, but not later in infancy, was associated with higher IQ at 8 years.264  
The few studies that have specifically looked for sex differences in the association 
between growth and neurodevelopment have found none.304,310 Comparisons of AGA and 
SGA children have not reported consistent results. One US study compared relatively 
healthy preterm AGA children with or without postnatal weight growth restriction and 
SGA children with or without weight catch-up growth.303 They reported that the children 
who had both prenatal and postnatal growth problems (n=43) had the poorest cognitive 
outcome, whereas SGA infants with good catch-up growth (n=68) performed similarly to 
AGA children with no growth problems (n=434).303 Among AGA children, those with 
postnatal growth problems (n=110), performed worse than those without.303 Somewhat 
in line, one Australian study of early preterm children (gestational age <33 weeks) 
reported that faster infant weight and BMI gain was strongly associated with better 
cognitive functioning among SGA children (n=50), but found much weaker effects among 
AGA children (n=511).304 In contrast, a Finnish study found that faster infant weight and 
head growth were associated with higher IQ only among AGA children (n=122), but not 
SGA children (n=59) in a cohort of very preterm and VLBW children.306 Finally, 
somewhat similarly, a Dutch ELBW study reported that AGA children whose weight z 
scores remained normal (≥-2SD at birth and at 5 years, n=53) had higher IQ, compared 
with those AGA children whose weight decreased below the -2SD cut-off (n=27), but 
catch-up weight gain among SGA (n=21) children was unrelated to IQ.311 The latter study 
reported a non-significant trend in the same direction among their small SGA group as 
among their larger AGA group (i.e., increasing and non-decreasing z scores were 
associated with better neurodevelopment),311 but the Finnish study did not.306 Because 
the cohorts and methodology varied in many ways, and potential interactions were not 
statistically addressed, it is difficult to get to the bottom of why these results conflict. 
The approach to dealing with potential confounders has varied quite considerably across 
studies. One recent study that specifically looked at the effects of adjustment for early 
illness (IVH, BPD, sepsis, NEC, and postnatal steroids) concluded that these had a 
significant role in explaining the associations between head growth sparing and infant 
neurodevelopment, even more so with cognitive than with motor outcomes.187 The others 
who found evidence of an association usually adjusted for some illnesses such as severe 
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IVH or other neonatal brain abnormality,181,184,304,308,310,313 postnatal 
corticosteroids,304,308,313 BPD,304,310,313 and the length of ventilation.181 Most who reported 
associations also adjusted for basic child characteristics (such as sex, age at assessment, 
and gestational age)181,184,187,303,304,306,310,313,309 and SES,181,184,187,303,304,306,308,313 and one 
even included maternal smoking during pregnancy and breast-feeding status at 
discharge.304 Some studies did not report adjusting for potential confounders:305,307,311,312 
this was perhaps because some aimed to simply describe the prognosis for growth 
restricted children, rather than untangle the effects of underlying factors, or because 
associations between growth and neurodevelopment were presented quite briefly as 
additional information. In one study, the associations remained after Bonferroni 
correction:303 others did not report correction for multiple testing.  
Further, study populations varied in many ways. Associations were found even in 
populations where disabled or severely ill participants had been excluded (depending on 
the study, this meant congenital malformations,187,304,306–308,310,313,309 chromosomal 
abnormalities,304,306,308 cerebral palsy,184,308 visual/hearing impairment,308 
hydrocephalus with shunt placement,187,309 or even anyone with low Apgar scores,310 
long-lasting corticosteroid medication,306 microcephaly at birth,309 or any severe illness 
or neurological impairment at all303). However, several studies did not mention any pre-
defined exclusion criteria.181,305,311,312 This can make interpretation more difficult, because 
some of these underlying conditions can affect growth, neurodevelopment, and perhaps 
even more worryingly, the reliability of neuropsychological assessment.  
Further, there was heterogeneity in the way growth variables were constructed, and even 
the choice of growth standards used across studies could have impacted the results.310 
There are also a number of studies which claimed to study growth, but actually looked at 
size at some specific point of development (rather than change in size). Size can certainly 
be relevant in a number of situations, however, for the purpose of this thesis, I specifically 
wanted to address the question of whether growth predicts adult outcomes, and I have 
thus not included all those studies that studied size in my literature review: they answer 
a different question. 
To give an idea of the background setting of the studies, I have listed the years of birth, 
the country, city or cohort name, and the number of participants who were included in 
the childhood follow-up analyses that were described in this section in Table 1.  
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Table 1. Background information of studies on growth after preterm birth and childhood 
cognitive functioning. 
Reference Years 
of birth 
City, area, or cohort name, 
and country 
Number of 
participants 
Stathis et al (1999)312 1977-1986 Brisbane, Australia 87 
Cooke (2006)315 1980-1981 Merseyside, UK 194 
Latal-Hanjal et al (2003)316 1983-1994 Zürich, Switzerland 219 
Casey et al (2006)303 1984-1985 IHDP, US a 655 
Kan et al (2008)308 1991-1992 Victorian Infant Cohort, Australia 179 
Cooke & Foulder-Hughes 
(2003)305 
1991-1992 Liverpool, UK 268 
Huang et al (2013)314 1993-1996 Hebei, Zhejiang, Jiangsu, China 654 
Ehrenkranz et al (2006)313 1994-1995 NICHD NRN GOS, US 495 
Lidzba et al (2016)184 1995-1997 Tübingen, Germany 136 
Franz et al. (2009)181 1996-1999 Ulm, Germany 219 
Claas et al (2011)311 1996-2005 Utrecht, the Netherlands 101 
Sices et al. (2007)236 1997-1999 Ohio, US 154 
Belfort et al (2011)304 2001-2005 DINO, Australia 613 
Leppänen et al (2013)306 2001-2006 PIPARI, Finland 181 
Neubauer et al (2016)307 2003-2009 Tyrol, Austria 273 
Nash et al (2011)310 2004-2006 Sunnybrook, Canada 289 
Meyers et al (2016)187 2009-2010 NICHD NRN GDB+F, US 658 
Raghuram et al (2017)309 2009-2011 CNN and CNFUN, Canada 1973 
 
a Belfort et al. later reported adult outcomes in this cohort, as described in the previous        
section. 264 
Abbreviations: CNFUN: the Canadian Neonatal Follow-Up Network; CNN: the Canadian 
Neonatal Network; DINO: DHA for the Improvement of Neurodevelopmental Outcome; IHDP: 
Infant Health and Development Program; NICHD NRN GDB: the National Institute of Child 
Health and Human Development Neonatal Research Network's Generic Database and Follow-
up Studies; NICHD NRN GOS: the National Institute of Child Health and Human Development 
Neonatal Research Network Growth Observational Study; PIPARI: Development and 
Functioning of Very Low Birth Weight Infants from Infancy to School Age 
 
It is noteworthy that while temporally varied, the results available for this review of 
childhood outcomes were almost exclusively based on cohorts born in wealthy Western 
countries, except for one study whose participants were born in China.314 That study 
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differed from the majority of others in many additional ways: it was one of the few not to 
report significant associations, the only to include (a majority of) late preterm infants in 
the study group, one of the few to look at weight gain from birth to 4-7 years without 
earlier measurement points, and the only one to adjust for maternal IQ among a large 
number of other family-related covariates.314 Because of these several differences, it is 
difficult to say why they reported findings that were different from most others. It is 
hardly only because of adjustment for maternal IQ: the adult study by Belfort and 
colleagues suggested significant associations between growth and cognitive functioning 
even when maternal IQ was adjusted for.264 It seems unlikely, also, that early growth after 
preterm birth would not matter in lower-income-settings, but it certainly may reflect 
partly different underlying mechanisms, as nutritional and medical resources are 
different and fewer extremely preterm or severely ill infants survive to assessment at 
all.229 Further, even among preterm infants born in low- and middle income countries, 
faster early growth predicts better adult educational attainment, as described in the 
previous section.229 One can even argue that in terms of survival and neonatal care, the 
cohorts born in high-income countries in the 1970s and early 1980s are more similar to 
the infants of low- and middle-income countries today, and that their results could 
generalise more to lower-income settings (with basic maternal and neonatal care), rather 
than to current preterm infants born in high-income countries where intensive care is 
available. 
Taken together, these adult and child studies suggest that growth in early infancy predicts 
cognitive functioning, more so than growth after this early period does. Further, head 
growth seems perhaps the most consistent growth marker of neurodevelopment, 
followed by weight gain, and only then, length growth. However, the first two have also 
received more research attention, and different growth measures may be differentially 
associated with neurodevelopment at different time points, and evidence regarding these 
effects is somewhat conflicting. Further, due to methodological differences, estimating 
any effects sizes is difficult. Only a few studies have looked at how these effects might 
persist into adulthood, what kind of measurements best predict what kind of outcomes, 
or whether some subset of preterm infants benefits more than others, and evidence 
regarding late preterm infants is lacking. Finally, and perhaps most interestingly, it is 
unclear what underlies the effects between growth and neurodevelopment - is it nutrition, 
intrauterine events and growth patterns, genetic potential, or illness, for example - and 
can something be done to help?  
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2.5.3.4.  Effects of early nutrition after preterm birth on cognitive and academic 
outcomes in adulthood 
Only a few studies have looked at the effects of early nutrition among preterm infants on 
adult cognitive outcome - or any other adult outcomes, for that matter.  
For the purpose of this review, the most interesting perhaps are the results from the 
feeding trials conducted by Lucas and colleagues among preterm infants (birth weight 
<1850g) born in the UK in the early 1980s. The trials and some of their other findings 
were also described in section 2.5.2.3.  
In these two separate randomised controlled trials, researchers compared multinutrient-
enriched preterm formula against standard formula commonly used for term-born 
infants,267 and preterm formula against unfortified donor milk.268 All mothers were given 
the opportunity to provide maternal milk, and the studied products were given as a 
supplement, or as the sole diet when no maternal milk was available. Later, the 
researchers combined data from both trials and showed that those randomised to receive 
multinutrient-enriched formula (vs term-formula or donor-milk) had higher VIQ at 13-
20 years of age.320,321 These positive effects contrast somewhat with the earlier findings 
within that same population, which did not find that fortified formula would consistently 
improve neurodevelopmental scores at 18 months322 or at 7.5-8 years.323 While it could 
be that some effects of early nutrition only become apparent with age, attrition 
complicates the interpretation of these findings: of the total of 926 infants who were 
originally enrolled in the trials, data for only 95 participants320 and 76 participants321 
were available for analysis at 13-20 years.  
Data from this adult/adolescent follow-up were also used to report observational 
findings: in a subsample of 50 participants of the 13-20 year follow-up, those who had 
received more maternal milk in infancy had higher VIQ.324 Maternal milk intake was 
understandably not randomised, and one can speculate that intake was limited by early 
illness and the amount of milk the mothers were able to provide, for example. Data on 
neonatal complications were not available in these publications. 
Two others, to my knowledge, have reported findings from adult observational cohorts. 
In the study by Brandt and colleagues that was also discussed in section 2.5.3.2., energy 
intake during the first 10 days of life was not associated with IQ at 23 years among 46 
VLBW SGA individuals born in 1967-1975, after adjusting for SES only.239 Neonatal 
complications were not addressed, but the VLBW survival rate of less than 40% at the 
time suggests that only the healthiest members of the cohort could be followed-up.239 
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Finally, Breeman and colleagues very recently compared a range of neonatal predictors 
of cognitive functioning among the 260 very preterm or VLBW adults of the Bavarian 
Longitudinal Study born in Germany in 1985-1986, as also noted in section 2.5.3.1.289 
They reported that a longer duration of parenteral nutrition was associated with higher 
adult IQ (with an effect size of 0.19 IQ points per day), when a large variety of other 
factors related to neonatal health and family environment such as gestational age, size at 
birth, BPD, RDS, and the duration of mechanical ventilation were taken into account.289 
Further, they reported that although those who were being breast-fed at the 5-month 
follow-up had higher adult IQ than those who were not in unadjusted models, the effects 
attenuated to non-significance after taking the multiple other predictors such as SES and 
illnesses into consideration.289  
2.5.3.5.  Early nutrition after preterm birth and cognitive and academic outcomes: 
evidence from childhood studies  
Literature concerning nutrition after preterm birth and neurodevelopmental outcomes 
in infancy is quite abundant. Some studies have also extended their follow-up to school-
age.  
In observational settings, among ELBW190,325 and VLBW326 children, higher energy,190,325 
protein,325 and lipid326 intakes during the first weeks of life predict better 
neurodevelopmental scores at 12-22 months. However, it would seem that these effects 
are mainly driven by the most critically ill neonates, among whom nutritional intake 
could reflect or mediate the effects of illness severity.190 Further, some have reported that 
ELBW infants born after the introduction of a more aggressive nutrition protocol (which 
changed, in particular, the provided amount of protein, amino acids, and total energy), 
rather than before this shift in protocol, receive better neurodevelopmental scores at 2-3 
years, after adjusting for some basic potential confounders,327 whereas others did not 
reported differences that would survive adjustment.328 Certainly, the risk of residual 
confounding in these studies remains.    
Perhaps the most compelling evidence exists for feeding with maternal milk, which is the 
recommended primary basis of nutrition for preterm and term infants alike.163,205,206,329 
Of course, randomised controlled trials of breastfeeding would be unethical and 
practically quite impossible to conduct. Thus, evidence of benefits is mostly based either 
on observational studies, or on studies that have compared donor human milk versus 
formula as a source of nutrition when sufficient amounts of maternal milk are not 
available. Although donor milk is pasteurised and may not provide the immunological 
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and mother-child-interaction benefits of maternal milk and direct breast-feeding, both 
maternal and donor milk are recommended over formula use, however both need to be 
fortified during the early period to enable the preterm infant to meet growth expectations, 
as discussed in section 2.4.4.5.163,205,206,329 
Many observational studies have indeed linked breastfeeding and maternal milk with 
better neurodevelopment. Among very preterm330,331 and extremely preterm infants,285 
and infants with birth weight <1850g,332 with VLBW,333 and with ELBW,334 those who 
received more or any maternal milk during the initial hospitalization,285,330,332,334 who 
were breast-fed at discharge,331 and who were breastfed for at least eight months333 had 
better cognitive test scores330–334 and school skills285,330 than comparison groups at 2.5 
years,334 2 or 5 years,331 and 7-11 years.285,330,332,333 All of these studies adjusted for some 
maternal background factors (such as maternal age, maternal education, marital status, 
employment status, income status, maternal or child ethnicity, and parity) and infant 
characteristics (such as gestational age and gender) and early complications (such as 
severe IVH, PVL, sepsis, BPD, and NEC), and a few studies also included maternal 
smoking during pregnancy333 and neonatal weight gain.330 Missing from this list of 
potential confounders is maternal IQ, which has been suggested to contribute to the 
observed associations between breast-feeding and child neurodevelopment.335 One 
observational study compared VLBW children who had been breast-fed (n=125) with 
those who had received maternal milk from a bottle but had never been actually breast-
fed (n=142) or who had never received maternal milk (n=153) in infancy.335 In the first 
group, they found significantly better general, verbal, visuo-spatial, and motor skills at 6-
8 years, but these associations were attenuated to non-significance after adjusting for 
SES-related factors and an estimate of maternal verbal IQ, except that visuo-motor 
integration scores were slightly better.335 
A few other studies have also conflicted with the studies that have reported that maternal 
milk or breast-feeding benefit neurodevelopment among preterm infants. One study 
found no association between the amount of maternal milk intake during the first month 
of life and cognitive outcomes at 20 months CA among 98 VLBW infants,336 and another 
reported no association between the duration and amount of breast-feeding during the 
first year of life and cognitive outcomes at 12 months CA among 148 VLBW infants.337 
These two studies adjusted for potential confounders that were similar to the ones listed 
in the previous paragraph, but interestingly, both assessed outcomes earlier than the 
studies which reported positive findings. It is possible that some subtle effects of breast-
feeding only become evident with age. However, it is also possible that the effects of SES 
66 
 
and other family factors on cognitive functioning become more evident with age, and 
breast-feeding in our society is a reflection of these others environmental factors, not a 
(major) causal agent behind improved neurodevelopment.  
Somewhat in line with this pessimistic view, donor milk vs formula trials among preterm 
infants have been unable to show that one would offer clear cognitive benefits over the 
other, although feeding with donor milk is otherwise beneficial (it is associated with a 
lower risk of feeding intolerance and NEC, which, one could argue, indirectly promotes 
also optimal neurodevelopment), as reported by a Cochrane review in 2014.205 The only 
neurodevelopmental data available to that systematic review were from the studies by 
Lucas et al., described also in the previous section, which compared unfortified donor 
milk against preterm formula before discharge among preterm children, either as a sole 
diet (sub-trial A) or as a supplement to any maternal milk the mother chose to provide 
(sub-trial B). At first, those who were given preterm formula as a supplement had less 
developmental problems than peers who were given unfortified banked donor milk as a 
supplement (B), based on the Knobloch screening inventory at 9 months CA, but there 
were no significant differences between those who received only donor milk vs preterm 
formula as a sole diet (A).268 In the follow-up however, when neurodevelopment was 
tested at 18 months CA, no significant developmental differences emerged between any 
of the four diet groups in either sub-trial A or B.322 Unfortunately, to my knowledge, the 
researchers did not provide comparisons of these original donor milk vs formula trial 
groups at later follow-ups.   
Despite intense interest, other randomised controlled studies and their meta-analyses 
have also failed to show that any other specific nutritional intervention would 
significantly benefit neurodevelopment. One Cochrane review from 2016 examined 
fortification of human milk (with protein, energy, and usually micronutrients) during 
hospitalization210 for preterm infants, and concluded that based on the published338 and 
unpublished data from the trials by Lucas and colleagues - again, the only ones to report 
neurodevelopmental outcomes at or after 1 year of age - multi-nutrient fortification of 
human milk before discharge did not affect neurodevelopmental status at 18 months.210 
A trial by Tan and al. further suggested that an intervention which increased both the 
energy and protein content of enteral and parenteral nutrition during initial 
hospitalization of very preterm infants was not associated with cognitive or motor 
outcomes at 9 months CA.339 
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Two other Cochrane reviews from 2012 and 2013 examined whether nutrient-enriched 
formula (vs standard term formula) after discharge211 or multinutrient-enriched 
human milk (vs unfortified human milk) after discharge209 had an impact on preterm 
infants' neurodevelopment. The first review identified four relevant studies which 
reported no effects on neurodevelopmental outcomes at 12-18 months CA,340–343 and 
concluded that there was no evidence to support the use of preterm formula after 
discharge.211 In line, nutrient-enriched formula trial findings published after the 
publication of the 2012 Cochrane review also showed no effects at 2 years CA.344 
Similarly, the 2013 Cochrane review found no evidence of benefits of fortifying human 
milk after discharge but rather stated that it had the potential to interfere with breast-
feeding,209 however they also cautioned that only one small study had examined 
neurodevelopmental outcomes (and found no difference among the fortified vs non-
fortified milk groups in mental, motor, or behaviour rating scales).345 
Trials of increasing the amount of amino acids in parenteral nutrition346–348 or the 
amount of amino acids in parenteral nutrition and of protein in enteral nutrition349 have 
also not shown differences in neurodevelopment, assessed at approximately 2 years CA 
among ELBW or VLBW neonates.346–349 One Cochrane review from 2016 examined the 
potential effects of supplementation with one common amino acid, glutamine, 
specifically.214 The authors identified three trials that assessed neurodevelopmental 
outcomes after early infancy, and none of them showed significant differences in these 
outcomes. One of the three studies reported no differences between early parenteral 
amino acid provision (n=154, ≥3g/kg/day at ≤5 days of life) vs late provision (n=714) in 
terms of neurodevelopment at 18 months CA among ELBW infants, in a secondary 
analysis of the NICHD NRN glutamine trial data.350 The two other studies were from a 
single trial that compared glutamine supplementation in milk or formula (n=40, 
0.3g/kg/day at 3-30 days of life) against placebo supplement (n=32) during the first 
month of life after very preterm or VLBW birth, and found that neither general 
neurodevelopment at 2 years CA,351 nor IQ, executive functioning, or parent- or teacher-
rated behavioural, mental health, and learning outcomes at 7.5 years were different 
between the groups:352 however visuo-motor ability was poorer in the glutamine 
supplement group.352  
Another Cochrane review from 2014 examined higher versus lower protein intake during 
the initial hospital stay in formula-fed preterm or low-birth-weight infants and found two 
small studies on preterm infants, and yet again reported that these offered no convincing 
evidence of cognitive benefits.213 One of the studies reported no difference between high-
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protein (3.2 g/kg/d, n=16) vs low-protein (2.6 g/kg/d, n=14) fed VLBW children at 2 
years.353 Another study reported, among a subset (n=15) of the 16 VLBW infants in the 
high-protein (3.1-3.8 g/kg/day) vs 7 infants of the low-protein (2.6 g/kg/d) group, that 
those who received more protein had higher scores on the Neonatal Behavior Assessment 
Scale.354 Methodological problems such as the very small number of participants and the 
unreliability of neonatal assessment for any long-term neurodevelopmental outcome 
make any conclusions difficult to draw. Further, two studies have reported that very 
preterm infants fed protein-enriched human milk (4.8 g/kg/day, n=19) vs a control 
supplement (3.5 g/kg/day, n=13),355 and infants with birth weight <2000g who were fed 
very high protein (6.0-7.2 g/kg/d, original n=152) vs high protein (3.0-3.6 g/kg/d, 
original n=152) diets356 had lower IQ scores at 3 months CA355 and at 5-7 years,356 
suggesting that effects of increasing protein content (considerably) could even be 
detrimental. Unfortunately, full text versions of these single studies which were mostly 
published decades ago were unavailable to me, and the number of participants may have 
been smaller in the cognitive outcome analyses. 
Long-chain poly-unsaturated fatty acid enrichment has also been investigated in several 
studies, some of which initially seemed to suggest beneficial effects, but later proved less 
encouraging. One important study was the DINO trial which initially reported improved 
neurodevelopment at 18 months CA among girls who received more docosahexaenoic 
acid,357 but later concluded that supplementing enteral feeds with docosahexaenoic acid 
before term age did not result in any differences in IQ, attention, executive functioning, 
behaviour, visual-spatial perceptual skills, educational progress, or quality of life at 7 
years CA among the 657 preterm (<33 weeks) participants enrolled in the study: if 
anything, girls who received the supplement had more parent-rated behavioural 
problems.358 The lack of long-lasting effects was confirmed in three different meta-
analyses published in 2008-2012 that overlapped in terms of included studies.359–361  
As to micronutrients such as different vitamins, iron, calcium, phosphorus, and 
magnesium, little evidence to clearly indicate the optimal intake among preterm infants 
exist:362 neither the few available vitamin A363 nor prophylactic enteral iron364 
supplementation trials have shown significant cognitive benefits. 
Of course, absence of evidence is not necessarily evidence of absence - many questions 
about the associations of nutrition and cognitive functioning of preterm infants have not 
been studied or have only been studied among very small samples that may lack sufficient 
power to show small or even moderate effects even if they do exist. The effects of neonatal 
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nutrition on long-term outcomes are not an easy topic to tackle, not least because 
nutrition forms just one piece of a large puzzle, inevitably intertwined with illness and 
other early determinants of infant development. In trials, comparisons are usually made 
between an intervention group and those who receive the standard nutrition in whatever 
settings the study was conducted in. Surely, providing some "adequate" level of nutrition 
is the prerequisite of normal neurodevelopment, since providing some adequate level of 
nutrition is the prerequisite of any development and survival at all, but how to improve 
the neurodevelopment of a preterm infant by altering nutrition remains unclear. Taken 
together, what these studies suggest is not that nutrition does not matter, but rather, that 
although observational studies have hinted at long-lasting effects, the nutritional 
intervention studies that have been conducted so far have seldom looked at long-term 
neurodevelopmental outcomes, and those that have, have not shown that any specific 
nutritional interventions would have consistent benefits. 
2.5.4. Mental health  
2.5.4.1.  Mental health among adults born preterm 
Preterm-born adults are more likely than term-born adults to have mental disorders, 
according to large Northern European register studies with partly overlapping 
data.284,365–370 For example, one  Swedish register study showed that very preterm adults 
were 2.5, 2.9, and 7.4 times more likely than term-born individuals to be hospitalised 
because of non-affective psychosis, depressive disorder, and bipolar disorder, 
respectively.365 However, the findings from these and other studies are partly conflicting, 
and the risks may be specific to some outcomes and to certain subgroups of the preterm 
population.  
The range of examined outcomes is wide. Register studies have shown that preterm 
adults have more mood disorders (including both depression and bipolar disorder),365,366 
autism-spectrum disorder (ASD),284,367 attention deficit hyperactivity disorder 
(ADHD),367,370 stress-related disorders,366 and eating disorders365 than controls do. 
Several studies have indicated an increased rate of psychosis and schizophrenia among 
preterm individuals,365,367,368 but confounding parental background factors are likely to 
explain some of the observed increase.367,369 These factors also seem to heavily contribute 
to the increased suicide rate among preterm individuals, however their role in explaining 
neuropsychiatric disorders seems less important.367 Smaller clinical studies have also 
suggested that, based on standardised diagnostic interviews, VLBW371–373 and ELBW374 
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adults have more anxiety disorders,371,372 mood disorders,372,373 somatoform disorders,372 
and ADHD,371 but no more substance use disorders372,374 than normal-weight term-born 
controls do, even when SES-related and some other background factors are taken into 
account.  
VLBW participants also have more internalizing and avoidant personality problems than 
term-born controls, according to a recent pooled meta-analysis by APIC of 747 VLBW 
adults and 1512 term-born controls born in Canada, Norway, US, Germany, and Finland, 
including the VLBW cohort examined in this thesis.375 On some other self-reported 
indices of psychosocial adjustment and wellbeing, however, preterm adults seem to do 
better than term-born peers: the preterm participants of that meta-analysis reported less 
externalizing problems, rule-breaking behaviour, and intrusive and antisocial personality 
problems than term-born controls.375 The pattern of findings was similar in the different 
cohorts, neurosensory impairment or parental education did not account for these 
differences, and while both preterm men and women reported more internalizing 
problems than term-born controls did, the pattern of some findings was more 
pronounced among women.375  
In line with this meta-analysis and the anxious and shy adult phenotype it suggests, meta-
analyses of preterm children have suggested an increased risk of internalizing-type 
problems,376,377 but also more parent- and teacher-rated externalizing problems.376,377 It 
is unclear whether this "change" in the rates of externalizing behaviours represents an 
actual alleviation of some certain types of problems from childhood to adulthood. Some 
methodological differences may also contribute, and the parent- and teacher-reported 
externalizing problems of childhood (such as oppositional behaviour and hyperactivity) 
could represent a partly different phenomenon than adult-reported externalizing 
problems (such as delinquent behaviour and substance abuse). Overall, several studies 
have shown that parents report more mental health and behavioural problems among 
their preterm offspring than what the preterm individuals themselves report 
experiencing, both in childhood378 and in adolescence and young adulthood.379–381 Of 
course, when comparing childhood and adult studies (or register and self-report studies, 
for that matter), individuals with mental health problems may be less likely to actively 
participate in any voluntary study. 
As to actual quality of life, a meta-analysis from 2008 suggested that differences are more 
pronounced in childhood and attenuate with increasing age, so that preterm and term-
born young adults report very similar quality of life despite differences in health.379 Some 
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recent adult studies, however, have reported that very preterm and VLBW young adults 
report poorer health-related quality of life compared with term-born peers, especially in 
relation to problems in economic and social life.382,383  
Studies concerning the effects of late preterm birth specifically are scarce. The late 
preterm adults examined in this thesis and their term-born controls had similar rates of 
mood, substance use, and anxiety disorder based on psychiatric interviews.384 In another 
Finnish study, late preterm men had an increased risk of suicide, but otherwise late 
preterm birth was not associated with substance use, psychotic, mood, anxiety, or 
personality disorders among a register cohort followed up to old age.385 In a Norwegian 
register study, late preterm birth was associated with an increased risk of schizophrenia 
and disorders of psychological development, behaviour, and emotion (relative risk ratios 
1.3 and 1.5, respectively), but not with ASD.284 In a Swedish register study, late preterm 
birth was associated with an increased risk of psychotic or bipolar disorder, ASD, and 
ADHD, whereas the risk of substance use disorders was similar between late-preterm and 
term-born adults.367 All these studies took some SES-related factors into account. 
Several studies have suggested that within the preterm population, with decreasing 
gestational age, the risk of psychotic disorders, ASD, ADHD, and mood disorders 
increases.365,367 However, quite interestingly and somewhat in line with the findings of 
self-reported psychological wellbeing, extremely preterm adults may have even less 
substance use disorders and criminal convictions than the general population, while 
those born moderately or late preterm have a similar or slightly increased risk, compared 
with term-born adults.365,367 It is difficult to say why exactly this is: one can hypothesise, 
for example, that different degrees of prematurity are associated with different 
underlying risk factors (such as maternal health and behaviour), which also differently 
affect the risk of mental health disorder in the offspring. It can also be that differences in 
the nature, timing, and magnitude of early neurodevelopmental insults translate to 
differences in mental health (for example, some subtle forms of early brain injury could 
be more important in determining the risk of neuropsychiatric problems or schizophrenia 
than that of depression or substance use disorders). Further, preterm birth, and 
especially very preterm birth and the hospitalization and morbidity it entails, could affect 
early social interactions and susceptibility to parenting effects,386 as well as peer relations 
later in childhood,387 and this could then potentially affect further developmental 
pathways to adult mental health.  
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SGA birth may explain the observed association between preterm birth and mental health 
problems at least in part, but the pattern of findings is not entirely consistent.  The 
Finnish register study of late preterm adults followed into late adulthood suggested that 
SGA status, but not late preterm birth, was a risk factor for severe mental disorders.385 A 
Swedish register study that examined a large population of young adults concluded that 
preterm birth itself only increased the risk of hospitalization for the combined diagnostic 
class of child psychiatric disorders and mental retardation, whereas SGA birth was much 
more closely associated with psychiatric hospitalization both among preterm and term 
populations, however quite puzzlingly this was mostly observed only among males.388 
Within the preterm group, SGA men were more likely than AGA men to be hospitalised 
for any psychiatric disorder, psychotic disorder, personality disorder, child psychiatric 
disorders and mental retardation, and other disorders, but among women the 
associations were non-significant: the reasons for potential differential susceptibility 
among men and women remained unclear.388 Another Swedish-Danish study with partly 
overlapping data reported that both preterm birth and SGA status increased the risk of 
mental disorders, however gestational age was not examined independently of SGA 
status.368  
In our VLBW adult cohort, the increased risk of depressive389 and ADHD390 symptoms 
was confined to those who were born SGA, after adjustment for several potential 
confounders, suggesting that IUGR rather than preterm birth per se could explain the 
increased risk of some mental health problems. However, our VLBW participants 
reported more social interaction related autism-spectrum traits (but less attention to 
detail),391 and also had a more pronounced physical stress response (blood pressure 
elevation) in a psychosocial stress test,392 compared with controls, and for these outcomes 
no clear difference between AGA and SGA participants was observed. In the APIC meta-
analysis of which our cohort was part, both AGA and SGA preterm adults reported quite 
similar (increased) rates of internalizing and (decreased) rates of externalizing, compared 
with term-born peers.375  
Methodological differences (such as the variation in the populations, outcomes, and 
statistical models) can contribute to this seemingly inconsistent pattern of findings, but 
the effects of IUGR may also be outcome-specific, and the underlying mechanisms 
remain debatable. It is likely that at least in part, early growth restriction in these 
situations reflects some unmeasured confounders that also assert their influence on child 
development after birth. Maternal mental disorders, for example, are associated with 
smoking and other risk behaviours during pregnancy, adverse perinatal outcomes 
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including SGA birth, and an increased risk of mental disorders in the offspring, which 
may be (partly) mediated by parenting and home environment factors and also linked 
with genetic susceptibility.393 However, animal studies and recent evidence from human 
models also point towards a more direct causal link, suggesting that the early-life events 
which cause growth restriction could alter the pathways to adult mental health, for 
example through epigenetic changes in the early development of the CNS and endocrine 
systems.393,394 These explanations or potential mechanisms are by no means mutually 
exclusive. 
Taken together, the studies on adult mental health suggest an increased risk of some 
mental health problems among preterm individuals. This risk seems at least partly due 
to intrauterine growth restriction and its underlying factors rather than preterm birth per 
se. Based on the few existing studies, late preterm birth has little independent effect on 
adult mental health. These findings further supports the hypothesis that the complex 
mechanisms which underlie the association between preterm birth and the different 
aspects of neurodevelopment, mental health, and cognitive functioning are outcome-
specific.367 
2.5.4.2.  Early growth and nutrition after preterm birth and mental health 
Although the role of intrauterine growth restriction in predicting long-term mental health 
has received an increasing amount of interest, the role of extrauterine growth has not 
been studied much. This paucity of studies is actually rather surprising, given that the 
period of EUGR among preterm populations largely coincides with the period of IUGR 
among term-born populations, but growth during this time is caused by partly different 
factors: comparisons could thereby shed some light not only on the development of 
preterm individuals, but also on the association between early growth restriction and 
mental health problems in general. 
Concerning ASD, among our adult VLBW cohort, we reported that faster growth in 
weight, length, and head circumference from birth to term, but not from term to 12 
months CA, was associated with less self-reported autism-spectrum traits in young 
adulthood, however none of the participants had a diagnosis of ASD.391 Several pre-, peri- 
and postnatal factors including parental education, maternal pre-eclampsia and smoking 
during pregnancy, a range of neonatal complications, developmental disability, or 
intrauterine growth patterns did not explain this association.391 Ikejiri and colleagues also 
reported that the nine VLBW children with diagnosed ASD in their study showed poorer 
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early weight gain and head growth, compared with the 50 VLBW controls without ASD, 
however the small number of ASD cases left little room for assessing the role of the other 
pre- and perinatal characteristics which differed between the two groups.395 In contrast, 
Moss and Chugani reported that among VLBW children, those diagnosed with ASD had 
faster head growth from 9 to 24 months, but head size measurements at birth or growth 
data during the early period before term-age were unavailable in this study.396 Among the 
mainly term-born general population, several studies in the early 2000s suggested that 
ASD may be associated with reduced brain and head size at birth, followed by 
dramatically accelerated growth in infancy,397 however more recent studies have 
suggested that because of methodological problems, these earlier findings may have 
painted a much simplified picture of the complex associations between early growth and 
autism.398–400  
Concerning ADHD, one study reported that growth in head circumference during the first 
two years of life among ELBW individuals was not associated with parent- or teacher-
reported symptoms of ADHD in childhood.312 As with ASD, the evidence concerning 
ADHD and early growth among the mainly term-born general population is conflicting, 
and potentially further complicated by some effects of medication.401–403 Certainly, one 
can hypothesise that early growth restriction during a sensitive early period is associated 
with subtle alterations in brain development which increase the risk of neuropsychiatric 
disorders, but information from preterm populations is very scarce.404 Overall, the 
complex genetic and early environmental origins of both autism-spectrum disorders and 
traits and ADHD remain, despite intense interest, enigmatic.405–407 
In terms of more broad behavioural problems, the Chinese study by Huang et al., also 
discussed in section 2.5.3.3, reported that weight gain between birth and follow-up at 4-
7 years was not associated with parent-rated internalizing, externalizing, or other 
behavioural problems among preterm children (and unlike the findings for IQ which 
were discussed earlier, these associations were not significant even in the crude model 
adjusted for sex only).314 Similarly, a US study discussed in section 2.5.3.3 did not find 
that weight gain among preterm children (whether AGA or SGA at birth) would be 
associated with child behavioural problems at 8 years.303  
Finally, one neonatal glutamine supplementation trial, also discussed in section 2.5.3.5, 
examined parent- and teacher-reported behavioural problems and found no effects 
among very preterm or VLBW children at 7.5 years.352  
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3. AIMS OF THE CURRENT STUDY   
The preterm infant is faced with an increased risk of morbidity, early growth restriction, 
and neurodevelopmental problems, however the majority of preterm infants grow up to 
be as healthy and well-functioning as adults as their term-born peers. Faster early growth 
may predict better neurodevelopmental outcomes, but evidence of whether these effects 
persist into adulthood are scarce. Moreover, it remains unclear what explains this 
association: nutrition, morbidity, and prenatal risk factors have been suggested to 
contribute. Further, intrauterine growth, perhaps even more so than preterm birth itself, 
may predict mental health in adulthood, but evidence concerning the role of postnatal 
growth after preterm birth is limited to a few studies on children.   
1. The first aim of this study is to examine whether early growth after preterm 
birth predicts better cognitive functioning and mental health in adulthood. 
And if so, I wish to seek answer to the following further questions: 
2. Is there evidence of a sensitive period? 
3. Are associations outcome-specific? 
4. Is there any indication of mechanisms that underlie the associations?  
Based on the available earlier literature, I hypothesise that those individuals who grow 
faster after preterm birth have better adult cognitive functioning, compared with those 
who grow more slowly. I would also expect mental health to be associated with early 
postnatal growth, although earlier, somewhat conflicting evidence to support this is 
based mainly on studies of prenatal growth. Any sensitive period is likely to include the 
first few weeks and months of life and not extend beyond infancy. I also hypothesise that 
early nutritional intakes are associated with neurodevelopmental outcomes, but based on 
earlier literature, these associations may not be independent of early morbidity and 
familial and individual background factors. These questions are addressed in the four 
publications included in this thesis, with the following focus: 
I. Early growth and cognitive functioning among VLBW adults 
II. a. Early growth and depressive and ADHD symptoms among VLBW adults 
b. Early growth and psychosocial adjustment among VLBW adults 
III. Early growth and cognitive, academic, and mental health outcomes among late 
preterm adults 
IV. Early nutrition and cognitive functioning among VLBW adults 
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4. METHODS 
4.1. Outline of the study 
The studies included in this thesis were part of two larger longitudinal follow-up studies, 
the Helsinki Study of Very-Low-Birth-Weight Adults (HeSVA), which provided the 
VLBW participants, and the Arvo Ylppö Longitudinal Study (AYLS), which provided the 
late preterm participants. The role of growth in predicting adult cognitive outcomes and 
mental health was examined among both cohorts. In the AYLS cohort, I also looked at 
growth and school outcomes. Because growth was associated with cognitive functioning 
and detailed data on early nutrition were available in the HeSVA cohort, I further used 
those data to examine whether early nutritional intakes predict cognitive outcomes. 
In both studies, all participants gave their written informed consent. Studies were 
approved by the Ethics Committee for Children and Adolescents’ Diseases and Psychiatry 
at the Helsinki University Central Hospital (in HeSVA) and the Helsinki and Uusimaa 
Hospital District Coordinating Ethics Committee (in AYLS). Research staff were unaware 
of the early medical history or perinatal characteristics of the participants when assessing 
their adult physical or mental health, cognitive functioning, and wellbeing. 
Neuropsychological tests were administered and psychiatric interviews conducted by 
trained master's level psychology students (including myself), who were supervised by 
experienced clinical psychologists and, in the case of psychiatric interviews, also by an 
experienced psychiatrist.  
4.2. The Helsinki Study of Very Low Birth Weight Adults 
4.2.1. Participants 
The HeSVA cohort is a regional cohort of VLBW individuals born between 1978 and 1985 
in the province of Uusimaa, Finland. Originally, 474 VLBW infants were born during this 
time in the five Uusimaa maternity hospitals and admitted to the NICU of the Children’s 
Hospital at the Helsinki University Central Hospital, which serves the entire population 
of Uusimaa. Of these neonates, 335 (70.7%) survived until discharge, which was 
comparable to other cohorts born in high-income countries around that time.408,409 
In 2004-2005, those 255 of these survivors who were still traceable through the Finnish 
national personal identification number system and living within 110 km of Helsinki were 
invited to the first clinical follow-up, and 166 participated. During this visit, in addition 
to an extensive medical check-up, the participants completed several questionnaires 
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(Study IIa). In 2007-2008, 159 of these 166 participants were invited to a second clinical 
follow-up, and 113 participated. During this visit, the participants completed more 
questionnaires and underwent another medical check-up including an intravenous 
glucose tolerance test and neuropsychological assessment (Studies I, IIb, and IV). Figure 
7 shows a flowchart of the formation of the HeSVA study sample.  
Figure 7.  Formation of the Helsinki Study of Very Low Birth Weight sample. 
 
  
Study IIa: Depression, ADHD, and growthVLBW infants born in 1978-1985 
in Uusimaa and discharged alive
n=335
Died after discharge n=6
Did not participate, n=89
Study IIa 
analytical 
sample, 
n=157 
Excluded from study IIa, n=9 
• Did not complete 
questionnaire, n=2
• Intellectual disability, n=3
• No growth data, n=4
Invited to 2nd adult follow-up
n=159
Could not be traced or lived 
>110 km from Helsinki, n=74
Could not be traced, n=1
Lived abroad, n=2
Intellectual disability, n=1
Not eligible for an intravenous 
glucose tolerance test, n=3
Did not participate, n=46
Participated in 2nd follow-up
n=113
Study IIb: Psychosocial adjustment and growth
Study IIb 
analytical 
sample, 
n=104 
Excluded from study IIb, n=9 
• Did not complete 
questionnaire, n=5
• Intellectual disability, n=1
• No growth data, n=3
Study I: Neurocognitive abilities and growth
Study I 
analytical 
sample, 
n=103 
Excluded from study I, n=10
• Intellectual disability, n=2
• Blind, n=2 
• Cerebral palsy, n=6
Study IV: Neurocognitive abilites and nutrition
Study IV 
analytical 
sample, 
n=86
Excluded from study IV, n=27 
• No nutrition data, n=18
• Intellectual disability, n=1
• Blind, n=2 
• Cerebral palsy, n=6
ATTRITION EXCLUSION AND SAMPLE SIZE
Invited to 1st adult follow-up
n=255
Participated in 1st follow-up
n=166
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To form a comparison group, for each VLBW infant, the next consecutive singleton same-
sex infant who was born AGA at term in the same hospital was invited to participate in 
HeSVA (172 participated on the first visit, and 105 on the second visit). In this thesis, I 
focused on differences within the preterm population, not between term-born and 
preterm populations, and thus did not use the data for the term-born controls. 
Characteristics of the HeSVA participants are presented in Table 2.  
Table 2.  Characteristics of the Helsinki Study of Very Low Birth Weight participants. 
Table continues on next page 
 
Participants of 1st 
clinical visit  
2004-2005 a  
 
Participants of 2nd 
clinical visit  
2007-2008 a 
 M (SD) n (%) N  M (SD) n (%) N 
Characteristics at birth        
    Size at birth        
   Weight, kg 1.1 (0.2)  157  1.1 (0.2)  103 
   Length, cm  37 (2.4)  155  37 (2.4)  102 
   Head circumference, cm 26 (2.0)  155  26 (2.0)  100 
Small for gestational age        
   Weight ≤-2 SD  51 (32) 157   37 (36) 103 
   Length ≤-2 SD  49 (32) 155   29 (28) 102 
   Head circumference ≤-2 SD  35 (23) 155   22 (22) 100 
Gestational age, weeks 29 (2.2)  157  29 (2.3)  103 
    24-32 completed weeks (very preterm)  139 (89) 157   89 (86) 103 
    32-33 completed weeks (moderately preterm)  12 (8) 157   10 (10) 103 
    34-35 completed weeks (late preterm)  6 (4) 157   4 (4) 103 
Sex, male  66 (42) 157   43 (42) 103 
Mother smoked during pregnancy  28 (19) 147   17 (18) 97 
Neonatal complications and illnesses        
Duration of ventilator treatment, median days  
(25th to 75th percentile) 
 
4.5  
(0 to 14) 
154   
4.0 
(0 to 14) 
100 
Septicaemia  12 (8) 154   9 (9) 100 
Bronchopulmonary dysplasia  29 (19) 152   25 (25) 99 
Received indomethacin  44 (28) 155   33 (33) 101 
Surgery due to patent ductus arteriosus  8 (5) 155   8 (8) 101 
Blood exchange transfusion  25 (16) 155   15 (15) 100 
Intraventricular haemorrhage   111    78 
       none  90 (81)    64 (82)  
       grade I or II  16 (14)    10 (13)  
       grade III or IV  5 (5)    4 (5)  
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 Table continues on next page 
Table 2, continued (2/3) 
 
 
Participants of 1st 
clinical visit  
2004-2005 a  
 
Participants of 2nd 
clinical visit  
2007-2008 a 
 M (SD) n (%) N  M (SD) n (%) N 
Mean energy intake in infancy, kcal/kg/day        
 Total, birth to 3 weeks      94 (17)  86 
     from human milk, birth to 3 weeks     77 (24)  83 
 Total, 3 to 6 weeks     119 (15)  82 
     from human milk, 3 to 6 weeks     108 (22)  78 
 Total, 6 to 9 weeks     125 (15)  79 
     from human milk, 6 to 9 weeks     108 (26)  75 
Growth during infancy        
Weight, birth to term, kg 1.4 (0.4)  157  1.4 (0.5)  100 
Length, birth to term, cm 9.0 (2.6)  148  9.0 (2.7)  96 
Head circumference, birth to term, cm 7.6 (2.1)  147  7.5 (2.2)  92 
Weight, term to 12 months CA, kg 6.0 (1.0)  131  6.1 (1.0)  84 
Length, term to 12 months CA, cm 27 (2.7)  120  27 (2.6)  79 
Head circumference, term to 12 months CA, cm 12 (1.5)  93  12 (1.6)  58 
Characteristics in adulthood        
Age during clinical visit, years 22 (2.1)  157  25 (2.1)  103 
Highest education of a parent   157    103 
basic/primary or less  17 (11)    10 (10)  
      upper secondary  34 (22)    20 (19)  
      lower tertiary  62 (39)    40 (39)  
      upper tertiary  44 (28)    33 (32)  
    Cerebral palsy  13 (8) 157   0 103 
    Blindness  2 (1.3) 157   0 103 
Cognitive outcomes        
   Estimated full intelligence quotient     102 (15)  103 
   Verbal fluency raw test score, phonetic mean     12 (4.6)  103 
   Verbal fluency raw test score, categorical mean     19 (5.1)  103 
   ROCF raw test score, copy task     34 (3.1)  103 
   ROCF raw test score, immediate recall task     22 (7.0)  103 
   ROCF raw test score, delayed recall task     22 (6.8)  103 
   TMT raw score part A, seconds     38 (15)  103 
   TMT raw score, part B, seconds     80 (42)  103 
   Stroop raw test score, baseline task, seconds     78 (19)  103 
   Stroop raw test score, interference task, seconds     130 (36)  102 
   CPT, number of commission errors     11 (7.2)  101 
   CPT, hit reaction time, milliseconds     350 (56)  101 
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a  The first column presents the HeSVA participants from the 1st clinical visit who had mental 
health data available (Study IIa analytic sample). The second column presents the HeSVA 
participants from the 2nd clinical visit who had cognitive data available (Study I analytic sample). 
For more detailed information about the participants in each of the separate studies, please see 
the publications in the appendix. 
Abbreviations: APQ: Adult Problem Questionnaire; ASR: Achenbach System of Empirically 
Based Assessment Adult Self Report; BDI: Beck Depression Inventory; CA: corrected age; CES-
D: Center for Epidemiological Studies Depression Scale; CPT: Conners' Continuous Performance 
Test II; M: mean; N: number of participants with data available; n: number of cases; ROCF:  
Rey-Osterrieth Complex Figure test; SD: standard deviation; TMT: Trail Making Test; %: 
percentage of cases in relation to number of participants with data available 
4.2.2. Growth 
Weight, length, and head circumference measurements were retrieved from hospital and 
child welfare clinic records. Size at term was interpolated between true measurements, 
provided a measurement had been made within 28 days. The median time period 
between term and the closest true measurement point was one day for weight and four 
days for length and head circumference. Size at 12 months CA was interpolated if a 
measurement had been made within 42 days to allow a wider time range to increase 
sample size, since measurements were made less frequently at this age. The median time 
period between 12 months CA and the closest true measurement point was 15 days for 
weight and 16 days for length and head circumference.  
Size at birth and at term were converted into z scores by sex and 
gestational/postmenstrual age according to Finnish fetal growth reference charts from 
approximately the time our study participants were born (as discussed previously in 
Table 2, continued (3/3) 
 
 
Participants of 1st 
clinical visit  
2004-2005 a  
 
Participants of 2nd 
clinical visit  
2007-2008 a 
 M (SD) n (%) N  M (SD) n (%) N 
Mental health outcomes        
APQ sum score  38 (18)  157     
BDI sum score  4.5 (5.4)  157     
CES-D sum score  9.5 (7.5)  157     
ASR Total Problems T-score     49 (10)  100 
Internalizing Problems T-score     51 (12)  100 
      Externalizing Problems T-score     48 (10)  100 
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section 2.4.2).138 To standardise size at 12 months CA, Finnish infant growth reference 
charts from approximately the time when the participants were born were used.139,140 
These charts provide z scores for length and for head circumference and a percentage 
score of current weight in relation to expected weight for sex and CA. Therefore, length 
and head circumference at 12 months CA were converted into z scores by sex and age, 
whereas weight at 12 months was first converted into percentage scores for sex and age 
and thereafter, to facilitate comparison of effect sizes, into z scores within the VLBW 
cohort. Participants were classified as SGA for weight, length, and head circumference if 
the measurement in question was at or below -2 SD at birth: others were considered AGA. 
4.2.3. Nutrition 
Nutritional data during the initial hospital stay came from hospital records and were 
available for the first nine weeks of life, after which the number of participants with 
sufficient data was reduced because of hospital discharge. The data were divided into 
three three-week periods (birth to three, three to six, and six to nine weeks of age). This 
approach was chosen so that we could examine effects that were specific to the first few 
weeks of life, when morbidity is especially high (as discussed in section 2.3). Daily mean 
total energy intakes and energy intakes from protein, fat, and carbohydrates from all 
enteral and parenteral nutrition, and energy intake from human milk, including donated 
and maternal milk, per kilogram bodyweight were calculated for each of these three 
periods. The macronutrient content of the mother's own milk was estimated based on the 
nutritional composition data published by Anderson et al., who followed the milk content 
of mothers who delivered preterm.410 The nutritional composition of banked human milk 
was based on values published by Rönnholm et al., who analysed macronutrient contents 
of the banked milk used in the hospital where our study participants were treated.411,412 
Among these infants, enteral feeding was initiated through a nasogastric tube with 
human milk on the first or second day of life. Milk intake was then increased to a 
maximum of 200ml/kg/day according to individual tolerance, and maintained at this 
level until discharge. All milk was pasteurised. During the 9-week period, of the 86 
participants with nutritional and adult outcome data available, 81 (94%) received pooled 
donor milk, 59 (69%) received maternal milk, and 19 (22%) received formula. If targeted 
enteral feeding was not possible, intravenous fluids with glucose were initiated, and 
amino acids and lipids were gradually introduced from the second or third day onwards. 
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4.2.4. Cognitive functioning and mental health 
IQ was estimated according to Finnish normative data using four subtests (Vocabulary, 
Digit span, Similarities, and Block Design) of the Wechsler Adult Intelligence Scale, 3rd 
edition (WAIS-III), which has good psychometric properties as an assessment tool for 
general cognitive ability.413,414 Many short forms of this scale have been used previously, 
and several four-subtest combinations have been reported to have good, roughly equal 
accuracy in estimating full-scale IQ: it has been recommended that the combination be 
chosen based on the clinical characteristics and time limitations of the study in 
question.415,416 For the purpose of this study, subtests were chosen to cover both verbal 
and visuo-spatial ability as well as more crystallised intelligence and, on the other hand, 
fluid reasoning, within time constraints. 
Executive functioning, attention, and visual memory were assessed using five tests. The 
Trail Making Test (TMT) measures visual-motor speed and tracking, attention, and 
cognitive flexibility.417 TMT is one of the most widely used instruments for assessing 
attention and executive function, and while it is considered to have good sensitivity to 
neurocognitive deficits and good overall psychometric properties, one could argue its 
weakness is the lack of specificity when determining the cause of poor performance 
(which is why it is best used as a screening tool or in combination with other tests, much 
like other similar tests).414,418 The Bohnen modification of the Stroop test measures 
verbal-motor function and flexibility, response inhibition, attention, processing speed, 
and working memory.419 The Stroop task is also one of the oldest and most used tests of 
attention and response inhibition, but like the TMT, it has been criticised for lack of 
specificity and also for the lack of consistency across the many different versions of the 
same test.414 The Verbal fluency task measures verbal ability, executive control, episodic 
memory, processing speed, and flexibility.420 It is also a widely used and well-established 
test, however it has been criticised for tapping into somewhat different cognitive domains 
in different populations such as different age groups.414,421 The Rey-Osterrieth Complex 
Figure test (ROCF) measures visual memory encoding, storage and retrieval, and visual-
motor processing.422 This test has also been used and studied quite extensively, and while 
generally considered acceptable in its psychometric properties, especially its Copy subtest 
tends to have a ceiling effect problem.414 Finally, the computerised Conners' Continuous 
Performance Test II (CPT) measures sustained attention and response inhibition.423 In 
contrast to the four aforementioned tests that are administered face-to-face, the 
reliability and validity of this computerised test is somewhat less clearly established, 
although it has currently become one of the most widely used tests of attention and 
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concentration.414,424 All of these tests yield several subscale scores. Local normative data 
were not available for standardization. To reduce the number of related outcomes, 
principal component analysis with Varimax rotation was used. The first four components 
were included, because they explained 75% of the variation and only their eigenvalues 
were greater than 1.0. The components were named Verbal flexibility (on which higher 
scores reflected better performance especially on the Verbal Fluency and Stroop tasks), 
Visual memory (higher scores reflect better performance on ROCF), Visual flexibility 
(higher scores reflect better performance in the TMT), and Impulsivity (higher scores 
reflect shorter reaction times but also more commission errors in the CPT). The rotated 
component matrix is presented in the Study I article in the appendix. 
Mental health was assessed through widely used self-report questionnaires. During the 
first clinical visit, the participants completed the Beck Depression Inventory (BDI)425 and 
the Center for Epidemiological Studies Depression Scale (CES-D):426 on these scales, 
higher scores reflect more symptoms of depression. Both were administered, as BDI 
focuses more on the severity of symptoms, while CES-D focuses more on the frequency 
of symptoms: however, both yield similar results with similar reliability and validity.427 
The participants also completed the Adult Problem Questionnaire (APQ),428 on which 
higher scores reflect more behavioural symptoms of ADHD. The psychometric properties 
of this self-rating scale have received little research attention, unfortunately, but within 
the HeSVA cohort, it showed good internal consistency: the general coefficient of 
reliability calculated as described by Tarkkonen and Vehkalahti was 0.96.390,429 During 
the second clinical visit, the participants completed the clinically validated and 
standardized Achenbach System of Empirically Based Assessment Adult Self Report 
(ASR).430 This questionnaire yields a Total Problems score, on which higher scores reflect 
lower overall psychosocial adjustment, and two subscores, the Internalizing Problems 
subscore, which reflects symptoms of anxiety, depression, withdrawal, and somatic 
complaints, and the Externalizing Problems subscore, which reflects delinquent and 
aggressive behavioural symptoms.  
4.2.5. Other information 
From initial hospital records, sex, gestational age at birth (based on the mother's last 
menstrual period and confirmed by a single neonatologist using the Dubovitz 
examination), maternal smoking during pregnancy (self-reported, yes or no), and 
maternal pre-eclampsia during pregnancy (using standard blood pressure and 
proteinuria criteria431) were retrieved. Data on neonatal complications and illnesses were 
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also retrieved from records from the original hospital stay. Septicaemia was diagnosed if 
the infant showed symptoms and a blood culture was positive. BPD was diagnosed using 
the Northway criteria (if the infant needed supplementary oxygen at 28 days after birth 
and a chest x-ray showed typical findings).60 Surgery or indomethacin treatment due to 
PDA, and blood exchange transfusion due to hyperbilirubinemia were also recorded. The 
duration of ventilator treatment was divided into none, less than 8 days, 8-14, 15-28, and 
over 28 days. Neonatal cerebral ultrasound was being introduced during the study 
period. IVH was graded as mild (grade I-II) or severe (grade III-IV).55 None of the 
participants were diagnosed with necrotizing enterocolitis. 
In young adulthood, participants reported the highest education of either parent (divided 
into basic, secondary, lower tertiary, and upper tertiary education). Information about 
intellectual disability and neurosensory impairments (cerebral palsy or blindness; none 
reported severe hearing impairment) was provided by the participant or by a parent and 
supplemented by information from the early childhood records. Participants with 
blindness, cerebral palsy, or intellectual developmental disability were excluded because 
cognitive functioning could not be reliably assessed, except in model I of study II, where 
those with blindness or cerebral palsy provided mental health data and were included in 
the first model. Age during the adult assessment (which correlated highly with the year 
of birth) and the time periods between the closest true measurement point and term or 
12 months CA were also considered as covariates. 
4.3. The Arvo Ylppö Longitudinal Study 
4.3.1. Participants 
The Arvo Ylppö Longitudinal Study was founded as the Finnish arm of the Bavarian-
Finnish Longitudinal Study.432 Originally, all 1 535 infants who were born between March 
15th 1985 and March 14th 1986 in Uusimaa, Finland and admitted to the neonatal wards 
in obstetric units in the area or transferred to the NICU at the Children’s Hospital at the 
Helsinki University Central Hospital within ten days of birth were included. The reasons 
for admission ranged from severe illness and prematurity to need for brief inpatient 
observation. Additionally, for every two of these hospitalised infants, one infant who was 
not admitted to neonatal wards nor to the NICU was prospectively recruited from the 
maternal hospitals of the same area, resulting in a non-hospitalised group of 658 infants. 
Altogether, this cohort of 2 193 infants included 315 late preterm infants. At 5 months 
CA, 20 months CA, and 56 months, 277, 274, and 227 late preterm individuals, 
respectively, participated in childhood follow-up examinations.  
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In 2009–2012, we invited all of the cohort members who could be identified through the 
Finnish personal identification number system and who were living within southern 
Finland to participate in an adult follow-up. 270 of the invited were late preterm, and of 
them, 158 participated in this follow-up. After excluding participants with intellectual 
disability, congenital malformations, chromosomal abnormalities, or insufficient data, 
we had an analytic sample of 108 late preterm adults (Study III). Figure 8 shows a 
flowchart of the formation of the AYLS study sample. Characteristics of the AYLS 
participants are presented in Table 3.  
Figure 8.  Formation of the Arvo Ylppö Longitudinal Study late preterm sample. 
  
Could not be traced through the Finnish 
identification number system, n=18
Lived abroad, would have required overnight 
accommodation to participate, or address could not 
be traced, n=27
Were invited but did not participate, n=112
No birth/childhood anthropometric data, n=5
No adult cognitive, academic, or mental health     
outcome data, n=3
No precise gestational age, n=34
Intellectual disability, n=4
Congenital malformations or chromosomal  
abnormalities, n=4
Late-preterm individuals in the original cohort 
born in Uusimaa in 1985-1986, n=315
Late-preterm individuals invited to the adult              
follow-up, n=270
Late-preterm individuals who participated in 
the adult follow-up, n=158
Analytic sample, n=108
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Table 3.  Characteristics of the Arvo Ylppö Longitudinal Study late preterm participants. 
 M (SD) n (%) N 
Characteristics at birth    
    Size at birth    
   Weight, kg 2.7 (0.6)  108 
   Length, cm  47 (2.4)  108 
   Head circumference, cm 33 (1.6)  107 
Small for gestational age    
   Weight ≤-2 SD  20 (19) 108 
   Length ≤-2 SD  13 (12) 108 
   Head circumference ≤-2 SD  5 (5) 107 
Gestational age, days 250 (6)  108 
Sex, male  62 (57) 108 
Mother smoked during pregnancy  20 (19) 108 
Neonatal complications    
Received ventilation treatment  8 (7) 108 
Suspected septicaemia  18 (17) 108 
Apnoea  3 (3) 108 
Convulsions  3 (3) 108 
Apgar score below 8 points at five minutes  7 (7) 104 
    Admitted to a neonatal ward or NICU within 10 days of birth  101 (94) 108 
Breast-feeding status at five months CA   108 
   Never breast-fed  8 (7)  
   Breast-feeding discontinued  66 (61)  
   Currently breast-fed  34 (31)  
Growth during childhood    
Weight, birth to 5 months CA, kg 4.7 (0.9)  108 
Length, birth to 5 months CA, cm 19 (2.3)  107 
Head circumference, birth to 5 months CA, cm  10 (1.5)  106 
Weight, 5 to 20 months CA, kg 4.5 (0.9)  103 
Length, 5 to 20 months CA, cm 19 (2.4)  97 
Head circumference, 5 to 20 months CA, cm 5.8 (0.7)  100 
Weight, 20 months CA to 56 months, kg 5.9 (1.3)  86 
Length, 20 months CA to 56 months, cm 23 (2.4)  79 
Head circumference, 20 months CA to 56 months, cm 2.8 (0.6)  82 
Table continues on next page 
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Table 3, continued (2/2) 
 M (SD) n (%) N 
Characteristics in adulthood    
Age during clinical visit, years 25 (0.6)  108 
Highest education of a parent   108 
           basic/primary or less  11 (10)  
           vocational education  27 (25)  
           general upper secondary or lower tertiary  37 (34)  
           higher tertiary  33 (31)  
    Cerebral palsy  0 108 
    Blindness  0 108 
    Mother had a history of mental disorder a  14 (17) 81 
Cognitive and school outcomes    
   Estimated full intelligence quotient 108 (10)  103 
   General memory score 103 (13)  105 
   Verbal fluency raw test score, phonetic mean 17 (4.6)  105 
   Verbal fluency raw test score, categorical mean 23 (5.6)  105 
   TMT raw score part A, seconds 31 (10)  104 
   TMT raw score, part B, seconds 60 (17)  104 
   Stroop raw test score, baseline task, seconds 68 (15)  102 
   Stroop raw test score, interference task, seconds 120 (29)  102 
   Grade point average in comprehensive school, scale of 4 to 10 8.2 (0.9)  92 
   Received special education  35 (35) 101 
Mental health outcomes    
Diagnosis of mental disorder based on psychiatric interview b  34 (35) 98 
ASR Total Problems T-score 44 (11)  89 
           Internalizing Problems T-score 44 (12)  89 
           Externalizing Problems T-score 47 (9.0)  89 
 
a Of the 14 mothers who reported that they themselves had had a mental disorder during their 
lifetime, 11 reported depression and 3 reported an anxiety disorder; none reported other 
psychiatric disorders.  
b Of the 34 late-preterm participants diagnosed with at least one mental disorder, 14 were 
diagnosed with mood disorder, 8 with anxiety disorder, and 25 with substance use disorder.  
Abbreviations: ASR: Achenbach System of Empirically Based Assessment Adult Self Report; CA: 
corrected age; M: mean; N: number of participants with data available; n: number of cases; 
NICU: neonatal intensive care unit; SD: standard deviation; TMT: Trail Making Test; %: 
percentage of cases in relation to number of participants with data available 
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4.3.2. Growth 
From medical records, weight, length, and head circumference at birth were retrieved 
and converted into z scores by sex and gestational age using Finnish fetal growth 
reference charts.138 Experienced research nurses took the corresponding measurements 
at the 5, 20, and 56 month follow-up visits, and size at these time points was converted 
into z scores by sex and age using the WHO growth standards.129,130 Age was corrected for 
prematurity at 5 and 20 months but not at 56 months. Participants were classified as SGA 
for weight, length, and head circumference, if the measurement in question was at or 
below -2 SD at birth: others were considered AGA. 
4.3.3. Cognitive functioning, school performance, and mental health 
The neuropsychological assessment protocol was designed to provide estimates of 
general intelligence and memory functions, as well as provide information about 
executive functions, attention and processing speed. Seven subtests of the WAIS-III413 
were used to estimate IQ: these were Information, Similarities, Arithmetic, Digit span, 
Picture completion, Matrix reasoning, and Digit symbol coding. This seven-subtest short 
form has been shown to have good reliability and validity for estimating full-scale 
IQ.433,434  Three subtests of the Wechsler Memory Scale, 3rd edition,435 were used to 
estimate General Memory: these were Logical memory, Verbal paired associates, and 
Faces, as recommended by Axelrod and Woodard.436 For estimating general intelligence 
and general memory, local normative data were available.  
Participants also completed the Verbal fluency test,420 the TMT,417 and the Bohnen 
version of the Stroop test,419 which were described in more detail in section 4.2.4. 
Principal component analysis with Varimax rotation was used to reduce the number of 
these outcomes. The first component had an eigenvalue of above 1.0 and explained 57% 
of the total variance, and was named Executive functioning. Higher scores on this 
component scale reflected better performance in the Fluency, Trail Making, and Stroop 
tests. The rotated component matrix is presented in the Study III article in the appendix. 
Participants reported grade point average (GPA) on their final comprehensive school 
diploma, which is usually issued the year an individual turns 16 years in Finland. 
Participants also reported whether they had received remedial or special education in 
comprehensive school.  
To assess mental health, the participants were interviewed using the M-CIDI structured 
psychiatric interview.437 This is a valid and reliable instrument and has good concordance 
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with the structured clinical interview for the Diagnostic and Statistical Manual of Mental 
Disorders, 4th edition.438–440 The interview was used to diagnose common mental 
disorders including mood disorders (major depressive disorder, dysthymia, bipolar 
disorder), anxiety disorders (general anxiety disorder, social phobia, agoraphobia, panic 
disorder with agoraphobia, panic disorder without agoraphobia), and alcohol or other 
substance use dependence or abuse disorders within the past 12 months. The participants 
also completed the ASR.430 
4.3.4. Other information 
Retrieved from medical records, gestational age was based on fetal ultrasound performed 
before 24 weeks of gestation for 72 participants and on the mother's last menstrual period 
for 36 participants. Sex was also retrieved from these records. Both pre- and perinatal 
records were used to establish pregnancy-related factors: these included multiple 
pregnancy (singleton vs multiple), parity (primiparous vs multiparous), maternal pre-
pregnancy BMI (kg/m2), age at delivery (years), and hypertensive disorders 
(normotension vs hypertensive disorder), diabetes (no diabetes vs gestational or type 1 
diabetes; none had type 2 diabetes), and smoking (self-reported, no vs at least one 
cigarette per day) during pregnancy.  
Data on neonatal complications were collected by the paediatricians in the study staff 
who also worked at the hospital and made daily visits to the wards. These included the 
Apgar score at five minutes (0-7 vs 8-10 points), suspected septicaemia (based on 
symptoms), ventilation treatment, convulsions, and apnoea (each no vs yes). Ventilation 
treatment included continuous positive airway pressure and mechanical ventilation. No 
participants were diagnosed with intraventricular haemorrhage, necrotising 
enterocolitis, or blood-culture-positive septicaemia.  
The highest education of either parent (basic, vocational, general upper secondary, or 
tertiary), and child breast-feeding status at 5 months CA (never breast-fed, breast-feeding 
discontinued by 5 months CA, or currently breast-fed) were recorded based on parental 
interviews during childhood. Mothers of the participants also completed a background 
questionnaire and reported history of any mental disorder of their own during the adult 
follow-up phase. Participants with intellectual developmental disability, congenital 
malformations or chromosomal abnormalities, and those whose gestational age at birth 
could not be reliably established were excluded. Information about neurosensory and 
developmental disabilities and congenital anomalies and malformations came from the 
initial study records collected at the hospital and during the follow-up visits, and these 
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data were supplemented by information provided by the participants or by their parents 
during the adult follow-up. 
4.4. Statistical analyses 
4.4.1. Growth and adult outcomes 
As main predictors of cognitive, academic, and mental health outcomes, I used infant 
growth in weight, length, and head circumference during different time periods. In the 
HeSVA cohort, I looked at growth from birth to term and from term to 12 months CA. In 
the AYLS cohort, I looked at growth from birth to 5 months CA, 5 to 20 months CA, and 
20 months CA to 56 months. 
So that the duration of the growth period or earlier growth would not interfere with the 
interpretation of results, I used, as growth variables, standardised residual change scores 
from linear regression models where weight, length, and head circumference z scores 
were regressed on corresponding measures at previous time points, creating uncorrelated 
residuals that reflect growth conditional on previous history.441,442  
These growth variables were then used as independent variables in linear and logistic 
regression models to predict continuous and dichotomised outcomes, respectively. To 
facilitate comparison of effect sizes, I first square- or square-root-transformed the raw 
scores if necessary to improve linear model fitting, and then standardised these outcome 
scores within the sample, as described in more detail in the publications in the appendix. 
In additional analyses, as reported in the appendix, size z scores at different time points 
were used to predict adult outcomes. 
4.4.2. Nutrition and adult outcomes 
In study IV, I used linear regression models to test if nutritional intake from birth to 
three, three to six, and six to nine weeks of age predicted cognitive functioning in 
adulthood. The different nutritional intake variables included mean daily total energy 
intake, energy intake from human milk, and protein, fat and carbohydrate intakes.  
4.4.3. Differences according to sex, gestational age, and birth size 
In additional analyses, I tested if associations between growth or nutrition and adult 
cognitive, school, or mental health outcomes varied by sex, birth size, or very vs 
moderately or late preterm status. I first included a product term (continuous 
independent variable [growth or nutritional intake] x continuous or dichotomised 
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perinatal variable [sex, or standardised birth size, or AGA vs SGA status, or gestational 
age below vs at least 32 weeks]) into the regression equation followed by the main effects. 
When statistically significant interactions (p-values <0.05) were observed, the sample 
was divided into very vs moderately or late preterm participants (study I), AGA vs SGA 
participants (study II), or into thirds by standardised birth size (study III), and the main 
effects were assessed separately in each group. 
4.4.4. Adjustment models 
In each of the studies, different models were presented to show how adjustment for 
potential confounders affected the results. In the first model, I aimed to show the 
associations after adjustment for some basic background characteristics. In further 
models, based on analyses of how the different covariates associated with the 
independent and dependent variables, on data availability, and on earlier literature and 
theoretical expectations, I also adjusted for neonatal illnesses and other early-life factors. 
The details of the adjustments in each of the different models are presented in Table 4.  
Table 4. Covariates that were (+) or were not (-) adjusted for in each of the models.  
 Study I Study II Study III Study IV 
 I II I II I II III IV I II III 
Gestational age at birth + + + + + + + + + + + 
Age at child measurement a + + + + + + + + - - - 
Age at adult assessment + + + + + + + + + + + 
Sex + + + + + + + + + + + 
Parental education + + + + + + + + - + - 
Maternal mental disorder - - - - - - - + - - - 
Smoking during pregnancy - - - + - + + + - + - 
Other pregnancy-related 
complications b - - - - - + + + - + - 
Breast-feeding at 5 months - - - - - - + + - - - 
Neonatal complications c - + - + - - + + - - + 
 
a Age at child measurement refers to the time period between the closest true measurement point 
and term or 12 months corrected age in the HeSVA study, and to age during the follow-up visit in 
the AYLS study (corrected age at 5 and 20 months, and chronological age at 56 months). In Study 
IV, growth measurements were not examined, however birth weight z score at birth was included 
as a covariate in the analyses. 
b In study III, these included multiple pregnancy, parity, maternal pre-pregnancy BMI, age at 
delivery, hypertensive disorder, and diabetes, and in study IV, pre-eclampsia. 
c In studies I, II, and IV, these included septicaemia, bronchopulmonary dysplasia, indomethacin 
treatment and surgery due to patent ductus arteriosus, blood exchange transfusion due to 
hyperbilirubinemia, duration of ventilator treatment, and intraventricular haemorrhage. In 
study III, these included low 5-min Apgar score, suspected septicaemia, ventilation treatment, 
convulsions, and apnoea. 
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4.4.5. Missing data 
Participants were included in a specific model only if they had the predictor (growth or 
nutrition) and outcome data (performance in neuropsychological tests, school outcome, 
or mental health outcome) in question available. The number of participants for whom 
data were available are presented in Tables 2 and 3, and detailed in the publications in 
the appendix. 
In the HeSVA cohort, the number of participants with missing data varied according to 
the model in question. A maximum of 46 participants lacked data on IVH and ten 
participants lacked data on maternal smoking during pregnancy. These were dummy-
coded into separate groups. Two participants who lacked all neonatal complication data 
were excluded in the analyses which adjusted for these complications. The few 
participants with some missing complication data were either excluded in the models that 
adjusted for these complications in studies I and II, or, in study IV, the missing data were 
individually imputed based on all the available information from the records. 
In the AYLS cohort, the four participants without 5-min Apgar scores were included in 
the “8–10 points” category based on their high 1- and 10-min Apgar scores and clinical 
descriptions. Eight mothers without mention of blood pressure measurements, 
hypertension, or pre-eclampsia in any records were included in the “no hypertensive 
disorder” group. Twenty-seven mothers who did not complete the maternal background 
questionnaire at all or did not respond to the question about their possible history of 
mental disorder were considered a separate category when dummy-coding the maternal 
mental disorder variable. 
 
5. RESULTS 
5.1. Comparison of the participants and non-participants 
Within the HeSVA VLBW cohort (n=255, Figure 7), I first compared those participants 
who had data available from the 1st clinical visit (n=157, Study IIa) with those who were 
not included in the analytic sample because of non-participation or missing data ("drop-
outs", n=92) (comparison A). Next, again among VLBW cohort, I compared those 
participants who had data available from the 2nd clinical visit (n=104, Study I, IV, or IIb) 
with drop-outs (n=127; among these 127 were the 96 cohort members who were not even 
invited to the 2nd clinical visit) (comparison B). I excluded all those who were known to 
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have an intellectual disability from these comparisons (n=6). In comparison B, I further 
excluded those with cerebral palsy (n=16) or blindness (n=2), as the cognitive abilities of 
these participants could not be reliably assessed and they were thus excluded in studies I 
and IV. Data on sex, gestational age at birth, birth size, maternal smoking and pre-
eclampsia, parental education, and neonatal complications in both the drop-out and 
analytical groups were available for these comparisons. In comparison B, I also compared 
mental health questionnaire scores from the 1st visit, and nutrition in infancy, which was 
retrieved from hospital records for individuals who participated in the 1st visit. The drop-
outs were more likely than the analytical sample to have mothers who smoked during 
pregnancy (32% vs 19% [p-value=0.03] in comparison A, and 29% vs 17% [p-
value=0.045] in comparison B), but no other differences between the analytic samples 
and the drop-outs were observed (p-values>0.11). 
Within the AYLS cohort, I compared those late preterm infants who were included in the 
analytic sample (n=108, Figure 8) with drop-outs (n=188). I excluded those with 
intellectual developmental disability (n=8) or congenital malformations or chromosomal 
abnormalities (n=11) from these comparisons. Between the analytic sample and attrition 
group, I found no differences in sex, gestational age, parental education, or age at 
childhood follow-ups; weight, length, or head circumference at birth or childhood follow-
ups; maternal age, diabetes, hypertensive disorder, or smoking during pregnancy; parity 
or multiple pregnancy; or infant Apgar scores, ventilation treatment, septicaemia, 
convulsions, or apnoea (p-values>0.07). Compared with the analytic sample, the attrition 
group had mothers with a higher pre-pregnancy BMI (mean=23.1 vs 21.8, p-
value=0.002) and received less breastfeeding (22%, 48%, 30% vs 7%, 61%, 31% never 
breast-fed, breast-feeding discontinued by 5 months, and breast-fed at 5 months, 
respectively, p-value=0.01). Compared with the analytic sample, the adults who 
participated in the adult follow-up in some way but were excluded because no growth 
data or data on the outcomes studied in this thesis were available (n=42, Figure 8) were 
slightly older during the adult follow-up (mean=25.5 vs 25.2 years, p-value=0.048), but 
I found no differences in cognitive, school, or mental health outcomes or maternal mental 
disorder (p-values>0.15). 
The exact number of drop-outs and participants with data available for these 
comparisons varied, and more detailed information is presented in the publications in 
the appendix.  
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Although recruitment for the HeSVA and AYLS cohorts overlapped geographically and 
partly in time (year 1985), none of the participants included in any of the studies in this 
thesis were part of both (HeSVA and AYLS) samples. 
5.2. Growth, cognitive functioning, and GPA (Studies I and III) 
Among both the VLBW and the late preterm participants, faster growth during the first 
months of life was associated with better cognitive functioning in adulthood.  
Among the VLBW individuals (Figure 9), faster growth from birth to term was associated 
with higher IQ and better visual and verbal flexibility and visual memory scores, but not 
with impulsivity component scores. Weight, length, and head circumference were all 
associated with these outcomes, however head growth was most consistently associated 
with neurodevelopment, especially after adjusting for neonatal complications and 
illnesses. Growth between term and 12 months CA was not associated with cognitive 
functioning. 
Among late preterm individuals (Figure 10), faster growth from birth to 5 months was 
associated with better general cognitive ability, executive functioning score, and GPA, but 
not with the general memory function score. Head growth between 5 and 20 months CA 
was also associated with better general cognitive ability and GPA. Growth after 20 
months CA, or growth in length during any of the examined periods was not associated 
with the adult outcomes. Adjustment for pregnancy-related and neonatal factors 
produced only small changes in the regression coefficients. Faster growth from birth to 5 
months was also associated with lower odds of receiving special education (OR=0.59 
[95% CI 0.36–0.97], and OR=0.49 [95% CI 0.28–0.88], per one SD unit faster weight 
and head growth, respectively): these effects, too, remained statistically significant and 
similar in magnitude after adjustment for pregnancy-related and neonatal factors (data 
shown in more detail in the appendix, Study III). 
The pattern of findings in the two cohorts was quite similar, including the magnitude and 
direction of the observed effects, the role of growth soon after birth rather at later time 
periods, and the persistence of associations after adjustment for neonatal complications. 
Within the VLBW group, I tentatively also examined whether very preterm birth (n=89) 
vs moderately or late preterm birth (n=14) and growth interacted in predicting cognitive 
outcomes, but found no evidence of any consistent differences between the two groups. 
In the only two cases where interactions were statistically significant (p-values<0.05 in 
model 1): 1) the main associations between weight gain from birth to term and verbal 
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flexibility was not statistically significant in either group (p-values>0.21), and 2) the 
association between length growth from birth to term and IQ was statistically significant 
among the very preterm (p-value=0.001) but not the moderately/late preterm group (p-
value=0.16), however after adjusting for neonatal complications the associations were 
attenuated to non-significance (p-values>0.06). 
The associations between growth and cognitive functioning were not limited to those with 
poor growth in utero. In the VLBW cohort, AGA/SGA status and growth did not 
significantly interact in predicting any of the cognitive outcomes (all p-values for 
AGA/SGA-status x growth interaction >0.05 in model 1). In the late preterm cohort, 
faster head growth from birth to 5 months CA was associated with higher GPA among 
those with the largest head circumference at birth (effect size 0.56 SD [95% CI 0.08–
1.04], n=31, head circumference >0.5 SD), but not among those in the middle third (effect 
size 0.34 SD [95% CI −0.04–0.73], n=31, head circumference between −0.2 and 0.5 SD) 
or among those with the smallest head circumference at birth (effect size 0.27 SD [95% 
CI −0.12–0.67], n=29, head circumference <−0.2 SD) (p-value for interaction 0.023).  
The associations between early growth and cognitive functioning were similar among 
women and men. Within the VLBW cohort, one statistically significant interaction 
between sex and head growth from term to 12 months in predicting visual memory was 
observed (p-value for interaction 0.008), however there were no significant main effects 
of growth during this period on visual memory among males or females (p-values>0.13). 
Otherwise, I observed no interactions between sex and growth in either cohort (p-
values>0.05, model 1). 
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5.3. Growth and mental health (studies II and III) 
Early growth was not consistently associated with mental health outcomes in either of 
the cohorts. Table 5 presents associations between growth and mental health outcomes 
in both cohorts. Only one statistically significant effect was observed among the large 
number of analyses, perhaps reflecting chance: among the late preterm cohort, faster 
head growth between 20 and 56 months was associated with less total and internalizing 
problems on the ASR scale, even after adjusting for neonatal and pregnancy factors and 
maternal mental health (effect sizes -0.30 and -0.33, respectively, 95% CI -0.66 to -
0.004).  
Table 5. Growth in weight, head circumference, and length in early childhood and mental 
health outcomes in young adulthood among VBLW and late preterm adults.  
 Weight Head circumference Length 
 OR β (95 % CI) OR β (95 % CI) OR β (95 % CI) 
VLBW cohort         
 Birth to term         
    ASR Total Problems  -0.05 (-0.28, 0.17)  -0.03 (-0.24, 0.18) -0.06 (-0.28, 0.17) 
    BDI sum score  0.01  (-0.19, 0.20)  -0.06 (-0.23, 0.11) 0.03 (-0.16, 0.21) 
    CES-D sum score  0.05 (-0.14, 0.24)  0.04 (-0.14, 0.22) 0.08 (-0.10, 0.27) 
    APQ sum score  -0.07 (-0.26, 0.12)  -0.02 (-0.19, 0.16) 0.05 (-0.12, 0.23) 
  Term to 12 months         
    ASR Total Problems  -0.02 (-0.26, 0.22)  -0.18 (-0.48, 0.13) 0.02 (-0.25, 0.30) 
    BDI sum score  -0.08 (-o.26, 0.10)  -0.11 (-0.33, 0.11) 0.07 (-0.12, 0.26) 
    CES-D sum score  0.00 (-0.18, 0.18)  0.03 (-0.19, 0.25) 0.04 (-0.15, 0.24) 
    APQ sum score  0.13 (-0.06, 0.31)  0.07 (-0.18, 0.31) 0.10 (-0.10, 0.29) 
Late preterm cohort         
 Birth to 5 months         
    ASR Total Problems  0.09 (-0.13, 0.32)  -0.02 (-0.25, 0.20) 0.08 (-0.14, 0.29) 
    Mental disorder 0.75  (0.47, 1.19) 0.76  (0.47, 1.24) 0.81  (0.52, 1.28) 
  5 to 20 months         
    ASR Total Problems   0.02 (-0.21, 0.25)  -0.10 (-0.34, 0.15) 0.08 (-0.16, 0.33) 
    Mental disorder 0.92  (0.58, 1.46) 0.63  (0.37, 1.08) 0.93  (0.56, 1.52) 
  20 to 56 months         
    ASR Total Problems  -0.14 (-0.38, 0.10)  -0.28 (-0.54, -0.02) 0.12 (-0.12, 0.37) 
    Mental disorder 0.87  (0.50, 1.53) 0.92  (0.53, 1.59) 1.31  (0.71, 2.40) 
 
The table shows change in mental health questionnaire scores in standard deviation units and the 
odds ratio for receiving a diagnosis of a at least one common mental disorder (mood, anxiety, or 
substance disorder) based on a psychiatric interview, per one standard deviation faster growth 
in weight, head circumference, and length during each time period. Associations are adjusted for 
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gestational age, sex, age at follow-up visits, and highest education of a parent (Model I in Studies 
I and III). Age was corrected for prematurity at 5, 12, and 20 months. 
Abbreviations: APQ: Adult Problem Questionnaire; ASR Total Problems: Achenbach System of 
Empirically Based Assessment Adult Self Report Total Problems Score; BDI: Beck Depression 
Inventory; CES-D: Center for Epidemiological Studies Depression Scale; CI: confidence interval; 
OR: odds ratio; VLBW: very low birth weight 
I found no evidence that faster growth would offer any mental health benefits specifically 
after prenatal growth restriction. In the VLBW cohort, faster head growth from birth to 
term was associated with more frequent depressive symptoms (CES-D scores increased 
by 0.61 SD units per one SD faster head growth [95% CI 0.13 to 1.09]) among those born 
SGA for head circumference, but not among those whose head circumference was above 
-0.2 SD (p-value=0.16) (p-value for interaction 0.001); a similar interaction (p=0.047), 
but no statistically significant main effects were observed for BDI scores. Otherwise, I 
observed no statistically significant interactions between birth size and any measure of 
postnatal growth in predicting mental health outcomes (p-values>0.05). 
5.4. Nutrition and cognitive functioning (study IV) 
Among the VLBW participants, higher energy intake during the initial hospital stay was 
associated with higher IQ and better Visual memory (Figure 11). For example, 10 kcal 
more energy per kilogram of bodyweight per day at age 3 to 6 weeks was associated with 
0.21 SD higher IQ at 25 years (Figure 11). Details concerning the source of energy can be 
found in the appendix: while the associations between energy intake at 3 to 6 weeks and 
cognitive functioning appeared to be due to energy from carbohydrates and fat and 
human milk, protein intake seemed to predict neurodevelopment slightly earlier, during 
the first three weeks of life. 
However, after adjusting for neonatal complications, there were no independent 
associations between nutrition and adult IQ (Figure 11). The only remaining statistically 
significant association was that between higher energy intake during the first three weeks 
and higher Visual memory, but any speculations based on this single association among 
the several that were tested seems ill-advised. Overall, IVH seemed to be the main down-
driver of the effect sizes, associated with both lower energy intakes during each of the 
studied periods and with poorer IQ (p-values <0.04). Those with longer ventilator 
treatment, BPD, blood exchange transfusion, and PDA also had lower total energy 
intakes, but although mean IQ's were slightly lower in those with these complications, 
compared  with  those  without  the  complications,  the  differences  were  not  statistically  
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significant (p-values>0.12). Associations between total energy, human milk, 
carbohydrate, protein, or fat intakes and IQ did not vary according to birth weight SD 
scores or to sex (p-values for interactions >0.06). 
 
6. DISCUSSION 
6.1. Strengths and limitations of the study 
6.1.2. Strengths 
The main strengths of the study include the long follow-up of VLBW and late preterm 
individuals to adulthood and validated and extensive outcome data. The detailed data on 
prenatal and background factors, early growth, nutrition, and health are exceptional for 
such a long follow-up. The similarity of the results among both VLBW and late preterm 
individuals provide mutual support, suggesting that the findings represent true 
associations rather than chance. 
Individual performance on different neuropsychological tests is quite highly correlated 
and, many would argue, heavily influenced by general cognitive ability - this means that, 
for example, the estimates of IQ and of executive functioning that were used in this thesis 
are hardly separate from each other. In situations where the studied associations or 
outcomes are not independent, but rather reflect different aspects of the same 
phenomena, there is no consensus over the optimal method of formally adjusting for the 
number of statistical tests, and one can argue that correction for multiple testing is overly 
cautious and may hide true associations. Thus, I chose to boil down the outcomes to some 
key components and show the regression coefficients with 95% confidence intervals, to 
give the reader the best possible opportunity to evaluate the pattern of findings.  
Unlike the majority of previous studies, I used the standardised residual approach to 
model growth,441,442 and feel this is a study strength. The conditional growth variables 
used in this study represent infants' deviation from their expected body size, based on 
their own previous measures, in relation to the growth of the other individuals of the 
cohort. This approach enabled me to look at growth as the change in body size that could 
not be explained by earlier growth, and thus to address the concern that any results could 
have been altered or explained by the background effects of earlier growth patterns.  
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6.1.2. Limitations 
Although not exceptional for long-term follow-up studies that require active 
participation,443 the rate of attrition is in my opinion the main limitation of this study. 
Those whom I could not include because of non-participation or missing data differed 
from the analytic samples in some ways: in the HeSVA, but not in the AYLS cohort, the 
mothers of the drop-outs were more likely to have smoked during pregnancy, whereas in 
the AYLS cohort, the mothers of the drop-outs had higher pre-pregnancy BMI and were 
less likely to have breast-fed their child, compared with those in the analytic samples. 
Although the drop-outs and the analytic samples did not differ from each other based on 
any other available data, loss of follow-up may cause selection bias and impact the 
generalizability of the results, perhaps most likely to the less healthy and more 
disadvantaged individuals. Further, the number of participants may hinder the detection 
of small-scale effects, and did not allow me to study many potentially interesting 
subgroup-specific effects, such as the effects of postnatal growth among participants with 
specific prenatal or postnatal complications, or the possible mediating effects of nutrition 
within the most severely ill of the VLBW individuals.  
Moreover, although mental health data included well-validated self-report 
questionnaires in both cohorts and structured diagnostic interviews in the late preterm 
cohort, these do not provide a window into all aspects of mental health, whose underlying 
mechanisms seem to vary according to the outcome in question. Less common 
psychiatric problems and illnesses such as schizophrenia or other psychotic disorders, for 
example, were entirely outside the scope of this study. Although our findings suggested a 
link between growth and ASD related traits and performance in tests of executive 
functioning, but not between growth and self-reported ADHD-related symptoms or 
impulsivity, diagnosed neuropsychiatric disorders could not be assessed.  
As always, the risk of residual confounding remains, and one must also be cautious when 
generalizing the results of adult follow-up studies to current neonates. Our participants, 
born in 1978-1986, may not be representative of preterm infants born in high-income 
settings today, where pre- and postnatal care have improved. For example, in the VLBW 
cohort, the nutritional intakes of the participants fell well below currently recommended 
levels especially during the first few weeks of life, and the participants showed 
considerable variation in early growth - also something of a study strength. Further, I was 
not able to evaluate the potential effects of corticosteroid administration, which would 
have been interesting since this treatment, which gained acceptance in the 1980s and 
1990s, may influence both growth, neurodevelopment, and neonatal morbidity. 
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Conclusions cannot be drawn regarding the term-born fetus or child, either: any 
discrepancies or similarities between the preterm and term-born populations were 
beyond the scope of this study. 
Although the volumes of maternal milk intake were recorded in detail, we did not have 
data available on any individual variation in milk composition, and thus had to estimate 
the nutrient content of the milk based on previous research on lactating mothers of 
preterm infants. Further, some data were only available in one of the two cohorts: for 
example, size at term was unavailable and could not be reliably interpolated for the AYLS 
participants.  
In the HeSVA cohort, only one non-verbal subtest of the WAIS-III, Block design, was 
used: the estimate of performance IQ may be less reliable than that of verbal IQ, but the 
other test data support the interpretation that performance on both verbal and non-
verbal tests is associated with early growth. The possible effects of parental cognitive 
ability on the studied associations were not addressed directly: parental education was 
used as a proxy of socioeconomic background.  
In an era when neonatal cerebral ultrasound was just being introduced, over 70% of our 
VLBW participants underwent the scan: a strength for an adult follow-up, yet a limitation 
in comparison to modern-day cohorts where cerebral ultrasound has widely become 
routine practice. Further, imaging techniques today are much more sophisticated than 
during the time when these preterm adults were born, and severe forms of IVH are rare, 
whereas more subtle signs of brain damage are worryingly common.293 Future studies 
may be able to link neonatal cerebral abnormalities with adult outcomes much more 
precisely than what is now possible.  
I did not test mediation in models where growth would mediate the effects of nutrition 
or where nutrition would mediate the effects of neonatal illnesses, on adult outcomes, for 
theoretical and practical reasons. In our data, there was the problem of temporal overlap 
that makes statistical assessment of mediation especially problematic: nutritional intakes 
were recorded simultaneously with the growth measures that were associated with 
cognitive functioning, and neonatal illnesses are also concentrated in those early weeks.  
Growth can certainly reflect nutrition, but it can also, in a sense, affect nutrition, since 
nutritional targets are determined based on the size of the infant. Further, both nutrition 
and growth can be affected by morbidity, and the rarity of these morbidities makes 
building complicated mediation models in small study samples difficult.  
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6.2. Implications of the findings  
In this study, faster growth soon after preterm birth was associated with better cognitive 
functioning in adulthood. The pattern on findings, including the size and direction of the 
effects was similar in both the VLBW and the late preterm cohorts. Head growth, in 
particular, seemed important in predicting adult cognitive functioning. In the late 
preterm cohort, those who grew faster also received less special education and had better 
grades in their comprehensive school leaving certificate, compared with those who grew 
more slowly.  
I did not find that just one specific aspect of cognitive functioning would be affected. 
Rather, early growth was reflected on performance across a number of 
neuropsychological tests that measure general cognitive ability, verbal and non-verbal 
reasoning, visuo-motor performance, executive control, and working memory. Further, 
the associations were not limited to performance in tests that require participants to 
adhere to strict time limits and perform quickly, suggesting that the associations were not 
explained by just differences in processing speed. However, in the VLBW cohort, it 
appeared that growth was associated with performance in tasks that rely on visuo-spatial 
processing and memory, while in the late preterm cohort the memory index score was 
not as clearly associated with growth. Further, it seemed based on the VLBW data that 
measures of impulse control and selective and sustained attention, unlike many other 
aspects of cognitive ability, were not associated with early growth. It is possible that these 
findings are explained by some subtle, uneven pattern of cognitive deficits associated 
with poor growth. It would be tempting to hypothesise that these differences reflect 
sensitivity periods for the developing brain: attention and impulse control in particular 
are closely related to the late-maturing prefrontal cortex, and differences between the late 
preterm and VLBW cohorts might reflect differential vulnerability during different time 
periods. Furthermore, differences observed between the two cohorts could relate to the 
methods we used to assess cognitive functioning. Even if memory functions were intact, 
problems in visuo-motor functioning could cause slow-growing VLBW infants to perform 
poorly in tasks that measure both visual memory and visuo-motor performance, whereas 
the memory index score that was calculated for the late preterm participants was based 
on tests that are more strictly focused on memory functions. However, these remain 
speculations. I feel that based on these findings and the previous studies discussed in the 
literature review, there is not enough evidence to say that early growth would be 
associated with some specific aspects of cognitive ability, and not others. 
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In contrast to cognitive and school outcomes, the effect size, direction, or confidence 
intervals of the associations between growth and mental health outcomes did not suggest 
any systematic associations in either cohort. In this thesis, I examined growth in relation 
to self-reported depressive and ADHD symptoms, diagnosis of depression, anxiety 
disorder, or substance use disorder, and overall psychosocial adjustment. These results 
support the hypothesis that the mechanisms underlying preterm birth and cognitive 
vulnerability are at least partly different from those that underlie preterm birth and the 
risk of common mental health problems.367 However, poor early growth was associated 
with some autism-spectrum traits in this cohort,391 suggesting that some mental health-
related neurobehavioural outcomes may be susceptible to the early insults that affect 
general cognitive ability. Further, the findings on mental health outcomes are interesting 
in light of the earlier, somewhat conflicting evidence regarding the associations between 
fetal growth restriction and mental disorders. They further encourage researchers to 
examine the early outcome-specific underlying mechanisms behind differential 
vulnerability to neurodevelopmental and psychiatric morbidity, while taking carefully 
into account potential confounders such as maternal characteristics.  
Of course, these follow-up data can only hint at potential causal pathways between early 
growth and adult cognitive functioning. Our results highlight the importance of an early 
vulnerable period after preterm birth, when the interruption of development in the 
normal protective intrauterine environment may alter brain maturation and growth 
through an interplay of early morbidity, nutrition, care, and individual susceptibility. In 
this study, higher nutritional intakes during the first weeks of life were associated with 
better performance during neuropsychological assessment, however these associations 
seemed to be largely intertwined with neonatal morbidities, which can affect both growth, 
nutrition, and neurodevelopment. Clinical recommendations concerning neonatal 
nutrition cannot be made based on these results. The results are in line with the many 
nutritional intervention studies that have had little lasting impact on neurodevelopment, 
and support the hypothesis that early differences in energy, human milk, and 
macronutrient intakes at the NICU may mediate the effects of neonatal morbidity on 
neurodevelopment, rather than independently alter its course.  
However, the neonatal morbidities I examined did not entirely explain the associations 
between growth and neurodevelopment, suggesting that other factors also underlie the 
connection. Gestational age, the most important determinant of morbidity among the 
preterm participants did not explain the associations, nor did manifest intellectual 
disability or neurosensory impairment, as participants with these conditions were 
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excluded. The effects were no more pronounced among those who were born small for 
gestational age, indicating that environmental factors during the growth period, rather 
than catch-up growth after previous growth restriction underlay the associations. 
Moreover, adjustment for a multitude of background factors, such as pregnancy-related 
factors and parental education produced only small changes in the results, further 
suggesting that a multitude of environmental factors during the early postnatal period, 
rather than just prenatal adversity, could alter both growth and long-term 
neurodevelopment. What these factors are remains unknown. 
Preterm birth, and the risk of hospitalisation and complications that follow, can form a 
stressful starting point not only for the life of the preterm infant him- or herself, but also 
for the family. In addition to any subsequent illness or nutritional regime, the disruption 
of early interaction with parents, as well as the noise, pain and other exceptional 
environmental stimuli that come with NICU life may alter both growth and 
neurodevelopment. One observational study among VLBW adults found that even after 
taking into account a number of potential confounders including SES, a good parent-
infant relationship was associated with a 5-point increase in adult IQ.289 In line, an 
increasing number of interventions are used to improve the interaction between the 
parent and the preterm infant and to reduce early stress. For example, these include 
sensitising the parent to the infant's cues, reduction of noise at the NICU, and increasing 
skin-to-skin contact, and despite methodological problems such as large heterogeneity 
between interventions and difficulties in randomization, the beneficial effects of these 
interventions seem to extend beyond infancy and into school-age.444 It is not that the 
mothers of preterm children would be less sensitive or responsive towards their children 
(they are not, as a recent meta-analysis reported),445 but rather that all infants - including 
preterm ones446 - benefit from interactions with parents that are positive, warm, and 
sensitive, and promoting these interactions could help compensate for early adversity. It 
will certainly be interesting to see whether these interventions could offer a persisting 
benefit for adult cognitive outcomes. 
It has been suggested that biological factors such as neonatal complications have an 
important role in explaining early and severe cognitive impairments, while the 
importance of the family and social environment is more pronounced when looking at 
more subtle differences in childhood, adolescence, and adulthood. However, the 
environment and the genetic build-up of the individual are inescapably intertwined and 
distinguishing "biological" effects from "social" or indeed "environmental" ones is a 
daunting task and, even more importantly, probably less fruitful than studying the 
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interactions between the two. In this study, I was unable to look at potential genetic and 
epigenetic factors which could affect the phenotype of these individuals, including growth 
trajectories, neurodevelopment, or even preterm birth and early morbidity, but these 
would be interesting to examine.  
Some have argued that increasing the rate of early growth after preterm birth presents a 
trade-off between improved neurodevelopment and poorer cardio-metabolic health, but 
I have not found convincing evidence for such a trade-off, based on the current or 
previous research. There is no clear evidence that faster growth during early infancy 
among a population of whom the majority experience at least some degree of growth 
failure would have significant detrimental effects on adult cardio-metabolic health, when 
the confounding effects of immaturity and IUGR are taken into account, however it would 
seem that faster growth is associated with neurodevelopmental benefits. In contrast, 
rapid weight gain and particularly the accumulation of fat in disproportion to other 
measures of growth later on in childhood and in adolescence may increase the risk of 
cardio-metabolic morbidity and are unlikely to offer neurodevelopmental advantages in 
return, however studies on these phenomena among preterm adults specifically are 
scarce.447 Of course, adult outcomes can only be examined among populations who were 
born much before the current standard of care. As infants, these individuals received, 
arguably, less adequate levels of nutrition, were more prone to several severe neonatal 
illnesses, and experienced high rates of early growth restriction compared with the 
preterm infants in today's high-income settings. Those of our cohort members who grew 
faster may have been the ones healthy enough to come close to today's recommended 
rates, but it is hardly plausible that accelerating early growth indefinitely beyond fetal 
growth rates would be beneficial. 
6.3. Conclusion 
Faster growth during the first weeks and months of life after preterm birth is associated 
with better cognitive functioning, and these associations persist into adulthood. While 
these findings suggest that early environmental factors could alter long-term 
neurodevelopment, the mechanisms explaining these associations are unclear, and seem 
outcome-specific. Early intakes of nutrients may reflect or possibly even mediate the 
effects of neonatal morbidity on neurodevelopment, however the neonatal morbidities 
commonly associated with preterm birth that were evaluated in this thesis do not wholly 
account for the associations between early growth and cognitive functioning in 
adulthood. Further studies are warranted to unravel why some preterm individuals are 
110 
 
vulnerable to subtle neurodevelopmental deficits and mental health problems while 
others remain resilient - and whether new kinds of targeted interventions during this 
critical early time period could compensate for the long-lasting risks associated with 
preterm birth. 
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